Regulation of the IGK Locus and B Cell Development by Taylor, Benjamin James Miles Taylor & Taylor, Benjamin James Miles Taylor
 
 
REGULATION OF THE IGΚ LOCUS 
AND 
B CELL DEVELOPMENT 
 
 
 
 
by 
Benjamin James Miles Taylor 
 
 
 
 
 
 
A thesis submitted to Imperial College London 
for the degree of Doctor of Philosophy 
 
 
MRC Clinical Sciences Centre 
Imperial College London 
September 2008 
 
2 
 
Abstract 
 
Allelic exclusion coupled to lineage and stage specific regulation ensure the Igκ locus 
undergoes RAG mediated V-J recombination only at the small pre-BII stage of 
lymphocyte development. These mechanisms also ensure the final antigen receptor is 
monospecific and allow self-specific receptors to be recognised and altered at later stages 
of development. Allelic exclusion is controlled by mechanism involving either epigenetic 
based allele selection early in development or probabilistic activation of a single allele at 
the small pre-BII stage. Current models favour the probabilistic model based on an 
elegant GFP reporter system. We present a reappraisal of this models based on an 
absence of the originally detected probabilistic activation. We find the absence to be 
explained in part by an aberrant splice event generated by developmentally regulated 
Igκ germline promoter usage. The activity of the promoter was investigated using in-vitro 
models of critical events during the B cell development but their role remains elusive. 
Intense investigation for the last 20 years has determined that chromatic regulation 
underpins the stage and lineage specification of rearrangement. The protein factors 
responsible for this regulation remain unknown. Using transgene reporters of cis-acting 
sequences and in-vitro model systems of B cell development, we find an involvement for 
members of the zinc finger family of Ikaros transcription factors, IRF4 and LEF1. We 
determined a bipartite role for Ikaros whereby its activity could both suppress 
rearrangement prior to pre-BCR signalling and promote rearrangement thereafter, 
possibly through an IRF4 based mechanism. Finally we present evidence for a role for 
Ikaros protein in later stages of B cell development. We find modulation of Ikaros activity 
directly influences the ability of cells to differentiate to the plasma cell fate. We used a 
transgenic model to allow genome-wide mapping of the transcriptional events regulated 
by Ikaros and find multiple small modulations of factors and pathways.   
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Chapter 1: Introduction 
1.1 REGULATION OF GENE EXPRESSION  
1.1.1 Chromatin 
There are between 20,000-25,000 gene in the genome, which after alternative splicing, 
post translational modification and modulation by protein interactions, account for many 
more protein activities (Orphanides and Reinberg, 2002; Human Genome Sequencing, 
2004). A central question for biology is how expression of these genes, in addition to the 
multitude of non-coding RNAs essential for regulation and biological function, are 
controlled so that progressive activation and silencing allows pluripotent embryonic 
stem (ES) cells to undergo lineage restriction to give cells with unique patterns of 
euchromatic and heterochromatic associated gene. The mechanisms of transcriptional 
regulation require that these patterns of association are passed to daughter cells on 
division to ensure stable inheritance of lineage restriction.  
DNA is packaged by wrapping 146 bases around the histone octamer, composed of 
histone H2A, H2B, H3 and H4 (Luger et al., 1997). The nucleosome forms the base unit of 
chromatin, the mix of protein and DNA that composes the nucleus. Arrays of 
nucleosomes ~100bp apart are further compressed by the linker histone H1, from the 
10nm nucleosomal ‘beads on a string’ into the 30nm fibre which undergoes still further 
looping and coiling which has not yet been fully resolved, but which are important for 
gene regulation as they form areas refractory to transcriptional activity (Woodcock and 
Dimitrov, 2001; Loden and van Steensel, 2005). The nucleosome itself blocks access to the 
DNA sequence which is required by the transcriptional machinery and therefore have to 
undergo either removal, unfolding or displacement (Imbalzano et al., 1994; Boeger et al., 
2003). Not only is access to the promoter region of genes required for transcriptional 
initiation, the chromatin downstream requires removal for transcriptional elongation 
(Orphanides and Reinberg, 2000). The Imbalzano study demonstrates an important 
control point for chromatin structure, that nucleosome remodelling, in this case by SWI-
SNF, can expose DNA to allow binding of sequence specific factors, in this case the 
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TATA-box binding protein, which allows transcription initiation. Sequence specific DNA 
binding transcription factors either bind nucleosomal DNA or are allowed access to DNA 
sequence by ATP-dependent chromatin remodelling enzymes, such as SWI-SNF, which 
continually shuffle nucleosomes to fleetingly expose target sequences (Felsenfeld and 
Groudine, 2003). Once bound, these factors act as nucleation sites for controlling 
nucleosome density and chromatin structure, through the recruitment of co-
activators/repressors which have nucleosome remodelling or DNA and histone 
modification activity (Orphanides and Reinberg, 2002). Covalent histone modifications 
can influence chromatin structure directly or can act as docking sites for further 
enzymatic activities and also provide the framework for inheritance of expression 
patterns. The gene promoter regions contain sequence specific binding sites for multiple 
factors and coupled with the multiple targets of histone modifications associated with the 
promoter, allows considerable diversity in factors controlling genes, so that many genes 
can respond uniquely to a signalling pathway (Orphanides and Reinberg, 2002).  
Histone modifications are covalent additions predominately on the unstructured histone 
amino terminal ‘tails’ which protrude outwards from the histone octamer. These 
modifications can be acetylation, methylation or phosphorylation and occur on an ever 
increasing number of histone tail residues. There are additional modifications, including 
ubiquitination, SUMOylation, and ADP-ribosylation, but the function of these is still not 
completely resolved (Kouzarides, 2007). These modifications are dynamic and we know 
many of the enzymes required for their acquisition and removal. Histone acetylation and 
methylation modifications are the best characterised with regards to gene transcription 
and the enzymes responsible for these marks fall into groups dependent on activity, with 
acetylation and methylation catalysed by Histone acetyltransferases (HATs) and histone 
methyltransferases (HMTase) and removal by histone deacetylases (HDAC) and the 
recently discovered group of histone demethylating enzymes. There is an expanding list 
of histone modifying enzymes, each with their own specificity, which allows spatial and 
temporal control of histone modifications. Histone modifications form docking sites, 
with the combination of marks forming the ‘histone code’ which is read by transcription 
factors to drive changes in accessibility and transcriptional activity (Strahl and Allis, 
2000). In addition to histone modification, DNA itself is modified through methylation of 
14 
 
cytosine of CpG dinucleotides by DNA methyltransferases (Dnmts). This is associated 
with transcriptional repression, as Methyl-CpG binding proteins (MBP) can recruit 
suppressive HDACs and HMTase activity to further block transcription (Fuks et al., 
2003).  
Proteins containing a bromodomain bind acetylated histone groups, while methylation is 
bound by chromodomains and PHD finger domain. Many chromatin modifying 
enzymes either contain these domains or are found in larger activatory or repressor 
complexes containing these domains and other chromatin modifier activities. The 
complexes of these factors and binding moieties allows combined control of histone 
modification and chromatin structure (Narlikar et al., 2002; Kouzarides, 2007). This is 
exemplified by the repressive Nucleosome Remodelling and Deacetylase (NuRD) 
complex. NuRD contains HDACs and the Mi-2 remodelling components which has a 
PHD finger and chromodomain and this complex can be recruited by the sequence 
specific transcriptional repressor, Ikaros (Xue et al., 1998; Kim et al., 1999). Modifications 
can interact with each other and promote formation of new sites by recruitment of 
factors, or block other modification and events by preventing certain factors binding, 
such as histone H4 lysine 4 (H3K4) methylation, which is found at transcriptionally 
active promoters and which can block the binding of the repressive NuRD complex and 
Suv39h1 mediated deposition of repressive histone H3 lysine 9 methylation (H3K9me) 
(Zegerman et al., 2002; Lee et al., 2005). While histone methylation can activate or repress 
transcription dependent on the position, histone acetylation is associated with active 
transcription. It is thought acetylation directly impacts on chromatin structure as it 
neutralises the charged lysine which can affect both histone-DNA contact as well as 
internucleosomal contacts important for higher order packaging (Kouzarides, 2007). This 
is exemplified by acetylation of H4K16 which prevents nucleosome arrays forming the 
30nm fibre (Shogren-Knaak et al., 2006). The link between acetylation and transcription is 
further strengthened by the finding that many HATs are associated with general 
transcription factors, while HDACs are found in complexes with transcriptional 
repressors (Narlikar et al., 2002).  
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ATP-dependent chromatin remodelling factors differ in mechanism and composition. 
They can slide nucleosomes, loop DNA out from nucleosomes, or replace histone 
subunits. The alterations in composition of cofactors allows targeting of remodelling 
complexes to specific genes, where they can mediate repression or activation of 
transcription (Kornberg and Lorch, 1999; Saha et al., 2006). Three families of remodelling 
complexes are defined by the ATPase subunit; these are the SWI-SNF, the ISWI and the 
Mi-2 families (Narlikar et al., 2002). The SWI-SNF family contains ATPase subunits with 
bromodomains, such as human BRG1 and drosophila BRM, and disrupts histone-DNA 
contacts and disorders regularly spaced nucleosomes to create accessible DNA and 
promote gene expression (Chi, 2004). The ISWI ATPase (SNF2h in humans) functions as 
part of the RSF, ACT or CHRAC remodelling complexes and rather than disrupting 
histone-DNA contact, ISWI remodelling causes nucleosome sliding, which can either 
expose or mask sequences but maintains an ordered nucleosome array along DNA. The 
Mi-2 ATPase contains both a chromodomain and PHD finger and is found as part of the 
larger NuRD complex. The NuRD complex also contains MBPs which target the complex 
to methylated DNA, allowing the associated HDAC and nucleosome remodelling 
activity to further suppress transcription. In addition to its role in repression, Mi-2 has 
been shown to promote activation, which may be directed through interaction other than 
with NuRD (Fujita et al., 2004; Williams et al., 2004). 
The nucleus can be divided into areas of differing DNA staining, first discovered by Emil 
Heinz in 1928 (Heitz, 1928; Passarge, 1979). The heterochromatic fraction describes areas 
of dense DNA staining, which has condensed DNA and is refractory to transcription, and 
euchromatin describes areas of light DNA staining, which is constituted of decondensed 
DNA with high transcriptional activity. These differences are generated at the 
nucleosome organisational level, with digestion with Micrococcal nuclease (MNase), 
which cleaves internucleosomal DNA, leading to an ordered pattern of nucleosomes 
from heterochromatin but a smear from the random nucleosome distribution in 
euchromatin (Cryderman et al., 1999). This has been supported by chromatin 
immunoprecipitation (ChIP) studies in yeast which, building on many years of locus 
specific experiments, have shown active genes have low nucleosome density promoters, 
while silent genes have high nucleosome density promoters (Bernstein et al., 2004; Lee et 
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al., 2004). However, this separation is actually more complex, as Bickmore and colleagues 
demonstrated in a microarray study. DNA was separated on the basis of density and 
found that while the general premise was true, there was a significant proportion of 
active genes in high density heterochromatic regions, while the low density euchromatic 
regions correlated tightly with gene rich areas that contained both active and inactive 
genes (Gilbert et al., 2004). This apparent paradox can be resolved when histone 
modifications are taken into account, which are more robustly associated with 
transcriptional status and can be used to define different subtypes of chromatin. 
1.1.2 Chromatin proteins and post translational histone modifications 
Euchromatin is characterised by a number of distinctive features. As mentioned, it has 
high gene density with actively transcribed genes associated with low nucleosome 
density which allows high accessibility to nuclease cleavage. Actively transcribed genes 
within this compartment are associated with particular histone modifications. A recent 
ChIP microarray study has given a genome wide view to what had previous been locus 
specific observations. Bernstein et al., demonstrated that both H3 and H4 are 
hyperacetylated in actively transcribed genes, and these modification correlate with 
H3K4 methylation at the 5’ end of the gene (Bernstein et al., 2005). Histone lysine 
methylation can be either mono, di or tri (me1,  2 or 3), and studies in S. cerevisiae have 
associated H3K4me2 with euchromatin domains of both active and inactive genes while 
H3K9me3 was restricted to active promoters (Santos-Rosa et al., 2002). The Bernstein et 
al., 2005 study showed that in mammalian cells, H3K9me2 is found in the vicinity of 
active genes, while H3K4me3 is preferentially located at the transcriptional start sites, 
with strong enrichment in active genes. At three loci, Bernstein et al., further 
demonstrated that high levels of H3K4me3 are coincident with the RNA polII initiation 
complex, further strengthening the relationship between this mark and transcriptional 
potential. H3K4 methylation can be catalysed by all members of mammalian MLL family, 
which is the homologue of Drosophila Trithorax and yeast Set1 (Ruthenburg et al., 2007). 
H3K79 methylation is also linked to active transcription in mammalian cells, and studies 
on the β-globin locus have shown a correlation between gene activity and this 
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modification (Im et al., 2003; Lee et al., 2005). In both yeast and mammals 
hypomethylation of H3K79 has been associated with silencing of certain loci (Ng et al., 
2003). 
Transcription also correlates with deposition of histone variants. H3.3 differs from H3 by 
four residues and this small change allows both replication dependent and independent 
deposition compared to the strictly replication dependent deposition of histone H3 
(Ahmad and Henikoff, 2002). H3.3 deposition correlates with active transcription, and 
this replacement may allow rapid removal of repressively methylated H3 (Janicki et al., 
2004). Studies in yeast have shown that a second variant, H2A.Z, plays a redundant role 
with nucleosome remodelling enzymes SWI-SNF (Santisteban et al., 2000). H2A.Z 
appears to mark the 5’ region of many yeast genes, regardless of their transcriptional 
activity (Raisner et al., 2005). However, studies in mammalian cells are not so clear cut, as 
H2A.Z localised with Heterochromatin Protein 1α (HP1α) containing heterochromatin 
foci (Fan et al., 2004), whereas genome wide analysis co-localised H2A.Z with the 
insulator CTCF, which marks the boundary between repressive and active regions 
(Barski et al., 2007). 
Heterochromatin can be split into the constitutive and facultative subgroups. 
Constitutive heterochromatin describes areas of strong DNA staining in the nucleus 
which remain condensed during interphase. These regions are permanently silent, 
nuclease insensitive, and are generally composed of gene-poor repeats, such as the 
mouse centromeric γ satellite region. Heterochromatin helps stabilise these centromer 
repeats by preventing homologous recombination (Grewal and Moazed, 2003). These 
areas are repressive to transcription as shown by their ability to induce position effect 
variegation (PEV). This phenomenon, first described in Drosophila, causes genes inserted 
next to centromeric repeats to undergo silencing, which is initiated in a variable number 
of cell and clonally inherited, leading to variegation of expression in tissue (Schotta et al., 
2003). Epigenetic marks of constitutive heterochromatin include high levels of H3K9me3, 
H3K27me1, H4K20me3, and hypomethylation of H3K4 (Peters et al., 2003; Rice et al., 
2003; Schotta et al., 2004). Other features include methylation of DNA and histone 
hypoacetylation, DNA methylation and late replication during S phase (Arney and 
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Fisher, 2004). These various modifications do not occur independently but form a self-
enforcing network to ensure establishment of a full contingent of repressive 
modifications. This is shown by the finding that H3K9me3 leads to recruitment of Dnmts 
and establishment of CpG methylation, which then provide binding sites for other 
repressive complexes, including HDACs and chromatin remodelers (Lehnertz et al., 2003; 
Fuks, 2005). The H3K9me3 modification is established by Suv39h1,2 enzymes (Peters et 
al., 2003; Rice et al., 2003). This mark is recognised by the chromodomains of HP1, which 
drives its enrichment at mouse centromeric repeats (Bannister et al., 2001; Lachner et al., 
2001). HP1 recruits Dnmts and can bind itself and Suv39h, which is thought can create a 
self sustaining loop and to allow heterochromatic to spread to adjacent nucleosomes 
(Nielsen et al., 2001; Maison and Almouzni, 2004). This spread is the underlying cause of 
PEV and both Su(var)3-9 and HP1 were identified as modifiers of PEV in Drosophila 
(Schotta et al., 2003) while HP1 has been shown to influence PEV in mammalian cells 
(Festenstein et al., 1999).  
A surprising additional factor in development of HP1 mediated ‘silent’ heterochromatin 
is RNA. RNaseA treatment disrupts HP1 localisation and H3K9 methylation (Maison et 
al., 2002) and transcripts from centromeric repeats have been detected which increase on 
loss of H3K9me3 and HP1 localisation (Rudert et al., 1995; Lehnertz et al., 2003). In S. 
pombe, deletion of components of the RNAi machinery resulted in loss of H3K9 
methylation, centromeric heterochromatinization, and accumulation of sense and 
antisense transcripts from the centromeric repeats (Hall et al., 2002; Volpe et al., 2002). 
The latter finding suggested a model where the opposing transcripts form dsRNA which 
are recognised by the RNAi machinery which recruits silencing complexes to promoter 
H3K9 methylation and subsequence heterochromatinization. A possible link between 
RNA and silencing complexes is also suggested by HP1, which can bind RNA through 
the hinge region (Muchardt et al., 2002). RNAi is thought to have developed as a 
mechanism to suppress potentially mutagenic transposable elements, from which the 
heterochromatic repeat sequences derive (Lippman and Martienssen, 2004), and 
tethering the RNAi silencing machinery to an actively transcribed gene resulted in gene 
silencing and establishment of heterochromatin modification (Bühler et al., 2006). In 
Drosophila, RNAi components are modifiers of PEV and deletion also caused loss of 
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H3K9 methylation and HP1 localisation (Pal-Bhadra et al., 2004). The RNAi machinery is 
conserved throughout evolution and in higher organisms, human chromosome 21 
harboured in a Dicer (a core component of the RNAi machinery) deficient chicken DT40 
line showed similar mis-regulation of centromers (Fukagawa et al., 2004) as did dicer 
deficient mouse ES cells (Kanellopoulou et al., 2005). However, results from our 
laboratory and others have questioned the role of RNAi in heterochromatin in mammals. 
A second dicer deficient cell lines showed a similar increase in centromeric transcripts to 
the Kanellopoulou study, but the chromatin structure and modifications remained 
unchanged (Murchison et al., 2005). Maintenance of centromeric heterochromatin in 
developing thymocytes did not require Dicer (Cobb et al., 2005), and dicer deficient 
mouse oocytes show no increase in expression or DNA methylation of repetitive 
elements (Tang et al., 2007). Additionally, a transgenic repetitive array which undergoes 
HP1 mediated heterochromatinization was shown not to produce siRNA from the repeat 
sequences, was unaffected by gene knockdown of Dicer, and activation of the locus could 
not be suppressed by ectopic siRNAs (Wang et al., 2006).  
Facultative heterochromatin describes areas of euchromatin which have undergone 
silencing during development. It forms the basis of cellular memory as this silencing is 
maintained on cell division. Division proceeds through semi-conservative mechanisms 
and nucleosomes are randomly distributed to newly synthesised strands which would 
allow the combination of histone modifications and DNA methylation to re-establish the 
pattern of repression in daughter cells (Annunziato, 2005). 
Epigenetic modifications indicative of facultative heterochromatin include H3 and H4 
lysine hypoacetylation and H3K4 hypomethylation around promoter regions which are 
replaced by H3K9me2 and H3K27me3, the latter of which are mediated by the Polycomb 
group (PcG) of silencing proteins (Arney and Fisher, 2004). H4K20me1,2 show a 
punctated pattern throughout euchromatic regions of interphase nuclei, which may 
represent facultative heterochromatin and in support, H4K20me1 is enriched on the 
inactive X chromosome which strongly correlates this mark with silencing (Schotta et al., 
2004). DNA methylation, although not a conserved mark throughout evolution, is 
thought to be involved in stabilisation of long term silencing through establishment or 
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maintenance of facultative heterochromatin (Jaenisch and Bird, 2003). The importance of 
DNA methylation is highlighted by the continual requirement of DNA methylation to 
maintain correct regulation of the inactive-X chromosome and imprinted genes (genes 
which are expressed only from one parental allele) (Jaenisch and Bird, 2003), and in 
maintaining cytokine silencing in developing thymocytes (Makar and Wilson, 2004; 
Wilson et al., 2005). Carcinogenesis is also associated with alterations in DNA 
methylation, as silencing of potential tumour suppressors correlates with 
hypermethylation of CpG islands in their promoter regions (Baylin and Ohm, 2006). The 
importance of all these factors is shown by the cytokine IL4 which requires a 
collaboration between DNA methylation, HMTases and transcription factors to establish 
and maintain silencing during thymocytes maturation (Makar et al., 2003). 
The X chromosome has provided an archetypal model for facultative chromatin, as in 
females one entire chromosome is randomly chosen to undergo silencing early in 
embryogenesis to ensure dosage compensation (Wutz and Gribnau, 2007). X-inactivation 
is mediated by the non-coding RNA Xist, which is expressed from the X chromosome 
(Brockdorff et al., 1991). During establishment of the inactive-X (Xi) in differentiating ES 
cells, expression of Xist is first blocked by Tsix, the antisense partner of Xist, which 
directs DNA methylation to the Xist promoter (Sun et al., 2006). The mechanism 
controlling choice of which chromosome undergoes inactivation is not clear, but the 
underlying mechanism could reveal clues about other monoallelic controlled genes, such 
as the immunoglobulin and T cell receptor genes during lymphopoiesis (Cedar and 
Bergman, 2008). Once this choice is made, Tsix is silenced on the future Xi allowing Xist 
upregulation, which then coats the Xi and induces silencing. At the active-X (Xa), Tsix 
expression is maintained and continues to directs methylation and silencing of the Xist 
promoter on this chromosome (Lee and Lu, 1999; Sun et al., 2006).  
Once established, the Xi chromosome has specific repressive epigenetic marks, including 
loss of histone acetylation and H3K4 methylation and acquisition of H3K9me2, 
H3K27me3, H3K20me, accumulation of the histone variant macroH2A and late 
replication (Payer and Lee, 2008). MacroH2A is thought to maintain the repressive state 
by providing increased internucleosomal contacts and blocking binding of transcription 
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and chromatin remodelling factors (Trojer and Reinberg, 2007). Methylation of promoters 
also correlates with silencing of the Xi but recent genome wide studies of methylation 
patterns have suggested that methylation of the gene bodies could follow the opposite 
pattern (Hellman and Chess, 2007). These studies showed that while hypermethylation of 
the promoter regions on the Xi was observed, the Xa had a higher gene body methylation 
pattern than the Xi and there have been suggestions that gene body methylation could be 
involved in dampening of transcriptional noise (Suzuki and Bird, 2008). The H3K27me3 
mark at promoter regions is established by an Xist mediated transient recruitment of the 
PcG complex, Polycomb Repressive Complex 2 (PRC2). This complex contains Eed, 
which can interact with HDACs (van der Vlag and Otte, 1999), and the H3K27 HMTase, 
Ezh2 (Cao et al., 2002) which can recruit Dnmts (Vire et al., 2006), and the activity of Eed-
Ezh2 PRC2 is essential for stabile silencing of the X chromosome (Plath et al., 2003; Silva 
et al., 2003). PcG proteins are involved in silencing of many developmentally regulated 
genes through formation and maintenance of facultative heterochromatin, which has 
been highlighted by genome wide studies in ES cells (Boyer et al., 2006; Lee et al., 2006). 
PRC2 is thought to establish silencing as in addition to H3K27 methylation, it can block 
chromatin remodelling by SWI-SNF and transcription in-vitro (Levine et al., 2004). Once 
the H3K27me3 mark has been established, it serves as a binding site for the 
chromodomain of Polycomb which is a member of the PRC1 maintenance complex 
(Trojer and Reinberg, 2007). Components of PRC1 are also localised through Xist 
interaction (Bernstein et al., 2006b), and there is evidence that PRC1 and HP1-Suv39 
machinery can interact to maintain silencing (Levine et al., 2004). The ability of HP1 to 
induce facultative heterochromatin was demonstrated by HP1 recruitment to 
transcriptionally active genes which resulted in heritable silencing (Ayyanathan et al., 
2003).  
Although the histone modifications associated with X-inactivation and gene specific 
silencing are similar, the formation of facultative heterochromatin on specific genes may 
follow alternative pathways. Formation of facultative heterochromatin requires sequence 
specific DNA binding protein, chromatin remodelling and HP1 or PcG proteins (Craig, 
2005) and there may be strict temporal order of factor binding (Cosma, 2002). An 
example of temporal order of silencing has been given through studies on the Dntt locus 
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(which encodes TdT) during thymocytes maturation (Su et al., 2004). Ex-vivo and 
transformed immature thymocytes can be induced to differentiate by in-vitro treatment 
with antigenic signal, which results in rapid silencing of Dntt. This silencing is stable in 
ex-vivo cells after 8 hours of treatment, but remains reversible in the transformed cell 
lines. In both cell types, silencing is nucleated by H3K9 deacetylation and the locus 
shows a decrease in accessibility within six hours and by 12 hours, the promoter 
undergoes H3K4 demethylation and H3K9 methylation. The reason for the stability of 
silencing maybe due to the bidirectional spread of H3K9 deacetylation and methylation 
at the locus, which was only seen in ex-vivo cells. DNA methylation did not appear to 
relate to stability of inheritance in this system, as it only occurs much later in 
development.  
To complicate the distinction between euchromatin and heterochromatin, there are also 
areas of bivalent chromatin in ES cells which display both H3K4 and PcG dependent 
H3K27 methylation. These domains are found at many developmentally regulated genes 
and this led to ideas that bivalency may allow these genes to be kept in a ‘poised’ state 
(that is, capable of transcription but blocked from doing so) before resolution during 
development (Azuara et al., 2006; Bernstein et al., 2006a). However, recent work using 
high throughput genome wide techniques have demonstrated bivalency also exists in 
differentiated cells, and some bivalent genes are those that undergo rapid developmental 
activation, suggesting bivalency as a general mechanism for maintaining genes in a 
‘poised’ state (Roh et al., 2006; Barski et al., 2007)  
1.1.3 Higher organisation of chromatin 
In addition to the sequence specific regulation of promoter regions, there is increasing 
evidence that regulation can occur through higher orders of chromatin structure. These 
can be long range interactions in cis, and through trans interactions through 
compartmentalisation of the nucleus (Fisher and Merkenschlager, 2002). Gene enhancer 
regions are located far from the transcriptional start site, from hundreds of bases in yeast 
to hundreds of kilobases in higher organisms, and show high levels of DNA binding 
protein and sensitivity to nuclease digestion (Dean, 2006). Classical examples include the 
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locus control regions (LCR) of β-globin and CD2. These regions can overcome 
heterochromatin mediated gene silencing and can be used to allow expression of 
transgenes buried within centromeric repeat regions (Festenstein et al., 1996; Kioussis and 
Festenstein, 1997). The β-globin locus contains four genes, the embryonically expressed 
εy and βh1, and adult erythroid expressed β major and β minor, with an LCR located 6-
60kb downstream. The LCR hypersensitive sites (HSS) have unique patterns of histone 
modifications and form sites for binding of transcription factors which allow formation 
of open domains of chromatin and nuclease accessibility which encompasses all the gene 
in the locus (Bulger and Groudine, 1999). In addition to the chromatin structure 
modulation, particular HSSs are capable of participating in direct transcriptional 
activation, and deletion of one HSS in the β-globin LCR allowed retention of open 
chromatin but blocked transcriptional activation (Reik et al., 1998). There are ideas of 
looping mechanisms, whereby the LCR HSSs function by making contact with the 
promoter to drive transcriptional activation, with support from the chromosome 
conformation capture (3C) technique that maps regions of DNA which physically 
interact (Tolhuis et al., 2002). The 3C results at the β-globin locus have given a more 
complete picture of locus control, as while nuclease accessibility and chromatin 
modifications are equivalent across the locus during development, expression is 
controlled by differential interactions of HSSs. Prior to expression, several HSSs interact 
to form a ‘poised’ hub, while in adult erythroid cells, β major, β minor and further HSSs 
are recruited to these hubs which correlates with expression (Palstra et al., 2003). RNA-
tagging and recovery of associated proteins (RNA-TRAP) is a Fluorescence in-situ -
hybridisation (FISH) based technique which causes an affinity tag to be deposited on a 
protein in proximity to elongating RNA. Results from RNA-TRAP support findings of 
differing LCR structures, as several hypersensitive sites were found to be in close 
proximity to the actively transcribed β major and β minor genes but not the silent 
embryonic genes (Carter et al., 2002). Similar loops have been found in other loci, such as 
the Th2 cytokine locus by Richard Flavells laboratory (Spilianakis and Flavell, 2004).  
Looping mechanisms are also found at the antigen receptor genes and this is thought to 
be a mechanism to bring distal regions together prior to recombination. Recently, 3D 
FISH was used to map the distances between two probes along the Immunoglobulin 
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Heavy Chain locus and mathematical extrapolation was used to determine the three 
dimensional relationship between the regions (Jhunjhunwala et al., 2008). The results 
from this study showed a condensation into a rosette like structure during development 
which brought together many distal regions prior to recombination. These results build 
on an earlier studies of both the heavy and light chain loci which showed these loci 
undergo contraction during B cell development (Liu and Garrard, 2005; Roldan et al., 
2005). 
The interphase nucleus is compartmentalised with each chromosome forming its own 
territory, and there is a preference for gene rich areas to cluster in the interior and gene 
poor regions to cluster in the exterior of the nucleus (Cremer et al., 2006). The periphery 
of the nucleus appears to be a repressive area, and in yeast, tethering of a reporter genes 
to the nuclear envelope resulted in silencing (Andrulis et al., 1998). There is evidence that 
many actively transcribed genes are looped out of the chromosome territories, into what 
could be transcriptional factories, areas of high density of transcriptional activators and 
machinery (Chambeyron and Bickmore, 2004; Gilbert et al., 2004). FISH studies of the 
MHC locus demonstrated that formation of a large loop coincided with the expression 
status of the genes contained in the loop (Volpi et al., 2000). Interestingly, work from 
Branco et al., demonstrate that chromosomes ‘intermingle’ at the surface of the territories, 
and this decreases on stimulation and increased transcriptional activity of human 
lymphocytes (Branco et al., 2008).  
Centromeric heterochromatin form clusters in the nucleus which undergo dynamic 
regulation during development and are thought to create repressive areas which can 
influence gene expression (Terranova et al., 2005). Studies in lymphocytes have shown 
many developmentally regulated genes undergo changes in nuclear position, with 
silencing correlating with repositioning to such heterochromatic foci (Brown et al., 1997; 
Brown et al., 1999; Skok et al., 2001; Kosak et al., 2002). Using 4C (unbiased 3C analysed by 
microarray) Simonis and colleagues showed inactive genes from different chromosomes 
physically group together, while active genes from different chromosomes also form 
contacts with each other (Simonis et al., 2006). The role of this clustering and recruitment 
to centromeric heterochromatin is not clear, but may help stabilise repression or 
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expression by bringing genes into areas high in silencing or activation factors, 
respectively (Fisher and Merkenschlager, 2002). Evidence to support an active role of 
repositioning in gene silencing has been provided by analysis of gene positions in models 
of PEV. Insertion of a satellite repeat region into the Drosophila Brown eye colour gene 
caused inactivation. However, this inactivation was dominant negative and in 
heterozygous cells, silencing of the wild type allele was caused by recruitment of both 
the mutant and wild type allele to constitutive heterochromatin. This suggested 
regulation of higher orders of chromatin regulation could control gene expression 
(Dernburg et al., 1996). The study of the Dntt locus has also linked reposition and 
silencing. Stimulation of ex-vivo cells resulted in repositioning of the Dntt locus to 
heterochromatic foci prior to the bidirectional spreading of heterochromatic marks and 
acquisition of stable silencing, but relocation did not occur in the transformed cell line 
which did not undergo stable silencing (Brown et al., 1999; Su et al., 2004).  
1.1.4 Ikaros, a complex haematopoietic transcriptional regulator  
Ikaros is a transcription factor expressed in lymphocytes and early haematopoietic cells 
and has been implicated in regulation through a variety of mechanisms involving direct 
regulation, interactions with co-repressors, and alterations of higher order chromatin 
structure. Ikaros, a relative of the repressive Drosophila Hunchback protein, was 
discovered through a screen for factors activating expression of CD3δ and repression of 
Dntt (which encodes TdT) during thymocytes maturation (Lo et al., 1991; Georgopoulos 
et al., 1992; Hahm et al., 1994). Ikaros is composed of a four zinc finger N-terminal DNA 
binding domain and a two zinc finger C-terminal dimerisation domain, and while it 
preferentially binds DNA as a dimer, a mutation in the dimerisation site has 
demonstrated that monomeric Ikaros can bind DNA and localise to the nucleus (Molnar 
and Georgopoulos, 1994). Ikaros mRNA undergoes alternative splicing to produce five 
isoforms in lymphocytes (Ikaros 1-5, figure 1.1) which differ in their composition of zinc 
fingers, while additional isoforms have been identified in myeloid and erythroid tissue 
(Molnar and Georgopoulos, 1994; Sun et al., 1996; Payne et al., 2003). All isoforms possess 
the dimerisation domain and while only zinc finger two and three are required for DNA 
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binding, high affinity DNA binding requires addition of zinc finger one or four. Only 
Ikaros 1 and 2 have the capacity to drive nuclear localisation of either homo or 
heterodimers. In-vitro studies on dimeric binding substrates showed heterodimers 
between full length isoforms and a mutant isoforms lacking the entire DNA binding 
domain, cannot bind DNA, leading to ideas that shorter isoforms without the DNA 
binding domain could act as dominant negative proteins in-vivo. It was further shown 
heterodimers between the full length and the truncated protein lacking the DNA binding 
domain were still competent to localise to the nucleus, suggesting that multimerisation 
occurs to allow these heterodimers to bind DNA and target the nucleus (Sun et al., 1996). 
Regulation of activity through control of alternative splicing has been suggested, as 
differing predominant isoforms were detected in different lymphoid tissues (Molnar and 
Georgopoulos, 1994), and differing homodimers show differential binding to target genes 
in in-vitro assays (Hahm et al., 1994). 
Early studies of Ikaros placed it as a transcriptional coactivator, through its ability to 
drive expression of reporter constructs carrying CD3δ promoter (Georgopoulos et al., 
1992) or tetrameric Ikaros binding sites (Sun et al., 1996). Sun et al., used deletion analysis 
to define the activation domain as a stretch of acidic and stretch of hydrophobic residues 
within the 5’ portion of exon seven. However, this activation domain does not appear to 
function in the full length protein. Rather than directly activating transcription, Ikaros 
 
 
Figure 1.1 Ikaros Isoforms. 
DNA binding zinc finger shown as red ellipse and dimerisation zinc fingers shown as 
blue ellipse. Adapted from Molnar and Georgopoulos, 1994. 
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enhances the activity of other transcriptional activators in a process which requires DNA 
binding and heterochromatic localisation, but not direct binding of the promoter 
(Koipally et al., 2002). A model was suggested where activation was induced by Ikaros 
relocating repressive complexes away from the promoter to other sites, allowing binding 
of transcriptional activators. However, the ability of Ikaros to directly promote 
transcription was supported by studies on the CD8 locus in developing thymocytes. 
Ikaros physically associated with the CD8 HSSs in-vivo only when the CD8 locus was 
accessible and expressed, was required for CD8 expression during thymocytes 
development and Ikaros deficient mice did not efficiently activate CD8 (Harker et al., 
2002).  
While the role of Ikaros as a potential activator still remains controversial, its role as a 
transcriptional repressor is accepted. The first ideas of Ikaros as a repressor arose when 
Brown et al., showed that Ikaros undergoes dynamic association with HP1/γ-satellite 
centromeric heterochromatin in interphase (Brown et al., 1997). Further, immuno-FISH 
staining showed that in two stages of B cell development, six developmentally regulated 
genes associated with Ikaros only when repressed, with no association when active. The 
association of Ikaros with pericentromeric heterochromatin was shown to be dynamic, as 
in resting B and T cell Ikaros was diffuse throughout the nucleus, but upon activation, 
the majority of Ikaros associated with these foci, which were also actively replicating 
areas of chromatin (Wang et al., 1998; Avitahl et al., 1999). Avitahl et al., further showed 
that disruption of Ikaros activity resulted in significant chromosomal aberrations during 
replication, suggesting Ikaros as a potent tumour suppressor. In an extension to the 
original study, Brown et al., demonstrated that in primary resting mature B and T cells, 
active and silent genes were found in euchromatic locations, and stimulation of these 
cells resulted in a relocation of silent genes to the Ikaros-pericentromeric foci (Brown et 
al., 1999). It was suggested that Ikaros could recruit these genes to pericentromeric foci 
and such relocation could be a general feature of heritable gene silencing in lymphocytes, 
as a T cell line which failed to relocalise the Dntt locus also failed to stable silence 
expression.  
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Direct evidence for repression was shown by tethering Ikaros to a reporter gene by a 
heterologous DBD (Koipally et al., 1999). Interestingly, the repression appeared cell type 
dependent, with B cells showing stronger repression than T cells, suggesting cell specific 
interacting partners can influence Ikaros activity. Further clues to the mechanism of 
Ikaros gene suppression were provided by a yeast-two hybrid screen using Aiolos (a 
member of the Ikaros family) as bait (Kim et al., 1999). This screen found Aiolos was 
contained in two chromatin remodelling complexes in T cells. The majority of Aiolos, and 
also Ikaros, were contained in a Mi-2/NuRD HDAC and chromatin remodelling complex 
which underwent an Ikaros dependent localisation to pericentromeric foci on cell 
activation. This complex could also be immunoprecipitated with full activity by Ikaros 
antibodies (Kim et al., 1999). Mi-2 interactions have also been found in Drosophila with 
Hunchback (Kehle et al., 1998). The ability of Ikaros to directly target pericentromeric 
heterochromatin, rather than being recruited by interacting partners, was shown when 
extensive mutagenic and deletional analysis demonstrated that Ikaros can bind the 
satellite repeat sequences of mouse centromers, and that this binding was essential for 
pericentromeric localisation in cells (Cobb et al., 2000). The targeting was not influenced 
by other factors, as Mi-2 did not localise with pericentromeric heterochromatin or ectopic 
Ikaros in the fibroblast cell line used for analysis. This also suggested other factors are 
required for Mi-2-Ikaros interactions. The binding of the satellite repeats raises the 
possibility that Ikaros can target genes to centromeric regions by multimerisation of 
dimers bound to the targets and satellite regions. Multimerisation of Ikaros was 
supported by finding that Ikaros elute over a broad peak by gel filtration, suggestive of a 
large heterogeneous complex (Hahm et al., 1998). Studies of pericentromeric targeting 
have also deconstructed the idea of shorter Ikaros isoforms acting as dominant negative 
proteins (Trinh et al., 2001). The authors showed overexpression of a short Ikaros isoform 
lacking the DNA binding domain (previously been shown to heterodimerise with full 
length Ikaros), did not block preferential binding of full length homodimers to targets in-
vitro, and did not block targeting of either full length or the short isoforms to 
pericentromeric heterochromatin. The authors concluded full length Ikaros at the 
pericentromeric repeats would therefore bind as the preferred homodimer, meaning that 
only multimerisation could allow targeting of the short isoforms to the repeats. Thus, 
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short Ikaros isoforms do not appear to block full length dimeric Ikaros DNA binding but 
may interfere with multimerisation. 
Kim et.al, identified a second Ikaros complex composed of SWI-SNF/Brg-1, implicating 
Ikaros in gene activation. This complex also localised with the small proportion of 
euchromatic localised Ikaros in activated T cell (Kim et al., 1999). The euchromatic 
localised Ikaros may also be associated with another distinct repressive complex 
containing the Sin3 co-repressor and its associated HDACs (Koipally et al., 1999). Ikaros 
can also mediate an HDAC independent repression through binding the co-repressors, 
C-terminal binding protein or CtIP-Rb, which can bind and potentially interfere with the 
activity of the basal transcriptional machinery (Koipally and Georgopoulos, 2000; 
Koipally and Georgopoulos, 2002) 
At specific loci, Ikaros has been found to target promoter sites and be essential for 
repression. The mechanisms of repression are beginning to be understood and at the Igll1 
and Dntt locus, several layers of repression occur. The Dntt promoter contains a tandem 
Ikaros binding site, one of which overlaps the activator of the locus, Elf-1 (Ernst et al., 
1996). A reporter transgene containing the promoter region of Dntt, demonstrated that 
the tandem Ikaros binding sites are essential for suppression during thymocytes 
development, and that simultaneous binding of Ikaros and Elf-1 was not possible. These 
factors compete for binding, suggesting that controlling binding to the locus during 
development could control transcription (Trinh et al., 2001). Trinh et al., also 
demonstrated Ikaros suppression results in a decrease in nuclease accessibility at the 
locus, and as has been discussed, while factor competition and chromatin remodelling 
can induce silencing, the Ikaros associated relocation of the locus during development 
allows establishment of permanent heritable repression. At the Igll1 locus (which encodes 
λ5), Thompson et.al., showed that a similar competition arises between the activator EBF, 
and Ikaros. Overexpression of either resulted in subsequence activation or repression 
respectively, and in mice deficient for Aiolos, Igll1 repression was reduced (Thompson et 
al., 2007). This study also demonstrated that during development, increasing Aiolos 
levels compete with EBF to drive suppression of Igll1. This follows earlier studies which 
demonstrated that the tandem Igll1 Ikaros binding site was essential for developmental 
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repression, and that a transgene carrying a mutation in one binding site, lost repression 
during development even when targeted into heterochromatin foci (Sabbattini et al., 
2001). However, the latter study found that although Ikaros binding and centromeric 
localisation are required for silencing, DNA methylation and nuclease accessibility 
analyses did not show heterochromatinization occurring, suggesting Ikaros does not 
always induce a complete set of silencing activities. 
Ikaros is expressed early in haematopoiesis so that to developmentally regulate genes, its 
activity requires modulation. We have already seen that Ikaros is associated in different 
complexes and that different isoforms or family members can aid in targeting Ikaros to 
different binding sites and control activity. Developmentally regulated 
expression/activity of any of these factors could therefore help control Ikaros regulation. 
Additionally, three studies have demonstrated that Ikaros can undergo post translational 
modification to control activity, providing a mechanism for cell signalling and activity to 
control Ikaros mediated gene repression. Ikaros activity blocks cell cycle progression but 
undergoes dissociation from DNA during mitosis, which also suggests that any control 
over stable gene expression will be in initiation rather than maintenance (Dovat et al., 
2002). Two studies have demonstrated that Ikaros regulation during the cell cycle is 
dependent upon phosphorylation by CKII, GSK3 and cdks. These phosphorylation 
events reduce the affinity of Ikaros for DNA, allowing cell cycle progression (Dovat et al., 
2002; Gomez-del Arco et al., 2004). Ikaros can also undergo SUMOylated on two sites, 
which interfere with interactions with Mi-2, Sin3 and CtBP co-repressors. However, these 
modifications did not affect pericentromeric localisation and did not affect interactions 
with activatory Brg-1, which could therefore allow direction between repressive or 
activatory activity (Gomez-del Arco et al., 2005). 
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1.2 B CELL DEVELOPMENT 
B cell development is characterised by a series of signalling checkpoints which control a 
set of gene regulatory networks. These checkpoints are essential as the B cell lineage 
undergoes potentially carcinogenic genomic rearrangement events to produce the mature 
antigen receptor. Strict regulation ensure these occur in a sequential manner, with 
rearrangement at the Immunoglobulin heavy chain (IgH) locus occurring before the 
Immunoglobulin light chain (IgL) locus (preferentially at Igκ over the Igλ). The 
checkpoints occur at the end of each rearrangement to test for functionality and finally, to 
avoid self-specificity. In the mid 1960s, immunofluorescence staining of mature plasma 
cells lead to the realisation that each cells produces antibodies of only one allotype, 
leading to ideas of allelic exclusion (Pernis et al., 1965). This process ensures in each cells 
only one allele undergoes rearrangement at a time, so that in each cell, only one heavy 
chain and one light chain is expressed, allowing generation of a monospecific B cell 
receptor (BCR).  
1.2.1 From the HSC to the B cell 
The development of the lymphocyte compartment is a hierarchical restriction of cell fates 
descending from the multipotent haematopoietic stem cell (HSC), commonly defined 
using the surface markers Lin-Sca-1hic-Kithi (LSK). HSCs, which themselves develop from 
the mesodermally derived hemangioblast (Huber et al., 2004), are a heterogeneous 
compartment of cells comprised of long term repopulating HSCs (LTR-HSCs) which self 
renew indefinitely, and short term repopulating HSCs (STR-HSCs) which have lost this 
capacity. The clearest experimental definition of HSC comes from repopulation 
experiments, where cells are injected into irradiated or immunocompromised hosts. STR-
HSCs allow formation of spleen colonies or repopulation of haematopoietic populations 
(erythroid, lymphoid and myeloid) for less than 5 months whereas LTR-HSCs repopulate 
all haematopoietic compartments indefinitely. Using these classification, the first 
definitive LTR-HSC cells are generated as early as embryo day (E) eight in the 
splanchnopleura and E10 in the aorta-gonad-mesonephors (AGM) embryo body tissue 
(Cumano et al., 2001) with more significant generation from E10.5 in the placenta and 
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AGM (Medvinsky and Dzierzak, 1996; Gekas et al., 2005; Ottersbach and Dzierzak, 2005). 
These cells can then colonise other tissues, including the yolk sac and foetal liver (FL). At 
E11, the FL becomes the major site of LTR-HSC colonisation, with this microenvironment 
supporting a large expansion of LTR-HSC numbers between E12 to E16 (Ema and 
Nakauchi, 2000; Takeuchi et al., 2002). Near birth, haematopoiesis shifts to the bone 
marrow (BM) and spleen where it is maintained throughout adult life. 
HSC development is directed by an expression cascade originating from Runx1, a 
homologue of the drosophila Runt protein. Ablation of this factor results in embryo 
death at E11.5 caused by complete failure of all haematopoiesis (Okuda et al., 1996). 
Expression of Runx1 is dependent on GATA, Ets and SCL factors binding sites in the 
promoter (Nottingham et al., 2007), and the combination of these factors identify HSCs 
and direct lineage potential.  
A central question to immunology has been at which stage of development lineages 
diverge and where final restriction to a certain lineages arises. Recipient transfer 
experiments have been enormously useful in these answering questions as transfer of a 
purified stage of development allows analysis of which compartments this stage can 
generate. When coupled to genetic ablation of particular genes, these experiments allows 
definition of lineage hierarchy and the molecular components required. Differentiation 
from the multipotent HSC begins with loss of long term repopulation ability concomitant 
with CD34 upregulation (Sato et al., 1999). The beginning of lineage restriction comes 
with upregulation of the FMS-like tyrosine kinase 3/Foetal liver kinase 2 (Flt3/Flk2) 
which correlates with an in-vivo, but importantly not an in-vitro, loss of myeloid potential 
(Adolfsson et al., 2001). Flt3/Flk2 upregulation forms an intermediate stage between the 
HSC and the lymphoid restricted, common lymphoid progenitor (CLP), known as the 
Lymphoid primed MultiPotent Progenitor (LMPP) (Adolfsson et al., 2005). Evidence for 
the beginning of lymphoid restriction comes from genetic ablation of the receptor or its 
ligand (Flt3/Flk2 ligand), which result in more pronounced effects on numbers of early B 
and T lineages than the myeloid cells (Mackarehtschian et al., 1995; McKenna et al., 2000). 
Transplant of wild type (WT) BM cells into Flt3/Flk2 ligand-/- irradiated recipients 
showed reduced generation of CLPs, but normal generation of common myeloid 
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precursors (Sitnicka et al., 2002). Interestingly, the mature B and T populations from these 
mice appear normal and functional analysis has suggested that Flt3/Flk2 signalling 
promotes expression of the IL7 receptor (IL7R), which is important for expansion of early 
B and T cell populations but not mature B cell populations (Borge et al., 1999). Loss of this 
proliferative response is seen by reduced cellularity of the IL7 responsive early pre-BI 
and DN T cells in Flt3/Flk2 ligand-/- mice (Sitnicka et al., 2002). Ablation of the IL7R 
results in a similar but more severe phenotype, with only 10% of mature B and T cell 
numbers and severely reduced DN T cell, an absent pre-BI subset and a reduced pre-BII 
population (Peschon et al., 1994). 
Ikaros, the founding member of the Ikaros family of Krüppel like zinc-finger protein 
transcription factors, is restricted to the haematopoietic lineage. Ikaros is first expressed 
at the LMPP stage and is required for restriction of these cells towards the lymphoid fate, 
and Ikaros deficient mice show a severe inability of short and long term rescue of lethally 
irradiated recipients (Nichogiannopoulou et al., 1999). Using a GFP reporter for the 
Ikaros enhancer-promoter, Ikaros expression was seen to directly correlate with 
upregulation of Flt3/Flk2 and loss of erythroid potential (Yoshida et al., 2006). It was 
further shown that Ikaros deficient LMPPs failed to upregulate Flt3/Flk2 and IL7R, which 
was postulated as the cause of the inability of these cells to develop into lymphoid 
lineages on in-vitro differentiation (Yoshida et al., 2006). Ikaros null LMPPs were, 
however, sufficient for myeloid differentiation in-vitro, demonstrating that expression of 
Ikaros at this stage is essential for restriction to the lymphoid lineage (Yoshida et al., 
2006). This conclusion is supported by Ikaros null, hypermorphic and dominant negative 
(DN) mutant mice, which show loss/dysfunction of Ikaros correlated with specific 
deficiencies in the B and T cell population rather than myeloid lineages (Georgopoulos et 
al., 1994; Wang et al., 1996; Winandy et al., 1999; Kirstetter et al., 2002). While the Ikaros 
null allele causes loss of all foetal lymphocytes, adults were able to generate a T cell 
compartment, although this was skewed to CD4 T cells which may be due to the 
requirement of Ikaros for CD8 expression (Harker et al., 2002). The DN Ikaros mutation 
resulted in a more severe phenotype with loss of all lymphocytes when homozygous, 
and severe T cell leukaemia when heterozygous, demonstrating Ikaros as a tumour 
suppressor. The reduced severity of the null allele was explained by partial 
34 
 
compensation of activity by the B and T cell restricted Ikaros family member, Aiolos 
(Morgan et al., 1997), and this is supported by the reciprocal finding of mild effects of 
Aiolos deficiency (Wang et al., 1998). The severe phenotype of the DN Ikaros allele is 
caused by its ability to block the activity of all Ikaros family members. Using an EMU 
screen, a mutation in Ikaros was identified which demonstrated the range of 
development in which Ikaros family members are involved; the mutation caused 
embryonic lethality with severe defects in lymphoid, myeloid and erythroid 
development (Papathanasiou et al., 2003). The Plastic mutation from this study is a more 
severe DN mutation caused by a point mutation in the DNA binding domain. Whereas 
the short DN Ikaros isoform used in the Georgopoulos study could localised to 
pericentromeric foci with endogenous Ikaros and Ikaros family members, 
heterodimerisation with the Plastic mutant blocked pericentromeric nuclear localisation 
of all Ikaros family members, abrogating all activity.  
A second factor required for lineage commitment at the LMPP stage is PU.1, which 
belongs to the Ets family of transcription factors and which is only expressed in 
haematopoietic lineages (Galson et al., 1993). PU.1 null embryos show an absence of B, T 
and myeloid cells, and cannot support generation of these cells in transplantation 
experiments (Scott et al., 1997), possibly due to the loss of IL7R expression which PU.1 
directly regulates (DeKoter et al., 2002). Regulation of Ikaros and PU.1 do not appear 
interrelated as transcripts of Ikaros are present in PU.1 null foetal livers, while PU.1 
transcripts are present in Ikaros null LMPP cells (Scott et al., 1997; Yoshida et al., 2006). 
Ablation of Ikaros or PU.1 results in loss of IL7R, suggesting both are required for its 
upregulation. Flt3/Flk2 is present at severely reduced levels in PU.1 null FLs but is 
completely absent in Ikaros null FLs, suggests both these factors are also required for 
efficient upregulation of Flt3/Flk2 and are therefore required for expression of these 
receptors and progression beyond the LMPP stage (DeKoter et al., 2002). In support of the 
requirement, but not sole responsibility of PU.1 for efficient IL7R expression and B 
lineage development, long term culture of PU.1 null FL were found to develop B cell 
progenitors at a severely reduced rate (Ye et al., 2005). The B cell outgrowth from these 
cultures however, showed IL7R expression, a normal B cell transcriptional program and 
were able to differentiate in-vitro to immature B cells. This suggests PU.1 is required for 
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efficient initiation of B cell development but is not required for its maintenance (Ye et al., 
2005). The requirement for PU.1 in initiation but not maintenance of commitment was 
also demonstrated by in-vitro deletion of PU.1 in fully committed CLP cells, which had 
little effect on the ability of these cells to differentiate to B cell progenitors (Iwasaki et al., 
2005). Additionally, in-vivo deletion of PU.1 in committed B cell progenitors 
demonstrated little effect on the ability to generate mature B cells (Iwasaki et al., 2005; 
Polli et al., 2005; Ye et al., 2005). PU.1 protein levels were once thought to regulate the 
myeloid to lymphoid choice, as ectopic expression of high levels in PU.1 null progenitors 
resulted in differentiation of myeloid cells, whilst low expression allowed B cell 
generation (DeKoter and Singh, 2000). Recent studies using a hypermophic allele have 
suggested that rather than controlling differentiation by graded expression, high levels of 
PU.1 are required for generation of both B and myeloid lineages, as reduction of PU.1 
activity by the hypermorphic allele resulted in loss of both lineages (Houston et al., 2007). 
A GFP reporter for PU.1 expression further demonstrated whilst HSC and CLP have 
equal expression of PU.1, B cell development was associated with reducing levels of PU.1 
whilst myeloid differentiation maintained high expression (Nutt et al., 2005), which 
suggests the graded expression of PU.1 occurs after lineage commitment.  
Full lymphocyte restriction occurs with IL7R expression at the CLP stage. CLPs haves 
altered surface morphology, with Lin-Sca-1loc-Kitlo, and show no in-vivo repopulating 
ability of lineages other than B, T or NK and, importantly, in-vitro no differentiation 
towards the myeloid fate (Kondo et al., 1997). These cells also show enhanced kinetics of 
B and T cell generation in repopulation assays compared to HSC, again suggesting they 
are a stage closer to the differentiated state (Kondo et al., 1997). CLPs differentiation 
along the B cell lineage involves hierarchical networks of transcription factors to generate 
a lineage commitment pathway illustrated in Figure 1.2, using the Melchers-Rolink 
nomenclature to describe the B cell stages (Osmond et al., 1998). The pro-B cell is the first 
fully committed B cell, and the combination of surface markers B220, CD19, CD43 and 
the sequential rearrangement of the IgH and IgL delineate the later stages (Hardy et al., 
1991).  
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Specification towards B cell identity is established by PU.1 and Ikaros to efficiently 
generate IL7R CLPs. Further development of the lineage requires the activities of the 
transcription factors, E2A, Early B cell factor (EBF) and Paired box factor 5 (Pax5). The 
basic helix-loop-helix (bHLH) transcription factor E2A comprises two proteins, E12 and 
E47 which are expressed by alternative splicing event from the Tcfe2a gene (Murre et al., 
1989). E2A null mice show absence of only B lineages, with a block at the pro-B stage 
with absence of B cell specific genes and the earliest D-J rearrangements at the IgH locus 
(Bain et al., 1994; Zhuang et al., 1994). Although ubiquitously expressed, E2A activity 
during HSC and LMPP stages could be tempered by the inhibitory Id proteins (Zhuang 
et al., 2004; Murre, 2005). E2A expression is required for upregulation of EBF, an atypical 
bHLH transcription factor, which, although expressed in other tissues, shows complete 
restriction to the B lineage in haematopoiesis (Hagman et al., 1993; Hagman et al., 1995).  
EBF null mice show a similar block in development to E2A null mice (Lin and 
Grosschedl, 1995). Recent work has demonstrated that E2A, PU.1 and IL7 signalling 
 
 
Figure 1.2 Illustration of B cell lineage commitment.  
Key transcriptional regulators, cell markers (expression indicated by bars) and 
rearrangement status of the Ig genes have been shown.  
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contribute to EBF expression (Smith et al., 2002; Ikawa et al., 2004; Medina et al., 2004; 
Kikuchi et al., 2005), EBF activity is also essential for generation of high expression of E2A 
(Zhuang et al., 2004). The cyclical nature of E2A-EBF regulation (Figure 1.2) ensures high 
levels of these two factors, which is important for full commitment to the B cell lineage. 
In support of these factors working in conjunction, double knockout mice show a greater 
effect on B cell lineage than loss of a single factor (O'Riordan and Grosschedl, 1999). The 
Ebf alpha promoter contains, in addition to an E2A site, an EBF binding site allowing 
autoregulation (Roessler et al., 2007). This report also demonstrated that the Ebf beta 
promoter contains binding sites for PU.1 and Pax5, allowing the EBF induced expression 
of Pax5 to feed back to sustain expression of EBF, again ensuring commitment to the B 
cell lineage is met with upregulation and self-sustainment of the transcriptional program 
(O'Riordan and Grosschedl, 1999).   
E2A initiates the final B cell specification program and can drive transdifferentiation of 
alternative lineages (Kee and Murre, 1998), and while early work suggested cooperation 
between E2A and EBF activity on downstream targets (Sigvardsson et al., 1997; 
Sigvardsson, 2000), it is now thought the majority of the E2A effects are mediated 
through upregulation of EBF and resultant activation of Pax5. EBF expression, but not 
Pax5, in E47 null cells was sufficient to restore B cell lineage identity and promote 
expression of all B cell lineage transcripts in the continued absence of E2A (Seet et al., 
2004). However, low levels of alternative E-box proteins were required for continued 
survival of these cells, as ectopic expression of the E-box inhibitory protein Id3, induced 
apoptosis suggesting some compensatory E2A activity is required. 
EBF and E2A can both function through epigenetic mechanisms. The AD1 domain of 
E2A proteins can recruit the HAT activity of p300 and CBP and can repress transcription 
through recruitment of the corepressor family ETO, which interacts with HDACs and 
chromatin remodelling enzymes (Qiu et al., 1998; Bradney et al., 2003; Zhang et al., 2004). 
EBF can drive recruitment away from repressive heterochromatic compartments, shown 
by studies on the nuclear position of an Igll1 transgene and the mb-1 locus (which 
encodes Igα). EBF activity also drives DNA demethylation and chromatin remodelling to 
allow Pax5 mediated transcription activation (Lundgren et al., 2000; Maier et al., 2004). 
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Pax5, which is solely expressed in B cells, binds DNA through an N-terminal Paired 
domain and mediates repression through interactions with the Groucho family of 
corepressors (Eberhard et al., 2000) and can mediate activation through interactions with 
Ets transcription factors, as is found at the mb-1 locus (Fitzsimmons et al., 1996). Pax5 is 
not responsible for specification of the B cell lineage, as Pax5 null mice show a block at 
the pre-BI stage with expression of pre-BCR components and early D-J rearrangement 
events at the IgH locus (Nutt et al., 1997). Pax5 was rather thought to be responsible for 
progression and maintenance of the B cell program and suppression of alternative 
lineage genes. Loss of Pax5 in pre-BI cells allowed them to differentiate in-vitro and in-
vivo into alternative lineages, even though E2A, EBF, PU.1 and Ikaros expression were 
unaffected (Nutt et al., 1999; Rolink et al., 1999) and conditional deletion of Pax5 in pre-BI 
cells resulted in loss of commitment with the ability to differentiate into myeloid and T 
cells but not B cells on transfer to irradiated hosts (Mikkola et al., 2002). Recent evidence 
has altered the sole role for Pax5 in commitment as ectopic expression of EBF in FL 
progenitors suppresses differentiation to lineages other than the B cell in both wild type 
(Zhang et al., 2003) and Pax5 deficient cells (Pongubala et al., 2008), demonstrating Pax5 is 
not required for restriction to the B cell lineage. Transdifferentiation of myeloid 
progenitors to B cells was also more potently enforced by ectopic expression of EBF than 
Pax5 (Pongubala et al., 2008) and EBF but not Pax5 can rescue B cell development in PU.1 
deficient LMPPs (Medina et al., 2004). Thus, it can be seen E2A is responsible for 
specification of the B cell program, and EBF and Pax5 are required for full and continued 
commitment to the B cell lineage. 
There are several other transcription factors which are required for development of the B 
cell lineage whose position on the transcriptional network is not yet fully understood. 
Targeted deletion of the LEF1 high mobility group (HMG) transcription factor, for 
instance, resulted in a severe block at the pre-BI stage of development caused by 
apoptosis of cells and which coincided with the stage it was most abundant (Reya et al., 
2000). Whilst having no transcriptional activity itself, LEF1 is able to bend DNA and act 
as a structural factor allowing development of larger complexes (Giese et al., 1995), and 
interact with β-catenin to allow integration of Wnt signalling (Behrens et al., 1996). Wnt 
signalling has been demonstrated to induce proliferation of pre-BI cells, which was 
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dependent on the presence of LEF1 (Reya et al., 2000). However, Reya et.al demonstrated 
that while the block at the pre-BI stage reduced overall numbers of following 
populations, these populations were normal and showed no further blocks in 
development. Recipient transfer of LEF1 deficient FL cells also allowed development of 
mature B cells, together suggesting LEF1 and Wnt signalling may only be important for 
the expansion of the early B cell compartment.  
1.2.2 IgH rearrangement and pre-BCR signalling  
Following acquisition of all transcription factors required for B cell commitment, pro-B 
cells undergo the first of a series of genomic rearrangement events catalysed by the 
RAG1,2 enzymes (Schatz et al., 1989; Oettinger et al., 1990). These events begin at the IgH 
locus with D-J rearrangements on both alleles in pro-B cells followed by V-DJ 
rearrangement in pre-BI cells (Alt et al., 1984). On completion of rearrangement, the IgH 
μ chain is expressed with Igα, Igβ, and the surrogate light chain (SLC) components λ5 
and VpreB, which allow translocation to the cell surface to form the pre-BCR. This 
complex then signals that a productive rearrangement has occurred (Karasuyama et al., 
1990; Tsubata and Reth, 1990). Signalling through the surface Igµ drives downregulation 
of components involved in rearrangement, such as Terminal Deoxynucleotidyl 
Transferase (Tdt) and the recombinase machinery (Galler et al., 2004), the latter of which 
are also negatively controlled by cell cycle progression, which is induced by pre-BCR 
signalling and requires continued IL7 signalling (Lin and Desiderio, 1993; Lin and 
Desiderio, 1994; Grawunder et al., 1995; Erlandsson et al., 2005). These events ensure that 
only one allele undergoes productive rearrangement to maintain allelic exclusion. The 
importance of these signalling events is highlighted by genetic disruption of the 
transmembrane domain of Igµ which prevents expression on the membrane surface 
(Kitamura et al., 1991). Animals homozygous for this mutation have a complete block at 
the pre-B stage of development while heterozygous animals show allelic inclusion, where 
a proportion of cells show rearrangement and expression of both IgH alleles as there 
were no signals of productive rearrangement from the mutated allele to halt further 
rearrangements (Kitamura and Rajewsky, 1992). 
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While Igµ surface expression and signalling appears essential for allelic exclusion and 
transcriptional changes, the SLC components only appear essential for the proliferative 
burst pre-BCR signalling generated. Around four to five cell division are generated 
which allows clonal expansion of cells with productively rearranged IgH alleles, and is 
followed by exit of the cell cycle and progression to the small pre-BII stage (Decker et al., 
1991; Rolink et al., 2000; Hess et al., 2001). Disruption of λ5 and/or VpreB1/2 results in a 
loss of the proliferative burst which causes a severe block at the pre-BII stage, but no 
further developmental effects (Kitamura et al., 1992; Mundt et al., 2001; Shimizu et al., 
2002). Allelic exclusion of mature B cells was not reported affected by the loss of 
VpreB1,2, λ5 or triple deficient cells. However pre-BI progenitors from λ5 null mice 
showed an apparent increase in allelically included cells which was resolved by the 
mature stage through an unexplained counterselection mechanisms to prevent allelically 
included cells from contributing to the mature population (Löffert et al., 1996). It 
therefore appears that the complete pre-BCR signals for expansion of the pre-BII 
population, but allelic exclusion in mature B cells requires only production of the Igµ 
chain. What has yet to be resolved is whether SLC components were substituted with 
other products (BiP chaperone and VpreB3 and possible germline light chain proteins 
have been suggested (Frances et al., 1994; Rangel et al., 2005)), allowing development of 
some sort of pre-BCR which signals allelic exclusion but not proliferative expansion in 
these cells.   
While signalling through the mature BCR requires cross linking by antigen, signalling 
through the pre-BCR appears cell autonomous as pre-BI cells will undergo pre-BCR 
mediated proliferation in-vitro in the absence of stromal cells or cytokines and this is  
dependent on the presence of λ5 (Rolink et al., 2000). An external pre-BCR ligand is 
provided by stromal cells, as has been reported by binding of recombinant SLC proteins 
to stromal and adherent cells (Bradl and Jack, 2001), with the pre-BCR binding 
specifically to a heparin sulphate motif on stromal cells which was dependent on the λ5 
non-Ig tail (Bradl et al., 2003). There is also evidence that λ5 can induce receptor 
aggregation through homodimerization of the non-Ig domains and that this is important 
for inducing receptor internalisation and downstream tyrosine phosphorylation events 
(Ohnishi and Melchers, 2003). In support of this, compared to the BCR, the pre-BCR has 
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increased association in lipid rafts (Guo et al., 2000). This study also demonstrated that 
cross linking of pre-BCR could increase lipid raft association, drive phosphorylation of 
the Igβ ITAM which correlated with recruitment of adaptors and signalling kinases 
including and PLCγ2, Lyn, Syk, Btk, Vav, PI3K and SLP65 (Guo et al., 2000). The 
definitive answer as to whether pre-BCR association is driven by autonomous λ5 
association or a stromal ligand remains unanswered. However, it must be remembered 
that proliferation but not developmental progression are blocked in mice with 
compromised surrogate light chains (Shimizu et al., 2002), suggesting that the Igµ chain 
alone can drive a developmental progression signal.   
The pre-BCR signal is mediated through Lyn dependent phosphorylation of the 
immunoreceptor tyrosine activation motifs (ITAM) on Igα and Igβ, and mutations in Igµ 
which prevent interactions with these proteins or deletion of the cytoplasmic portion of 
Igα, prevents progression to the pre-BII stage (Papavasiliou et al., 1995b; Reichlin et al., 
2000). Interestingly, deletion of the cytoplasmic tail of Igβ did not prevent pre-BII 
development, but did block cells at the immature B stage (Reichlin et al., 2000). To further 
demonstrate that an Igα or Igβ complex with Igμ is sufficient to generate a pre-BCR 
signal, Rag deficient mice were complemented with a rearranged Igµ chain which could 
not interact with endogenous Igα and Igβ. This prevented the transgenic Igµ chains 
rescuing progression to the pre-BII stage. By fusing the cytoplasmic domain of either Igα 
and Igβ to the transgenic Igμ, a pre-BCR signal was achieved and cells progressed to the 
pre-BII stage (Papavasiliou et al., 1995a; Papavasiliou et al., 1995b).  
Phosphorylation of the Igα/Igβ ITAMS on pre-BCR signalling causes localisation and 
activation of Syk (Rolli et al., 2002). There appear to be two signals mediated by Syk. The 
first signal drives proliferation through the Ras/MEK/ERK pathway, while the second 
drives developmental progression and is dependent on the adaptor protein SLP65 and 
the kinase Btk, which drive PLCγ2 activation for calcium mobilisation (Fu et al., 1998). 
This is highlighted by cells deficient for SLP65 which show a partial block at the pre-BI 
stage, with a high level of surface pre-BCR and an increased Ras/MEK/ERK dependent 
proliferation (signal 1) which is thought to be maintained by the high levels of pre-BCR 
rather than absence of SLP65 (Jumaa et al., 1999; Pappu et al., 1999; Flemming et al., 2003). 
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Restoration of SLP65 in these cells (signal 2) resulted in developmental progression, with 
pre-BCR internalisation and downregulation, upregulation of Rag enzymes and 
activation of Igκ rearrangement (Meixlsperger et al., 2007). Although SLP65 deletion 
results in only a partial block, this pathway is responsible for progression, as disruption 
of LAT-SLP76 (which can form a redundant adaptor complex which is not necessary for 
pre-BI progression) in addition to SLP65 results in a complete block at the pre-BI stage 
(Su and Jumaa, 2003). The role of Btk in this pathway is demonstrated by genetic ablation 
experiments. While deletion of Btk results in a similar but milder phenotype to SLP65 
deletion (Khan et al., 1995; Middendorp et al., 2002), deletion of both causes a complete 
block a the pre-BI stage (Jumaa et al., 2001).  
Developmental progression signals mediated by SLP65 cause upregulation of Irf4 and 
Ikzf3, with the latter allowing increased Aiolos levels to bind the Igll1 locus competing 
out EBF to mediate repression and downregulation of λ5 (Thompson et al., 2007). The 
Aiolos family member, Ikaros, is also involved in Igll1 repression as it recruits the locus 
to heterochromatin, which may mediate stable silencing (Brown et al., 1997). IRF4 and 
IRF8 are essential for progression as while each can compensate for the loss of the others 
activity, IRF4,8 double knockout mice show a block at the large pre-BII stage, fail to 
downregulate SLC components, upregulate Rag1,2 or activate the Igκ locus, suggesting 
this as an important candidate for downstream effector activity from pre-BCR signalling 
(Lu et al., 2003). In addition to activating Irf4 and Ikzf3 expression, pre-BCR signalling 
through SLP65 downregulates IL7R. This is essential for maintaining allelic exclusion, as 
the loss of IL7R signalling reduces STAT5 activity, allowing histone deacetylation at the 
IgH locus and decreased accessibility to prevent further rearrangement (Chowdhury and 
Sen, 2003; Bertolino et al., 2005). 
1.2.3 Regulation of Igκ rearrangement 
Signalling through the pre-BCR informs the cell of a functional IgH rearrangement and 
drives transcriptional changes, such as suppression of Tdt and Igll1, to promote 
development to the small pre-BII stage and IgL rearrangement (Hoffmann et al., 2002). 
Two fundamental questions of B cell immunology which still remain unanswered are 
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that of establishment and maintenance of lineage and stage specificity of rearrangement, 
and secondly, how allele choice is established, such that almost all cells only have one 
functionally rearranged IgH and IgL allele (Hardy et al., 1991). The RAG enzymes, which 
have identical expression and activity in B and T lineages, are able to cause 
rearrangement of multiple antigen receptor loci in an ordered and lineage specific 
manner, such that IgH rearrangement precede IgL in pro/pre-BI and pre-BII cells and 
TCRβ rearrangement precedes TCRα in DN and DP T cells (Alt et al., 1984; Hardy et al., 
1991; Sleckman et al., 1996). It is generally accepted that feedback inhibition prevents 
rearrangement of the second allele as demonstrated by transgenic mice bearing 
rearranged IgH or Igκ transgenes which prevent rearrangement of the endogenous locus 
(Meyer et al., 1990; Spanopoulou et al., 1994; Chang et al., 1999). While at the pre-BI stage, 
signals through the µ chain inform of a functional rearrangement, IgL rearrangement and 
deposition of surface IgM demarcates the immature B cell stage where the specificity of 
the antigen receptor is determined. It was historically thought that self specific receptors 
were removed from the population by clonal deletion (Nemazee and Burki, 1989), but it 
now appears that cells with either a self-specific or non-functional receptor undergo a 
regression to a pre-BII like stage where further light chain rearrangements take place, in a 
process termed Receptor Editing (Tze et al., 2000; Halverson et al., 2004; Tze et al., 2005).  
Rearrangement catalysed by RAG1,2 occurs through double strand breaks at the cis-
acting recombination signal sequence (RSS) to generate the hairpin coding break ends 
and the unligated signal break ends, followed by opening of the hairpins and religation 
by the non-homologous end joining machinery (Taccioli et al., 1993). Figure 1.3 depicts 
the structure of the Igκ locus and these rearrangements events. The RSS is composed of a 
conserved heptamer and nonamer separated by a 12 or 23 bp spacer and ensures correct 
selection of gene segment for rearrangement (Early et al., 1980). The RSS contain all the 
sequences to specify rearrangement (Akira et al., 1987; Hesse et al., 1987; Hesse et al., 1989) 
and rearrangement follows the 12/23 rule so that only RSS with opposing spacers can 
rearrange (Early et al., 1980). Gene segments within the same functional group have 
identical spacer, thereby preventing self-rearrangement and ensuring directionality of V-
D-J rearrangements at the IgH locus, which have 12RSS, 23RSS and 12 RSS respectively, 
and V-J for the IgL loci which have 12RSS-23RSS respectively (Akira et al., 1987). While 
44 
 
ensuring correct gene segment selection, the RSS does not provide a framework for 
defining how stage and lineage specific rearrangement is controlled as RAG activity at 
these stages is more than capable of rearranging an ectopic recombination substrate (Alt 
et al., 1984; Yancopoulos et al., 1986). 
1.2.3.1 Control of accessibility of antigen receptor loci 
The answer to how stage and lineage specificity of rearrangement is regulated began to 
emerge almost 20 years ago with the realisation that RAG access to the antigen receptor 
loci is controlled through chromatin accessibility, with only the correct loci in an 
accessible state in a particular stage of development. Early work demonstrated a 
 
 
Figure 1.3 The Igκ locus and RAG mediated rearrangement 
(a) The Igκ locus is 3.2Mb and contains approximately 95 functional Vκ genes groups into 
18 families, five Jκ genes, one of which is a pseudogene and a single Cκ (Brekke and 
Garrard, 2004). The three main regulatory sites, SIS, Eiκ/Matrix attachment region (MAR) 
and the Eκ3’, and two germline transcription promoters for the Jκ region are shown. The 
RS deleting element lies 25kb downstream of the Cκ exon and contains an RSS elements 
which allows rearrangement to inactivate the locus, an event that is found in the majority 
of Igλ expressing cells (Moore et al., 1985). (b) RAG mediated rearrangement of the Igκ 
locus occurring by deletional rearrangement leaving the VJ coding joint and the RSS 
signal joint loop. Inversional rearrangement can occur but this is an infrequent event 
(Sollbach and Wu, 1995). 
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correlation between DNaseI hypersensitivity of the locus and its propensity to undergo 
rearrangement (Persiani and Selsing, 1989), but definitive proof came with elegant 
experiments from the Schlissel Lab. They demonstrated that nuclei from the pre-BI stage 
would only undergo in-vitro V-DJ rearrangement at the IgH locus, nuclei from the pre-BII 
stage would only undergo rearrangement at the Igκ locus, and nuclei from T cells 
underwent neither IgH or Igκ rearrangements (Stanhope-Baker et al., 1996). However, 
purified genomic DNA from any of these stages and lineages underwent both V-DJ IgH 
and V-J Igκ rearrangements. This demonstrated control of rearrangement was mediated 
by trans-acting factors controlling the chromatin structure at the loci to regulate RAG 
accessibility rather than cis-acting sequences. This was supported by further reports 
demonstrating that short lived rearrangement intermediates (signal and coding break 
ends) from in-vivo rearrangement were only detected in particular stages of development 
from primary ex-vivo B cells (Constantinescu and Schlissel, 1997). Intermediates from the 
IgH chain were only detectable at the pre-BI stage, while abundant Igκ intermediates 
were only detected from the small pre-BII stage. Interestingly, low levels of Igκ 
intermediates were detected preceding IgH rearrangement and pre-BCR signalling, 
suggesting the possibility of early rearrangement events. Further confirmation of 
chromatin changes came with studies in cell lines representing stages of B cell 
development. These lines showed that Vκ and Jκ have developmentally controlled 
accessibility to DNaseI, with a maximum access in pre-BII cells, again suggesting that 
nucleosome remodelling occurs in correlation with RAG access (Maes et al., 2001). More 
recent work using sensitive CHART-PCR has confirmed these earlier findings, showing 
that while the IgH locus is accessible throughout B cell development, the Igκ Eκ3’ 
undergoes gradual increase in accessibility from the pre-BI stage onwards (McDevit et al., 
2005; McDevit and Nikolajczyk, 2006). Chromatic inhibition of rearrangement was 
verified by studies demonstrating that nucleosomes are able to block the binding and 
activity of RAG at the RSS sequences (McBlane and Boyes, 2000) and that the nucleosome 
position on the RSS, nucleosome remodelling factors and histone acetylation can 
influence RAG cleavage (Kwon et al., 1998; Nightingale et al., 2007). 
Further layers of epigenetic control were highlighted by FISH studies (Kosak et al., 2002). 
The nuclear location of both the Igκ and IgH loci appears developmentally controlled, as 
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in ES, lymphoid progenitors and T cells, the Igκ and IgH loci were associated with the 
repressive nuclear periphery. Early commitment to the B cell lineage was associated with 
a biallelic movement of Igκ and IgH away from the periphery to a central euchromatic 
region. These movements were independent of Rag expression and were influenced by 
signals through the IL7 receptor, signalling through which had previously been shown to 
promote rearrangement at the IgH locus (Corcoran et al., 1996; Corcoran et al., 1998). 
The central question of allelic exclusion had provoked development of two models. In 
the first, allelic choice is predetermined and at some point during development an allele 
is marked. When the correct time comes, this allele preferentially undergoes 
rearrangement. In the second model, allele choice is stochastic, with both alleles being 
equal and a probabilistic choice based on limiting factors decides which allele undergoes 
rearrangement (Coleclough et al., 1981). A problem with stochastic models is that in 
systems where multicopy transgenic rearrangement substrates are introduced, 
rearrangement of both the transgene and endogenous locus can occur normally, 
suggesting the presence of enough factors to correctly regulate multiple loci (Hiramatsu 
et al., 1995). With these two models in mind, regulation of Igκ regulation will be 
discussed. 
1.2.3.2 Germline Transcription and probabilistic activation 
Germline transcripts are a familiar theme in the antigen receptor loci with non-coding 
sterile transcripts being found at the IgH chain locus, Igκ V genes and TCR loci (Royer et 
al., 1985; Yancopoulos and Alt, 1985; Martin et al., 1991; Bolland et al., 2004). At the Igκ 
locus, germline transcripts are also produced from two promoter upstream of the Jκ 
region (Leclercq et al., 1989; Martin and van Ness, 1990). These sterile transcripts do not 
code for any protein, but correlate well with rearrangement of the loci; LPS induction of 
Abelson transformed pre-B cell lines increased rearrangement of the Igκ locus and also 
induced high levels of these germline transcripts (Schlissel and Baltimore, 1989; O'Brien 
et al., 1997). This correlation suggested they could be a cause or possibly a consequence of 
chromatin opening as an increase in DNaseI hypersensitivity at the intron enhancer was 
also found on LPS induction in these cells (O'Brien et al., 1997). The importance of 
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germline transcription for rearrangement has been demonstrated at the TCRα locus. The 
TCRα locus contains multiple Jα segments, many with individual germline transcription 
promoters. Blocking germline transcription by introduction of a transcriptional 
termination sequence correlated directly with a reduction in rearrangement in gene 
segments who were no longer read through by the transcriptional machinery 
(Abarrategui and Krangel, 2006; Abarrategui and Krangel, 2007). Those segments lying 
up and further downstream of the termination sequence which maintained germline 
transcription were rearranged as normal. Additionally, chromatin markers such as 
H3K4me2,3 were also directly correlated with germline transcription and rearrangement, 
linking all three events.  
The activity of transcription through the locus could open up repressive chromatin 
allowing RAG access (Orphanides and Reinberg, 2000). However, several studies have 
questioned the role of transcription in activation of rearrangement. Episomal 
rearrangement substrates show that transcription was not required for activation of 
rearrangement (Cherry and Baltimore, 1999), and a transgene which contain rabbit Eik 
underwent rearrangement without detectable germline transcription (Kallenbach et al., 
1993). Mutation of the KI and KII elements at the 3’κ˚ promoter region cause a reduction 
in Igκ rearrangement in both mice and cell lines, but did not affect germline transcription 
(Ferradini et al., 1996; Liu and Van Ness, 1999). Conversely, deletion of the region 
spanning from the 5’κ˚ promoter to just upstream of the 3’κ˚ caused a block in 
rearrangement that was cumulative with the KI KII mutations described (Cocea et al., 
1999). Some reports have implicated Pax5 in binding KI and KII and suggested that it 
undergoes cell cycle mediated dissociation on the large to small pre-BII transition (Sato et 
al., 2001). Although the KI KII mutations do not implicate germline transcription per se, it 
does implicate the germline transcription promoter regions in regulation. Using a TCRβ 
minilocus, the presence and position of the germline transcript promoter were shown to 
be essential for rearrangement, but the orientation, and therefore the ability of 
transcriptional read through of the locus, were not (Sikes et al., 2002). 
While stage specific germline transcription could help regulate ordered rearrangement, it 
does not provide a model for allelic exclusion. For germline transcription to allow allele 
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choice, they have to be monoallelic. However, a sensitive single cell PCR assay 
demonstrated that both wild type pre-BII and transgenic cells blocked at this stage of 
development showed low level biallelic transcription (Singh et al., 2003). However, in a 
novel reporter system generated by the Schlissel lab, a second monoallelic transcriptional 
stage was identified (Liang et al., 2004). In this system, Jκ1 was replaced by a GFP 
reporter cassette, leaving its expression under the control of the germline transcription 
promoters. The reporter showed developmentally regulated GFP expression, with a 
gradual increase in the number of GFP positive cells, with just under half of all mature B 
cells GFP positive, showing that these cells have preferentially maintained the ‘GFP’ 
allele in the germline configuration. What was also noted was that at the small pre-BII 
stage when cells undergo Igκ rearrangement, 5% of cells were GFP positive. It was 
postulated that the low level biallelic germline transcription reporter by Singh et.al., 
would not drive GFP detection, so that this population of cells represented a second 
transcription phase caused by high level upregulation of germline transcription. This 
population contained RAG induced break ends at the ‘GFP’ allele, and overnight in-vitro 
culture showed the majority of GFP positive cells went on to rearrange the ‘GFP’ allele. 
These results were taken to suggest that at the small pre-BII stage, a stochastic activation 
occurred on one allele which correlated with the choice for that allele to undergo 
rearrangement. This also explained allelic exclusion, as the chance for both alleles to 
undergo rearrangement is insignificant, with a probability of 0.25% (0.052). This is also 
supported by earlier findings that enhancer elements within the locus undergo 
probabilistic activation as measured by nuclease accessibility (Schlissel, 2002). Only a 
small proportion of cells at a stage competent to undergo rearrangement of the Igκ locus 
showed the ability to activate and increase accessibility at the Eκi. These findings suggest 
that the ability to drive rearrangement is limited by the availability of transcription 
factors to bind these elements and limited probabilistic activation can explain the finding 
that only a small proportion of cells undergo rearrangement and that the frequency of 
biallelic rearrangement is minimal. 
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1.2.3.3 Regulated allelic exclusion 
The first evidence for allele selection came with the identification that DNA methylation 
can influence rearrangement. A transgenic array of recombination substrates which 
underwent strain specific methylation, only rearranged in strains where it was either 
fully or partially unmethylated (Engler et al., 1991; Engler et al., 1993). Two further 
studies used an ectopic rearrangement substrates to demonstrate that in-vitro 
methylation blocked rearrangement and that this was dependent on plasmid replication 
suggesting full chromatin assembly was required (Hsieh and Lieber, 1992; Cherry and 
Baltimore, 1999). 
The role of methylation was developed when it was shown that the Igκ locus undergoes 
demethylation during development with mature B cells showing a demethylated locus, 
while full methylation was found in other tissue, and additionally, an Igκ transgene 
which underwent rearrangement in all tissues expressing Rag1,2 was found to be 
hypomethylated (Goodhardt et al., 1993; Lichtenstein et al., 1994). It was further shown 
that methylation was allele specific and that in mature B cells, only the rearranged allele 
was demethylated (Mostoslavsky et al., 1998). Using cells blocked in development at the 
pre-BI or pre-BII stage by a combination of Rag1 deficiency and a rearranged Igµ 
transgene, allele specific demethylation was shown to occur at, but not before, the pre-BII 
stage (Mostoslavsky et al., 1998). Using methylation sensitive restriction enzymes and 
detection of recombination intermediates, it was further shown that in nuclei from these 
transgenic mice, the preferred target of RAG cleavage was the unmethylated allele 
(Goldmit et al., 2002), all suggesting that at the pre-BII stage, an allele undergoes 
demethylation to become the preferred target for RAG. Maes et.al., placed demethylation 
after alterations in chromatin structure, as treatment of cell lines with LPS induced 
rearrangement and increased DNaseI hypersensitivity but did not induce demethylation 
(Maes et al., 2001). In agreement, demethylation of alleles by deletion of the Dnmt1 DNA 
methylase, did not induce rearrangement in Abelson transformed cell lines and 
rearrangement was still inducible by LPS, suggesting demethylation does not directly 
promote rearrangement (Cherry et al., 2000). 
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While demethylation occurs immediately prior to rearrangement, asynchronous 
replication of the alleles occurs much earlier in development (Mostoslavsky et al., 2001). 
Replication timing correlates with gene expression and active chromatin (Perry et al., 
2004), and asynchronous replication of the two Igκ alleles was shown to be established 
early in the embryo before establishment of lymphoid tissue. The timing differences were 
stably inherited, were independent of whether rearrangement would occur in cells, and 
the early replicating allele was preferentially rearranged (Mostoslavsky et al., 2001).  
FISH studies have demonstrated that in mature B cells, one Igκ allele is associated with 
Ikaros associated heterochromatin, suggesting after moving away from the periphery, 
heterochromatin can control the locus (Skok et al., 2001). Bergman and colleagues 
extended these finding, showing that the pre-BI to pre-BII transition was characterised by 
one allele relocating to a heterochromatic environment, leaving the second allele in the 
euchromatic environment and this allele was early replicating (Goldmit et al., 2005). This 
relocalisation appears to be controlled by the SIS regulatory element and Ikaros. Deletion 
of SIS specifically prevented Ikaros binding to the remaining region while binding to the 
rest of the locus was unaffected, but recruitment to heterochromatin was lost (Liu et al., 
2006). The Igκ locus undergoes a contraction and looping at the small pre-BII stage, 
presumably to bring distal regions into contact, followed by a decontraction after 
successful rearrangement (Roldan et al., 2005).  
Active histone modifications (H3Ac, H3K4me) increase at the Igκ locus on the pre-BI to 
pre-BII transition, however, at the same time, association with Ikaros and HP1γ 
heterochromatin protein also increases (Maes et al., 2001; Goldmit et al., 2005). These 
apparently disparate results were resolved by sequential ChIP, which demonstrated that 
one allele was associated with heterochromatic proteins HP1γ and Ikaros, while the other 
allele associates with the activating histone modification (H3Ac) and that these active 
marks further correlated with DNA demethylation in LPS induced pre-B cell lines 
(Goldmit et al., 2005). These data suggest that prior to rearrangement, one allele is packed 
into repressive heterochromatin while the second undergoes histone and DNA 
modification to make it more susceptible to RAG activity. Using Abelson transformed 
cell lines, the Jκ region was shown to undergo an enrichment of H3K4me2/3 
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modifications when the cells were induced to rearrange (Perkins et al., 2004). However, 
the increase correlated directly with RAG activity at the locus, suggesting these marks 
may not preselect an allele. Using the same system, other have seen less impressive 
alterations to histone modification, although induction caused rapid increase in germline 
transcription and DNaseI hypersensitivity (Fitzsimmons et al., 2007).  
Histone acetylation itself does not appear to control RAG activity as RSS packaged into 
nucleosomes are inaccessible to RAG binding and activity whether or not they are 
acetylated (McBlane and Boyes, 2000). However, in-vivo these marks may have more of a 
role, as histone acetylation by TSA treatment of pre-B cell lines caused increased 
rearrangement and DNaseI hypersensitivity at the Igκ locus, suggesting these 
modifications could interfere with higher orders of chromatin compaction (McBlane and 
Boyes, 2000). Recent work has suggested H3K4me3 as the major histone modification in 
regulating rearrangement. While the core domains of the RAG enzymes can catalyse 
rearrangement on plasmid substrates, it is less efficient at the endogenous loci (Kirch et 
al., 1998). Mutations in the RAG2 non-core PHD domain are associated with 
immunodeficiency diseases and recent work has demonstrated that this domain can bind 
nucleosomes with H3K4me2,3 modification and that binding this modification relieves 
autoinhibition, thus providing a neat framework for tying the epigenetic regulations to 
activity of the RAG enzymes (Liu et al., 2007; Matthews et al., 2007; Ramon-Maiques et al., 
2007). 
1.2.3.4 cis and trans-acting factors 
To understand the molecular mechanisms involved in regulation of the chromatin 
structure, much work has been undertaken to identify enhancer and regulatory elements 
at the locus. Several enhancers have been identified, including the Eκ3’, Intronic 
enhancer (Eiκ) and the Silencer in the Intervening Sequence (SIS) regulatory sequence.  
The Eκ3’ enhancer located 8.4kb downstream of the Cκ was first identified using reporter 
constructs to identify sequences which conferred transcriptional activity (Meyer and 
Neuberger, 1989). Plasmid reporters have been useful in determining the activity of these 
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enhancers, and have demonstrated that while both the Eκ3’ and Eiκ offer transcriptional 
activation specifically in B cells, the activity of the Eκ3’ is stronger than the Eiκ in early B 
cells (Meyer and Neuberger, 1989; Pongubala and Atchison, 1991). The activity of the 
Eκ3’ has been refined to a 132bp core which contains all the functional activity of the 
1.1kb Eκ3’, and includes binding sites for E2A and PU.1-IRF4, while flanking sites confer 
transcriptional repression (Pongubala and Atchison, 1991; Pongubala et al., 1992). IRF4 
has been shown to drive transcriptional activity only through binding with interaction 
partners, such as PU.1 and E2A (Eisenbeis et al., 1995; Nagulapalli and Atchison, 1998). 
While PU.1 can bind the Eκ3’ alone, IRF4 can only bind through a phosphorylated PU.1, 
and this binding is essential for PU.1 induced transcriptional activation (Pongubala et al., 
1993). Also identified was a cAMP responsive element (CRE), which binds the factors 
ATF-1, CREM, c-Fos and c-Jun, who can interact with PU.1 and can influence 
transcriptional activity allowing response to cAMP levels in-vitro (Pongubala and 
Atchison, 1995; Pongubala and Atchison, 1997). In-vitro work has demonstrated the 
ability of factors bound at these sites to form higher-order complexes, and disruption of 
this complex by mutation of any of these sites severely affected transcriptional activity 
(Pongubala and Atchison, 1997). One highly interesting finding is that PU.1 may function 
primarily as an architectural protein in this complex, with loss of its DNA binding 
domain and PEST protein interaction domain, but not the transcriptional activation 
domain, severely affecting formation of this complex and transcriptional activity 
(Pongubala and Atchison, 1997). The architectural role of PU.1 is further supported by 
the finding that B cell, but not macrophage development, can be restored in PU.1 
deficient progenitors by a truncated PU.1 missing a portion of the transcriptional 
activation domain (DeKoter and Singh, 2000).  
PU.1 does not appear to be the master factor in chromatin regulation at the Igκ locus as 
while PU.1 overexpression can drive chromatin accessibility and germline transcription 
at the IgH locus in pro-T or 3T3 cell lines, it cannot do so at the Igκ locus (Nikolajczyk et 
al., 1999; Marecki et al., 2004), and macrophages, which have high expression levels of 
PU.1, have an inaccessible Eκ3’ (McDevit and Nikolajczyk, 2006). ChIP and CHART-PCR 
have also shown that while PU.1 binds at a fully accessible Igµ at the pre-BI stage, PU.1 
binding to the Eκ3’ correlates with an increase in chromatin accessibility at the pre-BII 
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stage, suggesting that other factors are responsible for opening the chromatin at this 
stage (McDevit et al., 2005; McDevit and Nikolajczyk, 2006). IRF4 does not appear 
responsible, as expression levels of IRF4 or PU.1 do not directly correlate with their 
binding. However, IRF4 binding does correlates with histone acetylation, again 
suggesting these factors bind the locus when its accessible (McDevit et al., 2005).  
The activatory role of PU.1 at the Igκ locus has been disputed by a transgenic pre-B cell 
system using PU.1/Spi-B (an Ets family member) double deficient progenitors rescued 
with an IL7Rα transgene. These cells showed enhanced Igκ rearrangement and germline 
transcription on IL7 withdrawal, results verified by disruption of endogenous PU.1 
activity by a dominant negative form in wild type cells which mirrored this phenotype, 
suggesting PU.1 may actually play a repressive role at the locus (Schweitzer and 
DeKoter, 2004). 
IRF4 and its homologous family member IRF8 are essential for the pre-BII stage, as 
ablation of IRF4 and IRF8, results in a complete block at the large pre-BII stage (Lu et al., 
2003). The molecular basis for this block is still not defined, but ChIP studies 
demonstrated that in the absence of IRF4, PU.1 is unable to bind at the Eκ3’ and both Igκ 
germline transcripts and Rag1,2 are reduced (Lu et al., 2003). In addition to the PU.1 
interaction at the Eκ3’, an E2A-IRF4 interaction has been demonstrated in-vitro using 
reporter constructs. These demonstrate that both factors bind and activate transcription 
synergistically (Nagulapalli and Atchison, 1998; Nagulapalli et al., 2002). 
Reporter constructs containing miniloci have been used extensively to probe the role of 
the enhancers. Once such reporters suggested that the Eκ3’ alone was essential for full 
transcriptional activity of the locus (Meyer et al., 1990). Intriguingly, work from the 
Sakano lab demonstrated that this element also contained repressive elements, as a 
reporter construct with various deletion showed the Eκ3’ to be essential for restricting 
rearrangement to pre-BII cells (Hiramatsu et al., 1995). Deletion of this element, and in 
particular a 6bp sequence covering the PU.1 binding site, allowed rearrangement in T 
cells and pre-BI cells, whereas restoration of Eκ3’, even in an altered location relative to 
the Cκ, restored restriction (Hiramatsu et al., 1995; Hayashi et al., 1997).  
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While this is true for transgenic loci, genetic deletion of the endogenous Eκ3’ did not 
yield similar results (Gorman et al., 1996). Loss of the Eκ3’ in the endogenous loci 
reduced the rearrangement of the mutant allele in heterozygous cells, while homozygous 
mice showed reduced number of total B cells caused by a decrease in Igκ and increase in 
Igλ mature B cells as well as reduced Igκ germline transcripts (Gorman et al., 1996). 
Additionally, no rearrangement was seen in pre-BI or T cells bearing a deleted Eκ3’ (van 
der Stoep et al., 1998). An explanation for these discrepancies maybe provided by the 
recently identified SIS enhancer element (Liu et al., 2002). Deletion of this site results in 
reduced germline transcription but an increase in rearrangement which however, 
remained restricted to the pre-BII stage. Ikaros ChIP also demonstrated that while 
binding across the locus was not affected, loss of binding at the SIS region may explain 
the inability of a loci without the SIS to undergo the recruitment to heterochromatin 
indicative of pre-BII cells (Liu et al., 2006). This site is deleted in the constructs used in the 
Hiramatsu study and removal of this site may enhance effects of other mutations. An 
additional explanation for the differences is offered by a recent report which 
demonstrated that placing a VH gene segment close to the DH gene segment allowed VH-
DH rearrangements to occur when DH-JH but not VH-DH rearrangements are naturally 
occurring in T cells (Bates et al., 2007). This suggests that the distance between these 
segments normally prevents their rearrangement, which is supported by the finding that 
efficient IgH rearrangements require Pax5 mediated looping and contraction at the pre-BI 
stage (Fuxa et al., 2004). Similar locus contractions occur at the Igκ locus and therefore, 
artificially contracted loci could undergo rearrangement when deregulated that would 
not been seen in a decontracted locus, such as with the Hiramatsu constructs (artificially 
contracted) compared to the endogenous locus (decontracted). 
Deletion of the Eiκ and MAR resulted in a similar but more severe phenotype to the Eκ3’ 
deletion, as these mice showed reduced germline transcription from the Jκ and Vκ 
promoters, and analysis of rearrangement patterns suggested that many Igλ cells had 
bypassed Igκ rearrangement altogether (Xu et al., 1996; Inlay et al., 2002). These elements 
appear to function in partially redundant pathways and deletion of both caused a 
cumulative effect with almost complete loss of Igκ B cells (Inlay et al., 2002). 
Interestingly, deletion of the Eκ3’ appeared to block initial Igκ rearrangement while 
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secondary rearrangements were normal, leading to an accumulation of rearrangements 
to Jκ2-5, while deletion of Eiκ/MAR appears to block only the secondary rearrangement 
and resulting in an overrepresentation of V-Jκ1 rearrangement (Inlay et al., 2002). The 
effect on the deletion on the methylation pattern was also worth noting, as while deletion 
of Eκ3’ had little effect on methylation patterns, complete demethylation occurred with 
loss of Eiκ. Interestingly loss of both Eiκ and Eκ3’ caused complete methylation of both 
alleles. This suggested Eiκ maintains methylation of one allele and both are required for 
demethylation (Inlay et al., 2002).  
Extensive biochemical analysis has helped to address the factors which control stage 
specificity. The Eiκ appears to be the main site of LPS activation, as NF-κB binding is 
seen to increase on LPS induction of cell lines whilst the Eκ3’ undergoes no alteration in 
binding patterns (Shaffer et al., 1997). In ex-vivo cells however, the Eiκ NF-κB site is fully 
occupied at both the pre-BI and pre-BII stage, suggesting it does not play a role in 
regulating stage specificity. Interestingly though, the components of the NF-κB 
heterodimer appear to alter during development, which could have some influence. 
Minilocus substrates have suggested the Eκ3’ has an LPS responsive element which is 
not mediated by NF-κB (Meyer et al., 1990). All other binding sites in the Eiκ do not 
appear to change on the pre-BI to pre-BII transition, suggesting alterations in protein 
binding to this enhancer do not mediate the alterations in chromatin structure during 
development. E2A binding at the Eiκ was a likely candidate for activation of 
rearrangement as overexpression with Rag1 and Rag2 can induce rearrangement in 
kidney cells (Romanow et al., 2000). Its activity is important for full activation of 
rearrangement, as deletion of two E box binding sites in the Eiκ results in the same 
phenotype as deletion of the entire region (Inlay et al., 2004). However, footprinting 
studies have demonstrated that the E2A target site in the Eiκ and Eκ3’ are fully occupied 
in pre-BI cells and pre-BII, suggesting its activity alone does not induce chromatic 
changes in pre-BII cells which induce rearrangement (Roque et al., 1996; Shaffer et al., 
1997). Binding site studies at the Eκ3’ has revealed two sites which undergo 
developmental change; the PU.1/IRF4 site which becomes occupied at the pre-BII stage 
and a Pax5 site which undergoes slight loss of occupancy in pre-BII cells, and there was 
some evidence that Pax5 could block the PU.1 binding site (Shaffer et al., 1997). A 
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Lef1/TCF binding site has also been detected outside of the core Eκ3’ region, in a region 
thought to confer transcriptional repression which also contained binding site for the 
transcriptional repression and activator, YY-1, although this does not appear important 
for allelic exclusion (Park and Atchison, 1991; Meyer and Ireland, 1994; Roque et al., 
1996).  
After many years of intensive study, we are now beginning to understand the puzzle of 
allelic exclusion and regulation at the Igκ locus. There are still many questions, and we 
still do not have a definitive answer as to which of the enhancers and which factors are 
responsible for the chromatic changes at the locus. It may simply be that there is a level 
of redundancy at the locus which will prevent the requirement for any single cis or trans 
acting factor to dominate. 
1.2.4 B cell activation and plasma cell differentiation 
The spleen contains two populations of mature B cell, the Follicular (FO) and Marginal 
Zone (MZ) B cells, which represent 95% and 5% of the B cell population respectively 
(Oliver et al., 1997). These cells reside in different location, show variations in expression 
of surface markers, and while FO B cells recirculate, MZ B cells do not (Oliver et al., 1997; 
Loder et al., 1999). Antigen stimulation of these populations results in activation through 
a plasmablast stage and eventual terminal differentiation to the antibody secreting 
plasma cell (Sze et al., 2000). Activation of the FO population results in a germinal centre 
reaction where over an extended period, cells undergo iterative cycles of proliferation, 
somatic hypermutation and apoptosis to create high affinity plasma cell. MZ B cells 
respond to antigens with a rapid secretion of low affinity IgM antibodies to fight blood 
borne bacterial pathogens and also a more rapid antigen presentation capacity to activate 
a T cell response (Oliver et al., 1997; Dal Porto et al., 1998; Oliver et al., 1999; Martin et al., 
2001). FO and MZ cells both develop from the transitional B cell stage, and the BCR 
signal strength is thought to control the lineage fate, with high BCR signal strength 
developing FO B cells and low signal strength BCRs developing MZ B cells (Loder et al., 
1999; Cariappa et al., 2001).  
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Impairment of BCR signal strength in mice deficient for Btk (Xid mice) or the CD21 co-
receptor results in an increase MZ B cell compartment and reduced FO B cell 
compartment, whereas enhanced BCR signal strength, as measured by calcium flux, in 
Aiolos deficient mice show the opposite, with an enlarged FO over MZ B cell 
compartment (Loder et al., 1999; Cariappa et al., 2001). Aiolos-Btk double deficient mice 
show the same phenotype as Xid mice, suggesting Btk is upstream of the Aiolos effects 
(Cariappa et al., 2001). Supporting the signal strength hypothesis further are Bcl2 
transgenic or CD22 (a negative regulator of BCR signalling) deficient mice which show 
enhanced signal strength and a reduced MZ B cell compartment, whereas Bcl2 deficient 
mice have a reduced signal strength and an enlarged MZ compartment (Samardzic et al., 
2002a; Brunner et al., 2003). However, the simple signal strength model is questioned by 
the mice deficient for the lymphocyte transcriptional coactivator Obf1, which have a 
reduced BCR signal strength but show absence of the MZ compartment (Samardzic et al., 
2002b). 
The Ikaros family of transcription factors was first implicated in B cell activation when 
stimulation was shown to cause an increase in Ikaros-HP1β heterochromatic foci, which 
is important for heritable silencing of a number of genes (Brown et al., 1999; Baxter et al., 
2004). The family also appears involved in limiting activation or differentiation of 
lymphocytes by setting thresholds of activation through control of antigen receptor 
signal strength. Aiolos deficient B cells showed downregulation of CD21, a sign of 
activation, in addition to increased calcium flux, while both B and T cells from these mice 
show a reduced threshold of activation (Wang et al., 1998; Cariappa et al., 2001), and a 
hypermorphic Ikaros allele allowed development of mature B cell which had an 
enhanced proliferative response to simulation (Kirstetter et al., 2002). In the T cell lineage, 
Ikaros-Rag1 double deficient cells are able to develop to the CD4SP stage on recipient 
transfer, without development of a pre-TCR (Winandy et al., 1999). T cells from mice 
heterozygous for a DN Ikaros allele show hyperactivation on low and even no antigen 
stimulation, as do thymic T cells from Ikaros deficient mice (Winandy et al., 1995; Wang 
et al., 1996). Additionally, Ikaros null mice develop a SP T cell population which has 
bypassed positive selection, suggesting Ikaros normally functions to restricts 
development of this stage by setting the threshold of activation (Winandy et al., 1999).  
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Activation of FO and MZ cells initiates a series of transcriptional events which results in 
termination of the B cell program and initiation of the plasma cell program. The details of 
the requirements for the FO and MZ B cell responses are not clear, but the increased 
response to stimulation of MZ cells may be caused by higher level of the BCR signalling 
complexes proteins PLCγ2 and Syk which generate a higher calcium flux (Li et al., 2001). 
The general pathways and transcription factors are thought to be identical, and are 
outlined in Figure 1.4.  
One of the first events required for the transcriptional changes is the phosphorylation 
and ubiquitin dependent degradation of the transcription repressor Bcl-6. Bcl-6 is 
phosphorylated by Erk2, a member of the MAPK pathway, which is activated on B cell 
stimulation (Niu et al., 1998). Bcl6 limits activation by targeting transcription factors and 
activation markers and disruption of its activity by a dominant negative or genetic 
ablation results in B cells with a partially activated state and which undergo enhanced 
activation in response to stimulation (Shaffer et al., 2000). Bcl6 repression is mediated 
through interactions with MTA3, a component of the Mi-2/NuRD corepressor complex. 
Depletion of MTA3 impairs Bcl6 mediated gene repression and when expressed together, 
these factors can reprogram plasma cells to B cells (Fujita et al., 2004). Bcl6 is one of four 
transcription factors which are known to repress Blimp1, which is considered the ‘master 
 
 
Figure 1.4 Transcriptional pathways of Plasma cell differentiation 
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regulator’ of plasma cell differentiation (Shaffer et al., 2002), and ectopic expression of 
Bcl-6 prevents plasma cell differentiation and represses Blimp1 induction (Reljic et al., 
2000). The other members of this groups are Pax5, Bach2, and the Bach2 interacting 
partner Mafk, which all undergo downregulation prior to Blimp1 upregulation following 
stimulation (Muto et al., 2004; Ochiai et al., 2006; Kuo et al., 2007; Mora-Lopez et al., 2007).  
Blimp1 is a five Krüppel type zinc finger transcriptional repressor which is highly 
expressed on plasma cell differentiation (Turner et al., 1994; Angelin-Duclos et al., 2000). 
In-vitro reporter assays have demonstrated that Blimp1 interacts with Groucho, Class I 
HDACs and the histone methyltransferase G9a to suppress transcription, and STAT3 has 
also been implicated as an effector of Blimp1 repression (Ren et al., 1999; Reljic et al., 2000; 
Yu et al., 2000; Gyory et al., 2004). The majority of Blimp1 targets are transcription factors, 
and these fall into two indentified classes; growth and proliferation factors, and factors 
maintaining the B cell identity program (Shaffer et al., 2002). The former includes Myc, 
whose downregulation allows the terminal differentiation, while the latter includes, 
PU.1, Oct2, Stat6 and Spi-B (Lin et al., 2000; Nagy et al., 2002; Shaffer et al., 2002). Also in 
this group are Bcl6 and Pax5, which allows a self enforcing feedback loop (Lin et al., 2002; 
Shaffer et al., 2002). Pax5 downregulation is essential for plasma cell differentiation, and 
enforced Pax5 expression prevents terminal differentiation of plasma cells, while resting 
Pax5 deficient B cells show plasma cell characteristics (Usui et al., 1997; Nera et al., 2006). 
Recent work has questioned the role of Blimp1 as master regulator, as cells deficient in 
Blimp1 activity are able to undergo almost complete differentiation, including Pax5 
downregulation and Xbp1 upregulation and can secrete low quantities of antibody, 
suggesting Blimp1 is not required for initiation of plasma cell differentiation but is 
essential for final steps to develop into a plasma cell capable of a high level of antibody 
secretion (Kallies et al., 2007). 
In addition to transcriptional repression, Blimp1 activates expression of Xbp1, although 
full upregulation of this factor requires ER stressed induced factor ATF-6 and 
derepression following Blimp1 induced downregulation of Pax5 (Reimold et al., 1996; 
Yoshida et al., 2000; Shaffer et al., 2002). Xbp1 is a basic leucine zipper transcriptional 
activator which is ubiquitously expressed at low levels. However, during B cell 
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development, Xbp1 is specifically upregulated during plasma cell differentiation and is 
essential for terminal differentiation and antibody secretion (Shaffer et al., 2004). 
Recipient transfer of Xbp1-/- progenitors into Rag deficient hosts allowed full B and T cell 
development with the B cells showing normal activation and proliferation (Reimold et al., 
2001). However, these activated cells fail to terminally differentiate into Syndecan1 
positive plasma cells which were capable of secreting antibody. Blimp1 was still 
expressed in these cells, placing Xbp1 downstream from this factor, and suggesting that 
the combination of repression of the B cell program by Blimp1 and activation of the 
plasma cell program by Xbp1 are essential for terminal differentiation steps (Reimold et 
al., 2001).  
IRF4 undergoes transcriptional activation on B cell stimulation and is found at high 
levels in terminally differentiated cells (Falini et al., 2000; Kuo et al., 2007). B cells deficient 
for IRF4 cannot respond to antigen stimulation by proliferation, antibody secretion or 
terminal differentiation (Mittrucker et al., 1997; Klein et al., 2006). IRF4 upregulation upon 
B cell stimulation is dependent on direct regulation by Rel, a member of the NF-κB 
pathway, which is activated in response to mitogenic signalling (Grumont and 
Gerondakis, 2000). The transcriptional repressor Bach2 undergoes downregulation on B 
cell stimulation and is also involved in IRF4 regulation as Bach2 deficient mice show 
increased levels of IRF4, although this maybe indirect as Blimp1 deficient cells show no 
upregulation of IRF4 on stimulation (Muto et al., 2004; Kallies et al., 2007). IRF4 can 
directly suppress Bcl6 transcription as well as upregulate Blimp1 expression. These 
opposing activities of IRF4 have been supported by an in-vitro analysis of the CD23 
promoter, which IRF4 can positively regulate by interacting with PU.1 and negatively 
regulated through interactions with both Bcl6 and Blimp1 (Brass et al., 1996; Gupta et al., 
1999; Gupta et al., 2001; Sciammas et al., 2006; Saito et al., 2007). A conditional knockout of 
Irf4 in activated mature B cells has questioned the involvement of IRF4 in Blimp1 
upregulation, as Irf4 null cells upregulated Blimp1 to the equivalent level of WT cells. 
However, deletion occurs after activation, so Blimp1 expression maybe initiated prior to 
IRF4 depletion. These cells did show a block in Xbp1 upregulation, which was suggested 
as the explanation in the block of plasma cell differentiation (Klein et al., 2006). 
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Mice deficient for the transcription factor Obf1 demonstrated a surprising role in B cell 
maturation, however, its place in the transcriptional cascade is not yet clear. In addition 
to the absence of MZ B cell in OBF1 deficient mice, OBF1 restrains initial activation and is 
essential for terminal differentiation. OBF1 deficient cells, when stimulated with T 
dependent ligands, show rapid proliferation but fail to differentiate to full Syndecan1 
positive antibody secreting cells, and show misregulation of the transcriptional program 
with high Bcl6, Pax5 and Xbp1 expression and low Blimp1 and Irf4 levels (Corcoran et 
al., 2005).  
1.3 AIMS OF THIS THESIS 
The aims of this study are twofold. Firstly, to understand the importance of germline 
transcription and activity of the Igκ germline promoters during B cell development. For 
this study I use a reporter of germline transcription and models differentiation to assess 
promoter activity during B cell development.  
Secondly, to further define the role of Ikaros and Ikaros family members in B cell 
development. Previous work in the laboratory has highlighted the upregulation of Ikzf3 
and Irf4 at the small pre-BII stage and implicated Ikaros in regulation of the Igκ locus. 
The pre-BII stage of development is characterised by rearrangement of the Igκ locus. 
Results from Aiolos and Ikaros deficient mice have suggested Ikaros and Ikaros family 
members as downstream modulators of BCR signalling pathways. I use retroviral 
transduction of both early and mature B cells to determine the effects of modulation of 
Ikaros activity on regulation of Igκ rearrangement and on B cell differentiation. The 
regulation of the Igκ locus during development has also suggested other potential 
candidate factors, and I used similar experiment to understand the role of IRF4, PU.1 and 
LEF1 on regulation of Igκ rearrangement and how these factors are related in the 
transcriptional networks controlling development. 
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Chapter 2: Materials and methods 
 
2.1 MOUSE STRAINS 
Ig -GFP mice (Liang et al., 2004) were a gift of Prof. M. Schlissel (UCLA), Ig -transgene 
mice were a gift of Dr. J. Boyes (FBS, Leeds) and the Ikaros transgenic mice were 
provided by Dr D. Liberg (MRC, CSC).  
Ig -GFP mice were genotyped by multiplex PCR for the wild type and targeted allele 
using the following primers: 5’ AGCCAGACAGTGGAGTACTACCAC 3’, 5’ 
GCATCACCTTCACCCTCTCCACTGAC 3’, and 5’ 
GAAGCCACAGACATAGACAACGGAAGA 3’. Ig -transgenic mice were genotyped by 
PCR using the following primers: 5’ CAGGACTCTGGAGAAAGGAAGCTA 3’ and 5’ 
GTTAGGCCTGTAGAACCCATTTGC 3’ and the Ikaros transgenic mice were genotyped 
by PCR using the following primers: 5’ GCAGAAGGATCCTGAGAACTT 3’ and 5’ 
CCCTGATTTGGTCAATATGTGT 3’. All PCR was performed using standard conditions. 
2.2 CELL PURIFICATION AND CULTURE 
2.2.1 Primary pre-B cell extraction 
Bone marrow cells were obtained from 4-20 week old mice by flushing tibia and femurs 
with PBS/5% (v/v) Foetal calf serum (FCS) using a 21G needle and lymphocytes were 
purified over a layer of Ficoll-Plaque PLUS (Amersham Biosciences) by centrifugation at 
900g for 12 mins at room temperature. Lymphocytes were aspirated from the interphase 
and washed twice in PBS/5% FCS before use.  
B cell subsets were isolated from bone marrow lymphocytes by Flow Activated Cell 
Sorting (FACS) by the CSC Flow cytometry facility (MRC, CSC) using a FACSAria or 
Diva (Becton Dickinson) or Influx (Cytopedia) cell sorter. The following surface markers 
were used to identify populations; pre-BI cells B220+CD43+IgM-, large pre-BII cells 
B220loCD43-IgM-FSChi, small pre-BII cells B220loCD43-IgM-FSClo, immature B cells 
B220hiIgM+IgD-. 
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Primary pre-B cultures were derived from either adult bone marrow or foetal liver. Bone 
marrow pre-B cell cultures were obtained by isolating B220loIgM- by FACS. Foetal livers 
were extracted from day 12.5 to 14.5 embryos, disaggregated in PBS/5% FCS using a 21G 
needle and lymphocytes purified by ficoll gradient as described.  
2.2.2 Mature ex-vivo B cell extraction 
Spleens were disaggregated through a 0.4μm cell strainer (BD Pharmingen) and a single 
cells suspension obtained by passing through a 21G needle. Lymphocytes were then 
enriched by ficoll gradient or red blood cells lysed by treatment with ice cold Geys 
solution. Briefly, single cell suspension from one spleen were mixed in a 1:4 ratio with 
Geys solution (4 parts solution A (650mM NH4Cl, 25mM KCl, 4mM Na2HPO*12H2O, 
1mM KH2PO4, 28mM Glucose), 1 part solution B (20mM MgCl2*6H2O, 6mM 
MgSO4*7H2O, 30mM CaCl2), 1 part solution C (267mM NaHCO3) and 14 parts sterile 
distilled water) and incubated on ice for 2 mins. Excess medium was then added to dilute 
the Geys solution and cells were washed twice before use. 
Resting mature B cells were isolated by MACS CD43 microbead (Miltenyi Biotec) 
depletion according to manufactures instructions. Briefly, lymphocytes were stained with 
CD43 microbeads for 30 mins at 4°C in PBS/5% FCS, washed three times and passed over 
a LD or CS (Miltenyi Biotec) magnetic separation column. To extract mature resting B 
cells, LD columns were washed three times with 5ml cold PBS/5% FCS and CS columns 
were washed four times with 10ml cold PBS/5%FCS.  
Marginal zone (MZ) and follicular (FO) B cells were isolated by FACS on the following 
surface markers: MZ cells: B220hiCD21hiCD23hi; FO cells: B220hiCD21hiCD23lo. 
2.2.3 B cell culture 
All primary B cells and the pre-B cell lines, B3 and Slp65-/-ERt2-Slp65 (kindly provided by 
Dr H. Jumaa (MPI, Freiburg)), were maintained in Iscove’s modified Dulbecco’s medium 
(IMDM) (Invitrogen) supplemented with 10% (v/v) heat-inactivated FCS, 2μM β-
mercaptoethanol, 1% (v/v) penicillin-streptomycin and cells were maintained at 37°C and 
5% CO2. Bone marrow and foetal liver cultures were enriched for cycling pre-B cells for a 
minimum of four weeks before use. 
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Pre-B cultures were supplemented with 5ng/ml IL-7 (R&D systems) and primary pre-B 
cultures were subcultured on an irradiated ST2 stromal cell layer. To induce cell cycle 
arrest and differentiation, pre-B cell cultures were washed three times in PBS/5% FCS 
and recultured in media without IL-7 or ST2 stromal cells with or without the addition of 
30μg/ml Lipopolysaccharide (LPS) (Sigma). Slp65-/-ERt2-Slp65 pre-B cells were induced 
by first washing three times in PBS/5% FCS and then culturing with 1mM 
hydroxytamoxifen (4-HT) or EtOH (Sigma) in either 0.1ng/ml IL7lo or 5ng/ml IL7hi 
conditions. 
Mature resting B cells, marginal zone and follicular B cells were activated by LPS at 
stated concentration or CD40 activation by addition of 20μg/ml purified anti-CD40 
(monoclonal antibody FGK45), 10μg/ml purified anti IgM (monoclonal antibody H3074) 
and 2% IL-4 containing supernatant (from a T-helper cell line). 
2.2.4 Fibroblast cell culture 
293T cells provided by Dr S. Smale, UCLA, were cultured in Dulbecco’s modified Eagle 
Media (DMEM) (Invitrogen) supplemented with 10% (v/v) heat-inactivated FCS, 1% (v/v) 
penicillin-streptomycin and 1% (v/v) L-glutamine.  
2.2.5 Stromal cell culture 
The ST2 stromal cell line was maintained in IMDM with 10% (v/v) heat-inactivated FCS, 
1% (v/v) penicillin-streptomycin. Cells were irradiated (33Greys) and frozen in FCS/10% 
DMSO. Cells were thawed and plated at 14,000cells/cm3. 
Mouse embryonic fibroblasts (MEFs) were derived from disaggregated E12.5 embryo 
tissue where the head and internal organs had been removed. Cells were cultured in 
dishes in DMEM supplemented with 10% (v/v) FCS, 1% (v/v) penicillin-streptomycin, 1% 
(v/v) non-essential amino acids, 1% (v/v) L-glutamine, and 4μM β-mercaptoethanol for at 
least four days and passaged once to enrich for fibroblasts before use. MEFs expressing 
the MHC Class II H2b haplotype were obtained from C57BL/6 embryos and the H2d 
haplotype specific MEFs were obtained from BALB/c embryos.  
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2.2.6 293T cell transfection and retroviral production  
Retroviral vectors and the pCL-Eco or pCL-10A1 (Imgenex) retrovirus packaging vector 
were co-transfected into 293T using a calcium phosphate protocol (Cobb et al., 2000). 
Briefly, DNA-containing precipitates were formed by slowly adding 500μL of 2X HEBS 
buffer (280 mM NaCl, 10 mM KCl, 1.5 mM Na2HPO4.2H2O, 12 mM glucose, 50 mM 
HEPES free acid, pH 7.05 in distilled water) to 500μL of a 0.4M CaCl2 solution containing 
4µg of MSCV plasmid DNA and 4ug packaging vector DNA. 1ml of DNA precipitate 
was slowly added to a 30-40% confluent 10cm3 dish cultured in 9ml medium. Cells were 
fed with fresh media 12 and 24 hours post-transfection and supernatant containing virus 
particles were collected 36, 48 and 60 hours post transfection and pooled. 
2..2.7 Retroviral transduction of B cells 
Pre-B cells were transduced by resuspending 2x106 cells in 4ml virus supernatant in a 
single well of a 6 well plate. MZ and FO cells were transduced by resuspending upto 
5x105 cells in 1ml virus supernatant in a single well of a 24 well plate. Virus supernatant 
was supplemented with 4μg/ml polybrene and 10mM HEPES (both from Sigma) pH7.6 
per ml and plates were centrifuged at 900g for 1 hour at 30°C. Cells were incubated for 2-
3 hours at 37 C, then removed from virus supernatant and recultured in appropriate 
conditions. 
2.2.8 Gene knockdown by RNA interference (RNAi) 
Gene knockdown was performed using 2.5nmol siRNA (Dharmacon) introduced by 
nucleofection using the 104A1 Test Mouse B-cell Nucleofector Kit (Amaxa) following 
manufactures instructions. Cells were incubated for 72 hours before analysis. siRNA 
sequences used were siGENOME ON-TARGET Mouse LEF1 duplex #1 5’ 
GAAAGGAGCAGGAGCCCAAUU 3’ and LEF1 duplex #4 5’ 
AAUGAGAGCGAAUGUCGUAUU 3’ and siCONTROL Non-Targeting siRNA #1 5’ 
UAGCGACUAAACACAUCAA 3’ (all from Dharmacon). 
2.2.9 Generation of kappa-GFP mice 
Kappa-GFP ES cells (provided by Dr. M. Schlissel (UCLA)) were maintained in DMEM, 
10% (v/v) FCS, 1% (v/v) L-glutamine, 2μM β-mercaptoethanol (all from Invitrogen), 
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0.18% (v/v) LIF,  on a mitomycin C (Invitrogen) inactivated layer of SNL fibroblasts. Cells 
were processed to minimise the total number of passages. Cells were split every two days 
by trypsinization. For CRE mediated deletion of the neomycin cassette, 1-2x107 cells were 
washed twice with PBS, resuspended in 0.8ml PBS with 20µg pTurbo-CRE and incubated 
on ice for 5 mins before undergoing electroporation at 200V 960µF. Cells were then 
incubated on ice for a further 5 mins and then cultured on feeders. Five days later, 144 
individual colonies were picked and screened for loss of neomycin resistance gene by 
treatment with G418 (Invitrogen) and PCR using primers 5’ 
CCCCTGAACCTGAAACATAAAATG 3’ and 5’ 
TCTGAGCACCGAGTAAAGGTTTGTCTA 3’ for GFP-neomycin detection and 5’ 
ACCTGTCCACACAATCTGCCCT 3’ and 5’  ATGTTTCAGGTTCAGGGGGAGGTG 3’ 
for detection of the endogenous and kappa-GFP loci (Figure 3.3 and data not shown). For 
the PCR screen, DNA was prepared by treating individual colonies grown in a 96 well 
plate by first washing cells with PBS followed by treatment overnight at 55˚C in lysis 
buffer (100mM NaCl, 10mM Tris pH7.5, 10mM EDTA, 0.5% Sarcosyl, 1mg/ml Proteinase 
K). The following day, two volumes ice cold 100% EtOH were added to each well and left 
at room temperature for 30 mins, followed by inversion to remove supernatant. The 
wells were washed with 70% ice cold EtOH and after air drying, resuspended in water.  
Three targeted ES clones were identified which had deleted the neomycin cassette (data 
not shown). Colonies were expanded for Blastocyst injection and were karyotyped to 
ensured correct chromosome number. For karyotyping, cells were treated with 20ng/ml 
demecolcine (Sigma) for one hour to arrest in cells in metaphase. Cells were washed in 
PBS, trypsinized and washed again in PBS before resuspension in hypotonic solution 
(0.56% w/v KCl) for 6 mins at room temperature, followed by centrifugation at 750rpm 
for 5 mins and resuspension in ice-cold fixative (3:1 methanol:acetic acid) added drop 
wise up to 5ml. Fixative was left a room temperature for 5 mins before pelleting cells and 
repeating fixation three times. Cells were resuspended in 1ml fixative and one-two drops 
were dropped onto an acid washed slide (washed in 5% acetic acid) from 30-50cm and 
allowed to air dry. Slides were then stained with 10% Giemsa (VWR) for twenty mins, 
washed with water, and allowed to air dry before mounting with DPX mounting 
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medium (VWR). Slides were viewed on a light microscope and the chromosomes from 20 
to 30 nuclei were counted to ensure the correct number.  
Following identification of a colony which had both deleted the neomycin cassette and 
had the correct karyotype, four chimeric mice were generated by blastocyst injection and 
uterine transplant (procedures performed by J. Goodwin, Transgenics and Embryonic 
Stem Cell Laboratory, MRC, CSC). 
  
68 
 
2.3 ANTIBODIES  
Antibodies for FACS analysis 
Antibody Conjugate Host Clone Source Dilution 
Mouse B220 FITC/PE/APC Rat RA3-6B2 B.D. Pharmingen 1:100 
Mouse CD19 PE Rat 1D3 B.D. Pharmingen 1:100 
Mouse 
CD21/CD35 
PE Rat 7G6 B.D. Pharmingen 1:100 
Mouse CD23 FITC Rat B3B4 B.D. Pharmingen 1:100 
Mouse CD43 Biotin Rat S7 B.D. Pharmingen 1:25 
Mouse CD175b 
(λ5) 
Biotin Rat LM34 B.D. Pharmingen 1:50 
Mouse Ig  Biotin Rat 187.1 B.D. Pharmingen 1:50 
Mouse IgM APC Rat II/41 B.D. Pharmingen 1:100 
Mouse IgD Biotin Rat 11-26 Southern Biotech 1:100 
Streptavidin Per-CP   B.D. Pharmingen 1:100 
Streptavidin Tri-Color   Caltag 1:200 
Antibodies for Western blotting 
Antibody Conjugate Host Clone Source Dilution 
FLAG Unonjugated Rabbit M2 Sigma 1:2000 
HA Unconjugated Mouse F-7 Santa Cruz 1:1000 
GFP Unconjugated Mouse 
Polyclonal 
(A11122) 
Molecular Probes 1:500 
Human Histone 
H3 
Unconjugated Rabbit 
Polyclonal 
(ab1791) 
Abcam 1:2000 
Human Lamin B Unconjugated Goat C20 Santa Cruz 1:2000 
α-Tubulin Unconjugated Mouse DM1A Sigma 1:1000 
Ikaros CTS Unconjugated Rabbit Polyclonal Dr. S.Smale, UCLA 1:1000 
Mouse β-catenin Unconjugated Rabbit 
Polyclonal 
(ab6302) 
Abcam 1:1000 
Mouse Ig  Unconjugated Goat 
Polyclonal 
(A90-119) 
Bethyl Labs 1:1000 
Mouse IRF4 Unconjugated Goat 
Polyclonal 
(M-17) 
Santa Cruz 1:1000 
Mouse LEF1 Unconjugated Rabbit C18A7 Cell signalling 1:250 
Mouse PU.1 Unconjugated Rabbit 
Polyclonal 
(T-21) 
Santa Cruz 1:1000 
Mouse IgG HRP Sheep  
Amersham 
Biosciences 
1:2000 
Rabbit IgG HPR Donkey  
Amersham 
Biosciences 
1:5000 
Goat IgG HRP Donkey  Santa Cruz 1:2000 
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Antibodies for immunofluorescence 
Antibody Conjugate Host Clone Source Dilution 
HA TRITC Mouse F-7 Santa Cruz 1:50 
Ikaros CTS Unconjugated Rabbit Polyclonal Dr. S.Smale, UCLA 1:1000 
GFP Unconjugated Mouse 
Polyclonal 
(A11122) 
Molecular Probes 1:500 
Mouse β-catenin Unconjugated Rabbit 
Polyclonal 
(ab6302) 
Abcam 1:1000 
Rabbit IgG Alexa 488 Goat  Molecular Probes 1:400 
Mouse IgG Alexa 488 Goat  Molecular Probes 1:400 
Table 2.1 Antibodies used for FACS, Western blotting and Immunofluorescence.  
 
2.4 FLOW CYTOMETRY AND IMMUNOSTAINING 
2.4.1 Cell surface staining 
For cell surface staining, 1x106 cells were stained with primary antibodies at the 
appropriate dilution in 50ul PBS/5% FCS for 20 mins at room temperature. Cells were 
then washed twice in PBS/5% FCS and, if required, incubated with the appropriate 
secondary antibodies for 20 mins at room temperature in PBS/5% FCS, followed by two 
washes in PBS/5% FCS. Cells were then analysed on a FACSCalibur (Becton Dickinson) 
or sorted by FACSAria, Diva (Becton Dickinson) or Influx (Cytopedia).  When cells were 
to be used for mRNA analysis, all staining was performed on ice for 40 mins, and cell 
sorting performed at 4°C.  
Dead cells were excluded from the analysis and cell sorting where stated by Propridium 
Iodide (PI) fluorescence by adding 2.5µg/ml PI to the final buffer. PI can only penetrate a 
permeabilized cell membrane, which occurs during apoptosis or necrosis.  
Antibodies used for FACS staining are indicated in Table 2.1. 
2.4.2 Cell cycle analysis 
For cell cycle staining, cells were first FACS purified to obtain a pure population, then 
incubated in staining buffer (50ug/ml PI, 0.05% NP40, 1mg/ml RNaseA in PBS) for 30 
mins on ice, followed by analysis on a FACSCalibur. PI intercalates nucleic acid and 
when coupled with RNase digestion, allows quantitation of DNA content by flow 
cytometry 
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2.4.3 Immunofluorescence 
Cells were attached to poly-L-lysine coated coverslips, washed with PBS and fixed in 2% 
paraformaldehyde (PFA) for 15 mins. Coverslips were then washed three times with PBS 
then incubated for 5 mins in 0.4% Triton-X in PBS to permeabilized cells. Coverslips were 
then washed 2 x 5 mins in PBS, 1 x 5 mins in wash buffer (PBS with 0.2% BSA, 0.04% 
Tween-20), incubated for 30 mins in blocking buffer (PBS with 0.2% BSA, 0.04% Tween-
20, 10% Normal goat serum), followed by incubation with primary antibody in blocking 
buffer for 2 hours. Coverslips were then washed 3 x 5 mins in wash buffer and incubated 
with the secondary antibody in blocking buffer for 45 mins, then washed 3 x 5 mins with 
wash buffer, once in PBS and mounted on slides in Vectorshield with DAPI (Vector 
Laboratories). Antibodies used in immunofluorescence are indicated in Table 2.1. 
2.5 DNA AND RNA MANIPULATION AND QUANTIFICATION 
2.5.1 Isolation of plasmid DNA 
For isolation of 5-25µg plasmid DNA, a single colony of bacteria was used to inoculate 2-
10ml of LB broth containing 100µg/ml ampicillin, which was incubated shaking 
overnight at 37°C. Plasmid DNA was extracted using QIAprep Spin Miniprep Kit 
(Qiagen) according to manufactures instructions. For isolation of upto 500µg plasmid 
DNA, a 150ml culture in LB broth with 100µg/ml ampicillin was inoculated from a 1ml 
starter culture and grown overnight shaking at 37°C. Plasmid DNA was extracted using 
the Plasmid Maxi Kit (Qiagen) following manufactures instructions.  
2.5.2 Isolation of genomic DNA 
Cells were digested in 0.5ml lysis buffer (500mM NaCl, 25mM Tris pH8, 5mM EDTA, 
0.25% SDS, 100µg Proteinase K) at 55°C for 2 hours. DNA was then purified by 
Phenol/Chloroform (1:1) extraction followed by Chloroform extraction and precipitation 
with 2.5 volumes 100% ethanol. The resultant DNA pellet was washed in 70% ethanol, air 
dried and resuspended at 2000 cells/µl in water.   
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2.5.3 RNA extraction and cDNA synthesis 
RNA samples were extracted using RNAzol B (Tel-Test) or the RNeasy Mini Kit (Qiagen) 
according to manufactures instructions, followed by DNA digestion using the Turbo 
DNase Kit (Ambion) according to manufactures instructions. cDNA was prepared using 
Superscript III with oligo(dT) primer to copy all mRNA species and with addition of 
RNaseOUT RNase inhibitor (all from Invitrogen) following manufactures instructions. 
For gene expression analysis, equal concentrations of RNA, determined by absorbance at 
260nm or cell number, were used for all samples. Reactions without Superscript III were 
performed to control for genomic DNA contamination of RNA.   
2.5.4 Polymerase Chain Reaction 
PCR for DNA and cDNA analysis was performed using Hot Start Taq Polymerase 
(Qiagen), using 10-200ng DNA/cDNA, 1X PCR buffer, 0.2mM of each primer, 0.2mM 
deoxyribose nucleotide triphosphates (dNTPs) (Amersham), and 1.25 units Taq to a final 
volume of 25µl. Cycling conditions were 95°C for 15 mins, followed by 35 cycles of 
denaturation at 95°C for 30 seconds, annealing at 55°C for 30 seconds and elongation at 
72°C for 30 seconds per 500 base pairs product length, followed by final elongation step 
at 72°C for 10 mins. 
PCR for cloning was performed using high fidelity Phusion Taq (NEB) using 200ng 
cDNA or 50ng plasmid DNA with 10µl 5X HF buffer, 0.2mM each primer, 0.2mM 
dNTPs, 2 units Phusion Taq. Cycling conditions were 95°C for 15 mins, followed by 35 
cycles of denaturation at 95°C for 30 seconds, annealing at 55°C for 30 seconds and 
elongation at 72°C for 30 seconds per 1 kb pairs product length, followed by final 
elongation step at 72°C for 10 mins. 
2.5.5 Restriction enzyme digest and DNA ligation 
All restriction enzymes, T4 DNA ligase and buffers were purchased from New England 
Biolabs (NEB) and used according to manufactures instructions. Restriction digests were 
performed for at least one hour at the recommended temperature and ligations were 
performed overnight at 16˚C. 
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2.5.6 DNA agarose gel electrophoresis and gel extraction 
DNA was separated on 0.8%-2% agarose gels in 0.1% TAE with Ethidium bromide. If 
products were to be purified, they were excised and purified using the QiaQuick Gel 
purification Kit (Qiagen) extraction kit according to manufactures instructions. 
2.5.7 General cloning 
Cloning was performed by restriction digest, gel purification of fragments and ligation 
into the target vector or through PCR amplification from appropriate DNA/cDNA using 
Phusion taq and primers listed in Table 2.2. Primers either contained restriction sites to 
allow ligation into target vector or contained complementary sequences to allowing PCR 
SOEing to join two genes. All constructs were confirmed by sequenced by the MRC 
Genomics Core Facility genomics facility to ensure no mutations had occurred during the 
PCR reaction. 
2.5.8 Plasmids and constructs 
The pMIG vectors containing full length Ikaros 1 and the Ikaros DN N159A point 
mutation, fused to an N-terminal HA epitope tag upstream of an IRES-GFP were a kind 
gift from Prof. S. Smale (UCLA) (Cobb et al., 2000). Fusion of a double FLAG epitope 5’ of 
the gene start site was achieved by subcloning sequences through a pcDNAIII-FLAG 
vector provided by Dr B Cobb (MRC, CSC). The retroviral expression vector pMSCVpuro 
(Clontech) was used as the backbone for generation of pMICy and pMIR bicistronic 
fluorescent reporters where CFP from pCFP-C1 or DsRed from pDsRed-Express (both 
from Clonetech) were fused downstream of an internal ribosome entry site (from pIRES, 
Clontech) by PCR SOEing and cloned into the EcoRI-ClaI site. Figure 2.1 shows the 
cloning sites for the pMSCV, pMIG/MICy/MIR, pCDNAIII (Invitrogen) and pCDNAIII-
FLAG vectors. 
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Figure 2.1 Vector maps with cloning sites. 
The maps (not to scale) show selected features and restriction sites (unique ones are in 
red). Features shown are the cytomegalovirus immediate early promoter (pCMV IE); long 
terminal repeats (LTRs); virus packaging signal (ψ+); internal ribosome entry site (IRES); 
puromycin resistance gene (PuroR); green fluorescence protein (GFP); cyan fluorescent 
protein (CyFP); DsRed-express fluorescent protein (DsRed); murine phosphoglycerate 
kinase promoter (PGK). 
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Primers for cloning 
Gene Orientation Sequence 5’-3’ 
Restriction 
site 
5’κ˚ Forward CGACTAGGTACCGATCCACTTACTGTTTTCTC KpnI 
3’κ˚ Forward CGACTAGGTACCCTTCAGTGAGGAGGGTTTTTGTACA
GCC 
KpnI 
Kappa-GFP Reverse CGACTAGAATTCGTGATGCTATTGCTTTATTTGTAACC EcoRI 
Endogenous 
kappa 
transcript 
Reverse TAGTCGGAATTCACACTCATTCCTGTTGAAGC EcoRI 
β-cateninΔex3 into pCDNAIII-FLAG 
 Forward CGACTAGGTACCATGGCTACTCAAGATATTGACGGG
CAGTATG 
KpnI 
Reverse GCTGATGGATCCTTACAGGTCAGTATCAAA BamHI 
β-cateninΔex3 from pCDNAIII-FLAG into pMIG 
 Forward  CGACTAGGATCCATCTACTAGTCCACCATG BamHI 
Reverse  GCTGATCAATTGTTACAGGTCAGTATCAAA MfeI 
IRF4 Forward CGACTAGGTACCATGAACTTGGAGACGGGCAGC KpnI 
 Reverse  GCTGATGAATTCTCACTCTTGGATGGAAGAATG EcoRI 
LEF1 Forward CGACTAGGTACCATGCCCCAACTTTCCGGA KpnI 
LEF1DN Forward CGACTAGGTACCATGATGCCCAATATGAACAGC KpnI 
LEF1WT&DN Reverse GCTGATGAATTCTCAACAAGCTTCCATCTC EcoRI 
PU.1 Forward CGACTAGGATCCATGTTACAGGCGTGCAAAATGG BamHI 
 Reverse  GCTGATGAATTCGGGCGACGGGTTAATGCTA EcoRI 
IRES Forward GCGGATGGATCCTAGCGGAATTCCGCCCCTCTCCCT EcoRI 
CyFP Forward  GATAATATGGCCACAACCATGGTGAGCAAGGGCGAG
GAG 
SOEing IRES-
CyFP 
Reverse  CTCCTCGCCCTTGCTCACCATGGTTGTGGCCATATTAT
C 
SOEing IRES-
CyFP 
Reverse CGACTAATCGATTTACTTGTACAGCTCGTCCATGCC ClaI 
DsRED Forward  GATAATATGGCCACAACCATGGCCTCCTCCGAGGAC
GTC 
SOEing IRES-
DsRED 
Reverse  GACGTCCTCGGAGGAGGCCATGGTTGTGGCCATATTA
TC 
SOEing IRES-
DsRED 
Reverse CGACTAATCGATCTACAGGAACAGGTGGTGGCGGCC ClaI 
Table 2.2 Primer sequences used for cloning. 
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2.5.9 Quantification of genomic DNA and cDNA 
Quantitative real time PCR (qPCR) was performed on an Opticon DNA engine (MJ 
Research) using the Opticon Monitor 3 software running the following program: Taq 
activation for 15 mins at 95°C, followed by 45 cycles of denaturing at 95°C for 30 seconds, 
annealing at 60°C for 30 seconds, elongation at 72°C for 30 seconds and plate reads at 
72°C, 75°C, 78°C and 81°C. The PCR reaction mix contained SYBR PCR Master Mix 
(Qiagen), 0.3mM each primer and 2µl template DNA or cDNA in a final volume of 30µl 
for DNA and 20µl for cDNA. All reactions were carried out in duplicate and normalised 
to stated genes using the ΔC(T) method outlines in the Applied Biosystems protocol for 
reverse transcriptase-PCR. 
Primers used for analysis were tested for efficiency and linearity over a range of template 
concentrations. The C(T) (cycle at which the PCR reaction amplifies in the exponential 
phase) of a reaction was plotted against log(template concentration). A trend line for a 
two-fold linear dilution series was generated and only primers with a R2 value exceeding 
0.9 and efficiency of 1.85-2.15 were used. All primer sequences are shown in Table 2.3. 
2.5.10 Southern analysis  
Kidneys, thymi and spleens were dissected from 5-9 week old mice. Red blood cells were 
removed by Geys treatment. Pre-BI, pre-BII and immature cells were sorted from BM and 
spleens as described. DNA was purified as described and concentration determined by 
PicoGreen (Invitrogen) according to the manufacturer’s instructions and normalisation 
was assessed by qPCR where specified. Four nanograms of DNA of sorted cells or 100ng 
of tissue DNA were amplified by twenty two cycles of PCR using primers for β-globin or 
Igκ using the Vκ21C and Jκ5 primers, described in Table 2.3. The PCR products were 
separated on a 1% agarose gel and then treated for 15 mins in denaturing buffer (1.5 M 
NaCl, 0.5 M NaOH) followed by 45 mins in neutralisation buffer (1 M Tris, pH 7.4 1.5 M 
NaCl) with buffer changes. The DNA was then transferred overnight by capillary action 
to a Hybond N+ membrane (Amersham), followed by cross linking by UV irradiation. 
Membranes were then pre-hybridised in Ultrahyb (Ambion) for 1 hour  at 42˚C followed 
by addition of a radioactively labelled probe and incubated overnight. The following 
day, the membrane was washed twice for 10 mins in 2X SSC, 0.1%SDS at 42˚C, and then 
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twice for 15 mins in 0.1X SSC, 0.1%SDS at 42˚C, and the signal quantified with a 
phosphorimager. Probes were generated using the Prime-It II kit (Stratagen) following 
the manufactures protocol and purified through a G50 column (Amersham) following 
the manufactures protocol. The β-globin probe was generated from a 155 bp XhoI - XbaI 
fragment isolated from the mouse β-globin LCR hypersensitive site 3 region while the 
V21C probe was the BglII-BglII fragment from the pMM221 vector and the Jκ1-5 probe 
was the SphI and PstI fragment from the pMM222 vector (Hiramatsu et al., 1995). 
2.5.11 Analysis of rearrangement by qPCR 
To detect rearrangement of the transgenic or endogenous Igκ locus, equal numbers of 
cells between samples were sorted by FACS (100,000 for transduction experiments) and 
the DNA extracted as described. Equal amounts of DNA were then used in a standard 
qPCR reaction using the Igκ-V21C and Igκ-J1 (transgene detection) or VκII and Igκ-J1 
(endogenous locus detection) primer pairs described in Table 2.3 and the C(T) values 
normalised to the genomic controls specified in the text. 
2.5.12 Chromatin accessibility by real time PCR (CHART-PCR) 
At 72 hours post nucleofection, FACS isolated live cells were re-cultured for 2 hours to 
allow recovery. 105 cells were then washed twice in ice-cold PBS and resuspended in 
500µl 0.5% NP-40 solution in ice-cold CHART buffer (10mM Tris pH 7.4, 15mM NaCl, 
60mM KCl, 0.15mM spermine, 0.5mM spermidine (Sigma), Complete protease inhibitors 
(Roche)). The suspension was mixed and incubated on ice for 5 mins and then spun at 
1500g for 5 mins at 4˚C. The nuclei pellet was then resuspended in 5ml ice-cold CHART 
buffer and spun at 1500g for 5 mins at 4˚C and resuspended in 100µl of appropriate NEB 
restriction enzyme buffer supplemented with protease inhibitors and the restriction 
enzymes NcoI (final concentration of 0.5U/µl to 0.03125U/µl) or SpeI (final concentration 
of 1U/µl). The samples were incubated at 37˚C for 1 hour and the restriction enzymes 
were then inactivated by incubation at 80˚C for 20 mins and the DNA was purified. DNA 
was quantified by qPCR with primers (Table 2.3) spanning the NcoI site in the Eκ3’ (Eκ3’ 
HSS) and two control sites which do not span an NcoI or SpeI site (PU.1 and β2M). 
Digestion efficiency (DE) was calculated as follows: DE=RTreated/RUntreated, where RTreated and 
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RUntreated are the relative abundance in the NcoI HSS in NcoI treated or SpeI ‘untreated’ 
sample relative to the control loci calculated by the ΔC(T) method. 
2.5.13 RNA Ligase Mediated Rapid amplification of cDNA ends (RLM-RACE) 
RLM-RACE was performed using FirstChoice RLM-RACE Kit (Ambion) following  the 
manufactures instructions. This method enhances detection of transcriptional start sites 
by a three step enzymatic protocol to enrich for undegraded mRNA. The RNA is first 
phosphatased to remove free 5’ phosphates from any degraded RNA or contaminating 
DNA, followed by removal of the 5’m7G cap with tobacco acid pyrophosphatase. This 
leaves only undegraded transcripts with a free 5’ phosphate group, to which a RNA 
linker is ligated. Reverse transcription is then performed using random primers, 
followed by two rounds of nested PCR using a primer in the RNA linker and gene 
specific primers. Primers used for 5’ and 3’ RLM-RACE are shown in Table 2.3. 
Sequencing of PCR products allowed determination of the transcriptional start site; 
Amplified products were gel purified and cloned into the pCRII vector using the TA 
cloning kit (Invitrogen), transformed into competent cells and grown on LB Agar plates 
containing 100µg/ml ampicillin streaked with 100mM Isopropyl β-D-1-
thiogalactopyranoside (IPTG) and 40mg/ml 5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside (X-gal) for blue/white selection. Single white colonies were picked into 
50ul LB broth with 100µg/ml ampicillin, grown for 2 hours at 37°C. 1µl of culture was 
used directly in a PCR reaction using the M13 forward and M13 reverse primers. PCR 
products were then sequenced using the T7 5’ TAATACGACTCACTATAGGG 3’ and 
SP6 5’ ATTTAGGTGACACTATAG 3’ primers.  
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2.5.14 Rapid amplification of cDNA ends poly(A) test (RACE-PAT PCR) 
RACE-PAT PCR was performed as described in (Salles et al., 1999). Briefly, RNA and 
200ng RACE-PAT Oligo-dT-Anchor primer (Table 2.3) in 6µl volume were first heat 
denatured at 65˚C for 5 mins and then transferred to 42˚C where the following was were 
added; 4µl 5X AMV reverse transcriptase buffer, 1µl RNaseOUT (40U/µl), 2µl 100mM 
DTT, 1µl 10mM dNTPs, 4µl H2O, 2µl AMV reverse transcriptase (10U/µl) (all from 
Invitrogen). The sample was then incubated at 42˚C for one hour and heat inactivated at 
65˚C for 15 mins. The cDNA was then used in a standard PCR reaction which used the 
indicated forward primer but a 32P labelled RACE-PAT Oligo-dT-Anchor reverse primer. 
The primer was labelled by 45 minute incubation of 2µl of 100µM primer with 5µl of 10X 
PNK buffer, 2μl PNK (all from NEB) 5μl γ32P ATP (Amersham Biosciences) and 36µl 
water. The primer was then purified over a G-50 Microcolumn (Amersham Biosciences) 
according to manufactures instructions. The PCR products were separated using a 
SequaGel 8 (National Diagnostics) acrylamide gel following manufactures instructions. A 
DNA ladder was end labelled as described and run alongside the PCR products for size 
quantification. The gel was dried onto Whatman paper and exposed to a Phosphor screen 
overnight and visualised using a Storm 820 PhosphorImager (GE Life Sciences) and 
analysed using ImageQuant (GE Life Sciences).  
2.5.15 Northern analysis  
mRNA was enriched using Oligotex (Qiagen) poly-A+ purification according to 
manufactures instructions. 1µg of poly(A) mRNA was mixed with an equal volume of 
glyoxal sample buffer (Lonza), denatured at 65°C for 15 mins and chilled on ice. 
Denatured RNA was separated on a non-denaturing Reliant agarose gel (Lonza) in 
MOPS buffer (20mM MOPS, 5mM NaAc, 1mM EDTA, 1mM EGTA) at a field strength of 
3.5 V/cm. RNA was transferred to a Hybond N+ nylon membrane (Amersham 
Biosciences) by capillary transfer with 20X SSC transfer buffer (3M NaCl, 300mM Sodium 
Citrate). Following transfer, RNA was visualised by Methylene Blue by staining the 
membrane for 1 minute in staining buffer (0.01% Methylene (Sigma)), followed by 
destaining in water. The membrane was pre-hybridised in UltraHyb (Ambion) at 65°C 
for 30 mins. The purified Riboprobe was added directly and hybridised overnight at 
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65°C, followed by 2 x 15 minute washes in 2X SSC  and 2 x 30 mins 0.1X SSC at 65°C. The 
membrane was exposed to a Phosphor screen overnight and visualised using a Storm 820 
PhosphorImager (GE Life Sciences) and analysed using ImageJ. The normalisation profile 
was calculating by measuring the pixel intensity of along a line segment for each lane, 
and normalising the values to the total pixel intensity for the HPRT band.  
The riboprobes were generated by ligating the PCR product of GFP or HPRT into the 
pCRII (Invitrogen) vector. PCR using M13 forward and reverse primers then amplified 
the product with the T7 promoter region. Primers used for generation of probes are 
shown in Table 2.3. RNA probes were then generated by in-vitro translation of a gel 
purified product using the T7 MAXIscript Kit (Ambion). In-vitro translation was 
performed for 2 hours at 37°C using 6000 Ci/μmole γ-32P-dCTP following manufacturer’s 
instructions. The in-vitro translation reaction was purified across a G-50 Microcolumn 
(Amersham Biosciences) according to manufactures instructions.  
2.5.16 Polysome analysis by sucrose gradient separation  
Sucrose gradients were prepared by diffusion (Abe and Davies, 1986). 5ml of 15% 
sucrose solution (300mM NaCl, 15mM MgCl2, 15mM Tris pH 7.6, 100U/ml RNase OUT, 
1mg/ml heparin, 0.1mg/ml cycloheximide) was layer on top of 5ml 50% sucrose solution. 
The tubes were sealed with parafilm and slowly tilted to 90° at room temperature and the 
gradient allowed to form for 3 hours. Gradients were then stored upright at 4°C 
overnight. 
Transcription was blocked by the addition of 0.1mg/ml cycloheximide (Sigma) to cell 
media for 30 mins at 37°C. Cells were then were washed twice with ice cold PBS with 
0.1mg/ml cycloheximide and 1 x 107 cells were lysed on ice for 10 mins in 0.5ml lysis 
buffer (300mM NaCl, 15mM MgCl2, 15mM Tris-HCl pH 7.6, 1% Triton X-100, 50U RNase 
OUT (Invitrogen), 1mg/ml of heparin, 0.1mg/ml of cycloheximide). Nuclei were pelleted 
at 20,000g for 10 mins, and the resulting supernatant was layered onto a 10ml continuous 
15-50% sucrose gradient and centrifuged at 260,000g for 90 mins. Approximately 0.4ml 
fractions were collected using a Teledyne ISCO density gradient fractionation system 
with continuous monitoring at 254nm. RNA was extracted from samples using Trizol LS 
(Sigma), following manufactures instructions. 
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2.5.17 Microarray analysis 
100ng of RNA was amplified by two cycles of reverse transcription and in-vitro 
transcription following the Small Sample Protocol developed by the CSC/IC Microarray 
Centre (available on request), using the GeneChip Two-Cycle cDNA synthesis kit, 
GeneChip IVT labelling kit, GeneChip Sample Cleanup Module (all from Affymetrix) 
and the MEGAscript High Yield Transcription Kit (Ambion). RNA integrity was assessed 
at the beginning of the protocol and cRNA was assessed following each amplification 
step using a RNA Nano Chip and a Bioanalyser (both from Agilent) following the 
protocol provided by the CSC/IC Microarray Centre (available on request). The final 
cRNA was hybridised to GeneChip Mouse Genome 430 2.0 Arrays (Affymetrix) by the 
CSC/IC Microarray Centre and microarray images were processed and analysed for 
differential expression by Dr M. Leleu (MRC, CSC) using the Bioconductor Package for R 
(normalisation and processing parameters available on request). Heatmaps shown in 
Chapter 5 were generated using the fold change values generated from microarray 
analysis and visualised using the matrix2png program available at 
http://bioinformatics.ubc.ca/matrix2png/.  
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2.5.18 PCR primers 
Primers for qPCR 
Primer Orientation Sequence 5’-3’ 
Amylase 
Forward CAAAGCAAAATGAAGTTCGTTCTGCTGC 
Reverse GAAGTTATCTTACCTGCACCCCTCCAAATC 
β2M 
Forward CACCCGCCTCACATTGAAAT 
Reverse TCGATCCCAGTAGACGGTCTTG 
PU.1 
Forward GGATCTGACCAACCTGGAGCTCAG 
Reverse TCCGGGGAGGAAACACCAAC 
Igκ-V21C Forward CAGGTTCAGTGGCAGTGGGTCTA 
VκII  
(Diss et al., 
2002) 
Forward TTCAGTGGCAGTGGGKCAGG 
Igκ-J1 Reverse GCCACAGACATAGACAACGGAAGAAAG 
Eκ3’ HSS 
Forward ACTGGCCTGAGAAGATTAAAAAAAGTAATG 
Reverse CAGTGTGACGGTAGCTATGACAGTTG 
Primers for qRT-PCR 
Primer Orientation Sequence 5’-3’ 
1.1kb transcript 
Forward GTGACTGATAAACTGGGAAGAGAAAATT 
Reverse CAGCATCAGCCCCTGGCACTG 
0.8kb transcript 
Forward TTTTGTACAGCCAGACAGTGGAGTA 
Reverse GGACGCCATTTTGTCGTTCAC 
Bcl6 
Forward GTGAGCCGTGAGCAGTTTAGAGC 
Reverse ACATGAAGTCCAGGAGGATGCAA 
Cd43 
Forward GCTCCAAGTACCTCTGAAGCCC 
Reverse CCAGCAGAAGTCTCCAAAGAAGAC 
Ctnnb1 
Forward GCTTATGGCAATCAAGAGAGCAA 
Reverse TGCATCCCACCAGCTTCTACA 
Ebf 
Forward AGATCTGGTTGAAGCCCTGTATGG 
Reverse CATGTCACATCTCAGATCCTGTGTTCT 
Total GFP 
Forward AGACAACCATTACCTGTCCACACA 
Reverse AATCCCAGCAGCTGTTACAAACT 
Spliced GFP 
Forward GCTGCTGGGATTACACATGGC 
Reverse CCTTGGGACTGTGAATCTTAGAGC 
Transcript C 
Forward GTGATTTACTGCCCAAAGACAAGTC 
Reverse CATCACCATCTGGCACTGGAATA 
Transcript D 
Forward TGAAAATCAGCAGTTCTCTGTCAGA 
Reverse TTTTGTACAGCCAGACAGTGGAGTA 
Hmbs 
Forward ACTGGTGGAGTCTGGAGTCTAGATGGC 
Reverse GCCAGGCTGATGCCCAGGTT 
Hprt 
Forward TTGAAATTCCAGACAAGTTTGTTGTTGG 
Reverse CCTGCTAATTTTACTGGCAACATCAACA 
Igκ-C 
Forward GCACCAACTGTATCCATCTTCCC 
Reverse CCAACTGTTCAGGACGCCATT 
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Igll1 
Forward GGACTTGAGGGTCAATGAAGCTC 
Reverse GTGGGATGATCTGGAACAGGAG 
Ikzf1 
Forward CAACCATTCAGCACAGGACGC 
Reverse ATAAGGCCGCTGCGCTGTT 
HA-Ikaros 
Forward CCCATACGATGTTCCAGATTACGC 
Reverse TGCTGTGCTCCAGAGGTAGTGG 
Ikzf3 
Forward AGAAGATCTTGCCTTCTGAACGAGGTC 
Reverse CTCCTTCAGAAGAGGCATCCCAT 
Irf4 
Forward CCAGTCACACCCAGAAATCCCA 
Reverse ATGGGGATTCCAGGAGCCTG 
Lef1 WT 
Forward TCAGACAAGCCCCGTCCTCT 
Reverse CGGGTCGCTGTTCATATTGG 
Lef1 WT&DN 
Forward ATCCCACCCGTCACACATCC 
Reverse TGGGGTGATCTGTCCAACGC 
Myc 
Forward TTCATCTGCGATCCTGACGAC 
Reverse AGGGGTCAATGCACTCGGA 
Pax5 
Forward TTGTGAATGGACGGCCACTCC 
Reverse CGGCTTGATGCTTCCTGTCTCATA 
Pou2af1 
Forward ACATGTACGTGCAGCCTGTGTGC 
Reverse AGGCCACGGGAAATAAGTGAGG 
Prdm1 
Forward CGCTGACGGGGGTACTTCTGTT 
Reverse CCTGTTGGCATTCTTGGGAACTGT 
Rag1 
Forward AGAGAGCAAGGAGAGAGTAGACAGCA 
Reverse GGTGTTGAATTTCATCGGGTGC 
Rag2 
Forward GCTTGGCACAAACTAAACAGTGAC 
Reverse CTGCTTGTGGATGTGAAATACTCTTT 
Sdc1 
Forward AGCCTGCCCTCCCGCAAATT 
Reverse GGAAGGTGTCTGCCGTGACAA 
Sfpi1 
Forward GACTACTACTCCTTCGTGGGCAGC 
Reverse ACGCTCTGCAGCTCTGTGAAGTGG 
Ube 
Forward AGGAGGCTGATGAAGGAGCTTGA 
Reverse TGGTTTGAATGGATACTCTGCTGGA 
Vκ-Jκ 
Forward TTCAGYGGCAGTGGRTCTGG (Diss et al., 2002) 
Reverse TGGGAAGATGGATACAGTTGGTGC 
Xbp1 
Forward GCAGCGCAGACTGCTCGAGATAGA 
Reverse GCCGTGAGTTTTCTCCCGTAAA 
Yhwaz 
Forward CGTTGTAGGAGCCCGTAGGTCAT 
Reverse TCTGGTTGCGAAGCATTGGG 
Primers for RLM-RACE, RACE-PAT, riboprobe generation and Southern analysis 
Primer Orientation Sequence 5’-3’ 
RACE Outer Forward GCTGATGGCGATGAATGAACACTG 
RACE Inner Forward CGCGGATCCGAACACTGCGTTTGCTGGCTTTGATG 
GFP Outer Reverse TGAACACCATAGCACAGAGTAGTGACTA 
GFP Inner Reverse GCAACATACGGAAAACTTACCCTG 
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RACE-PAT 
Oligo-dT-
Anchor 
Reverse GCGAGCTCCGCGGCCGCG-(T)12 
RACE-PAT 
Spliced GFP 
Forward GCTCTAAGATTCACAGTCCCAAGG 
RACE-PAT 
Unspliced GFP 
Forward CCCTCAGTCCTCACAGTCTGTTCA 
GFP riboprobe 
Forward ACTCTTCACTGGAGTTGTCCC 
Reverse 
ATGTTTCAGGTTCAGGGGGAGGTG (Liang et al., 
2004) 
HPRT 
riboprobe 
Forward GGCTATAAGTTCTTTGC 
Reverse TCCAACACTTCGAGAGGTCC 
M13 
Forward GCCAGGGTTTTCCCAGTCACGA 
Reverse GAGCGGATAACAATTTCACACA 
β-globin 
Forward TGGGCAAATACCAGACAC 
Reverse CACATCTTCCAAAGCAGC 
Vκ21C-Jκ5 
Forward AGCCAGTGAAAGTGTTGATAG 
Reverse AGGTTGCCAGGAATGGCTCA 
Table 2.3 Primer sequences used for PCR analysis. 
 
2.6 PROTEIN QUANTIFICATION AND DNA BINDING ANALYSIS  
2.6.1 Cell lysis and SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) 
Cells were washed in cold PBS and resuspended in lysis buffer (50mM Tris pH 6.8, 1% 
SDS, 10% glycerol, 0.001% bromophenol blue, 5% β-metcaptoethanol), vortexed, 
denatured at 95 C for 5 mins and vortexed again. Protein concentration was determined 
using a BCA protein assay (Pierce Biotechnology) according to manufactures 
instructions, using samples without bromophenol blue and β-metcaptoethanol. 20-40μg 
protein were separated on a SDS-polyacrylamide gel, contain a stacking gel (5% 
acrylamide, 125mM Tris pH6.8, 0.1% SDS, 0.067% ammonium persulfate (APS), 0.0012% 
N, N, N’-tetramethylethylenediamine (TEMED)) and separating gel (8-12% acrylamide, 
400mM Tris pH8.8, 0.1% SDS, 0.05% APS, 0.001% TEMED) run in Tris-glycine 
electrophoresis buffer (25mM Tris, 192mM glycine, 0.1% SDS) at 120V for 1 hour using 
the Mini-PROTEAN II Electrophoresis Cell Kit (Bio Rad). Protein size was determined 
using the Benchmark prestained Protein ladder (Invitrogen) run with each gel.  
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2.6.2 Western analysis 
Protein gels were transferred to a nitrocellulose membrane (Schleicher and Schuell 
Bioscience) using the Trans-Blot SD Semi-Dry Electrophoretic Transfer Cell (Bio Rad) for 
1 hour 15 mins at 1.5mA/cm2 gel in transfer buffer (48mM Tris-Base, 39mM glycine, 
0.037%SDS, 20% Methanol). The nitrocellulose membrane was then blocked for 30 mins 
in blocking buffer (150mM NaCl, 10mM Tris pH7.4, 5% milk powder) and probed with 
primary antibodies for 1-16 hours in blocking buffer. Following three 5 minute washes in 
washing buffer (150mM NaCl, 10mM Tris pH7.4), membranes were probed with 
secondary antibody for 1 hour in blocking buffer. Membranes were washed three times 
for 5 mins and developed using the ECL plus detection system (Amersham Biosciences) 
following manufactures protocol. Antibodies used for western blotting are show in Table 
2.1.  
2.6.2 Electrophoretic mobility assay (EMSA) 
GST-Ikaros was purified according to Hahm et al., 1994, with modification. Briefly, 
bacteria were induced with 1mM isopropylthiogalactopyranoside (IPTG) and 100mM 
ZnCl2 for 2 hours. Cells were pelleted and were resuspended in 1/10 volume NTN buffer 
(100mM NaCl, 20mM Tris pH 8.0, 0.5% NP-40) followed by sonication for 3 x 30 seconds. 
Glutathione-agarose beads were then added and after 2 minute incubation, beads were 
pelleted and washed three times with PBS and then eluted three times by resuspension in 
50mM Tris (pH 8.0), 5mM reduced glutathione followed by centrifugation at 500g and 
collection of the supernatant. All steps were performed at 4˚C. 
PU.1, LEF1, LEF1DN and Ikaros nuclear extracts were prepared from 293T cells 
transfected with pEF-XC (empty vector), pEF vectors expressing PU.1, LEF-1 or LEFDN 
cDNAs from the E1F  promoter, or with pcDNAIII-HAIk where full length Ikaros is 
expressed under the pCMV promoter. 48 hours after transfection, cells were washed in 
PBS and the cell pellet was resuspended in five cell pack volumes of hypotonic lysis 
buffer (20mM HEPES pH7.9, 1.5mM MgCl2, 10mM KCl, 0.1% NP40, 1mM DTT, 0.2mM 
PMSF). Cells were incubated for 5 mins and the nuclei pelleted by centrifuged at 16,000g 
for 5 mins. Nuclear proteins were then extracted by resuspending the pellet in five cell 
pack volumes of extraction buffer (20mM HEPES pH 7.9, 1.5mM MgCl2 750ul, 0.2mM 
85 
 
EDTA, 0.42M KCl, 20% (v/v) Glycerol, 1mM DTT, 0.2mM) and incubated for 2 hours 
with agitation. Debris was removed by centrifugation at 16,000g for 5 mins leaving 
nuclear proteins. All steps were performed at 4˚C. 
The oligonucleotides used for gel shift analysis were:            
 WT Eκ3’: 5’ AAGAAGACCCTTTGAGGAACTGAA 3’, 
 mIkPU Eκ3’: 5’ AAGAAGACCCTTTGAGTCCAGTAA 3’,  
mIkPU.1lo Eκ3’: 5’ AAGAAGACAAGGGTAGGAACTGAA 3’. 
The probes were end-labelled with 32P γ-ATP and annealed. The probes (10-50 fmoles) 
were incubated for 30 mins on ice in binding buffer (10mM Tris pH 7.5, 50mM NaCl, 
1mM DTT, 1 mM EDTA and 5% glycerol), with 0.5 to 2µg of protein, 1µg of herring 
sperm DNA and 2µg of BSA in 20µl final volume. Herring sperm DNA was omitted 
from binding reactions with Ikaros-GST. For antibody supershifts (antibody show in 
Table 2.1), proteins were pre-bound to the probe for 10 mins before adding antibody. 
Samples were run on 4-5% native polyacrylamide gels in 0.25X TBE and dried onto DE-
81 paper prior to autoradiography.  
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Chapter 3: Regulation of Igκ sterile transcripts 
3.1 INTRODUCTION 
Development of early B lymphocytes involves two major stages. The first is the 
rearrangement of the IgH chain at the pre-BI stage, with subsequent expression of the µ 
chain allowing formation of a pre-BCR and progression to the large pre-BII stage. Pre-
BCR signalling drives a proliferative burst which is followed by arrest of the cell cycle 
and progression to the small pre-BII stage. At this stage, the second major event occurs, 
that of light chain rearrangement, preferentially at the Igκ locus. A major question of 
lymphocyte biology is the regulation of allelic exclusion, the process ensuring that only 
one allele undergoes rearrangement to maintain monospecificity of the final antigen 
receptor. Sterile transcription of the Igκ locus is known to correlate with rearrangement 
(Schlissel and Baltimore, 1989) and low level biallelic sterile transcripts are produced at 
the large pre-BII stage (Singh et al., 2003). Using a GFP reporter placed under the control 
of the sterile transcription promoters (herein referred to as kappa-GFP) a second sterile 
transcriptional phase was detected (Liang et al., 2004). At the small pre-BII stage, a small 
proportion of cells (5%) underwent high level sterile transcription which was predictive 
of allele choice for rearrangement. These findings supported a probabilistic model of 
allelic exclusion, whereby the probability of activating one allele for high level germline 
transcription and subsequent rearrangement at the small pre-BII stage is 5%, the 
probability of both alleles undergoing activation in the same cell is minimal, just 0.25% 
(0.052). In this study we look at the developmental activity of the two sterile transcription 
promoters to understand their importance during B cell development. In addition, we 
present evidence for a reassessment of probabilistic models of allelic exclusion.  
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3.2 RESULTS 
3.2.1 Developmentally regulated usage of Igκ germline promoters. 
The Igκ-J region contains two promoters which drive sterile germline transcription. The 
most  5’ promoter (5’κ˚) is located 3.6kb upstream of Jκ1, whilst the second, the 3’κ˚, is 
located approximately 52-126bp upstream of Jκ1 (Leclercq et al., 1989; Martin and van 
Ness, 1990) (Figure 3.1b). The 5’κ˚ produces an initial transcript of 8.4kb which reads 
through the locus to the Igκ-C gene and is spliced 394bp after the start site to the Igκ-C 
gene to give a final 1.1kb transcript. The 3’κ˚ transcribes an initial 4.7kb transcript which 
is spliced after the Jκ1 to the Igκ-C gene to a final size of 0.8kb. 
To study the role of germline Igκ transcripts we first determined their regulation during 
development. Development of B lymphocytes can be followed by the expression of a 
series of surface makers (Hardy et al., 1991). Bone marrow (BM) and spleen cells were 
extracted from 4-12 week old wild type C57BL/6 mice. Lymphocytes were enriched on a 
ficoll gradient followed by antibody staining for the surface markers B220, CD43, IgM 
and T-cell receptor β (TCRβ), which distinguish pre-BI, pre-BII, and mature B and T cells, 
as described in Figure 3.1a. The pre-BII population was further refined into large and 
small cells. Cells were isolated by flow activated cell sorting (FACS) (Figure 3.1a) and 
following RNA extraction, the abundance of transcripts was determined by quantitative 
reverse transcription real time PCR (qRT-PCR) (Figure 3.1c). Transcript levels were 
normalised to the housekeeping genes Ywhaz and Ube, the two most stability expressed 
housekeeping genes in the leukocyte pool (Vandesompele et al., 2002). Both the 1.1kb and 
0.8kb sterile transcripts showed an increase in abundance during development with a 
gradual increase in level coinciding with the known increase in accessibility of the Igκ 
locus during development (McDevit et al., 2005), with peak expression at the small pre-
BII stage. Interestingly, the 1.1kb transcript was downregulated at the mature stage, 
whilst expression of the 0.8kb transcript remained high. Three control genes were used to 
verify the populations. We have previously demonstrated Igll1 undergoes ~100 fold 
repression on pre-BI to large pre-BII transition, and a further 10 fold repression on 
transition to small pre-BII stage (Thompson et al., 2007). Cd43 undergoes repression 
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during development, which was reflected in both surface expression and transcription. 
Assessment of Igκ-C detected expression of both sterile and mature transcripts and 
showed increased expression in mature cells as expected. 
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Figure 3.1 Developmental regulation of Igκ J region germline promoters. 
(a) BM and spleen cells were extracted from 4-12 week old wild type C57BL/6 mice and cell 
populations were FACS purified using the following surface markers: pre-BI (BM: 
B220loCD43+IgM-), large pre-BII (BM: B220loCD43-IgM-FCShi), small pre-BII (BM: B220loCD43-
IgM-FCSlo), mature B (Spleen: B220hiIgMloIgDhi) and mature T (Spleen: B220-TCRβ+). (b) 
Scheme of the Igκ locus showing location of V region, two sterile Igκ-J region promoters, Igκ-
J1-5 and the Igκ-C gene. (c) qRT-PCR on isolated cell population to show RNA abundance 
during development. Relative abundance of the 1.1kb and 0.8kb transcripts are shown. Cd43, 
Igll1 and Igκ-C transcript abundance are shown for control. RNA levels are normalised to 
Ywhaz and Ube (average = 1) (mean±range, n=2). 
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3.2.2 A reappraisal of the kappa-GFP reporter system.  
To further investigate the role of sterile Igκ transcripts during development, we utilised 
the kappa-GFP reporter model where Jκ1 was replaced by GFP (Liang et al., 2004). Using 
heterozygous kappa-GFP mice (kappa-GFP+/-), BM and spleen cells were extracted and 
stained with surface antibodies to define the populations described, with the addition of 
immature and transitional B cells which are defined on the basis of IgM and IgD 
expression. Flow cytometry was used to determine the GFP population at each 
developmental stage (Figure 3.2a). As described by Liang et al., B lymphocyte 
development was characterised by a developmentally regulated increase in the 
percentage of cells expressing GFP. Immature, transitional and mature cells showed an 
8%, 30% and 50% GFP+ population respectively. However, no GFP+ population was 
detected at the small pre-BII stage, the stage at which Liang et al., found the 5% 
stochastically activated population.  
To determine whether the absence of detectable GFP was a result of absence of protein, 
we used immunofluorescence antibody staining and detection by confocal microscopy on 
sorted cell populations from kappa-GFP+/- mice. This technique allows detection of lower 
protein concentrations compared to flow cytometry and the use of a polyclonal anti-GFP 
antibody allowed detection of both folded and unfolded proteins. The mature GFP+ cells 
show detection of GFP whereas pre-BI cells, small pre-BII and GFPˉ mature B cells 
showed no detectable GFP protein (Figure 3.2b). A staining control where the GFP 
antibody was omitted from the protocol demonstrated the signal detected in GFP+ cells 
was from the antibody detection and not from endogenous GFP fluorescence.  
To further demonstrate absence of GFP protein at the pre-B stage of development we 
used western analysis on cultured pre-B cells and ex-vivo mature B cell. Pre-B cells 
extracted from BM or foetal livers can be cultured indefinitely on stromal cells in the 
presence of the cytokine IL-7 (Rolink et al., 1991). Flow cytometric characterisation of 
kappa-GFP+/- and wild type pre-B cell cultures is shown in Appendix I and demonstrates 
that adult bone marrow derived wild type cultures are at the pre-BI stage of 
development, with all cells negative for intracellular Igµ, while the d11.5 foetal liver 
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derived kappa-GFP+/- cultures contains both intracellular Igµ negative pre-BI and 
intracellular Igµ positive pre-BII cells. Although the substages differ, they are IL7 
dependent pre-B cell cultures which is widely used as a model system to study early B 
cell development (Rolink et al., 1991). The kappa-GFP+/- encompasses both pre-BI and pre-
BII stages, the stage where GFP expression was first detected and so this culture provides 
a suitable in-vitro model system to investigate the absence of GFP protein. Protein 
extracts from cultured wild type and kappa-GFP+/- pre-B cells and mature ex-vivo kappa-
GFP+/- B cells (both GFP+ and GFPˉ) were separated by SDS-PAGE and subjected to 
western analysis (Figure 3.2c). Probing with antibodies to histone H3 showed equivalent 
protein concentrations between samples. Probing using a polyclonal GFP antibody gave 
a strong signal from the mature B cell extract, running at the expected 30kDa for GFP 
protein. No signal was detected in extracts from kappa-GFP+/- or wild type pre-B culture. 
A signal was detected from mature B cell extracts serially diluted to estimate the protein 
concentration from a 5% GFP+ population, demonstrating the expected GFP signal from 
pre-B cells was detectable. Both the immunofluorescence and western analysis 
demonstrate the absence of a GFP+ population at the pre-BII stage is caused by an 
absence of protein rather than failure to fold or mature GFP proteins. 
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Figure 3.2 Developmental regulation of GFP expression in kappa-GFP+/- reporter mice. 
(a) BM and spleen cells from kappa-GFP+/- mice were analyzed by flow cytometry to 
distinguish the following cell populations: pre-BI (BM: B220loCD43+IgM-), small pre-BII 
(BM: B220loCD43-IgM-FCSlo), Immature B (BM: B220loIgMhiIgDlo), Transitional B (Spleen: 
B220hiIgMhiIgDlo), Mature B (Spleen: B220hiIgMloIgDhi). (b) Histograms show log-GFP 
detection verses cell number at each stage of development. The percentage of GFP 
expressing cells is shown, determined by the gate in the bottom panel (mean±SD, n=3-6). 
(c) Pre-BI, small pre-BII and GFP+ and GFP- mature B cells were FACS purified from 
kappa-GFP+/- mice and stained by immunofluorescence with anti-GFP antibodies (green) 
or DAPI (blue). Staining control shows GFP+ mature B cells stained with anti-rabbit 
Alexa488 only. (d) Protein extracts from wild type and kappa-GFP+/- pre-B cell cultures 
and mature ex-vivo kappa-GFP+/- B cells were probed by SDS-PAGE and western analysis 
using antibodies for histone H3 and GFP.  
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3.2.3 Absence of GFP in rederived kappa-GFP mice. 
Absence of detectable protein in the small pre-BII stage or culture pre-B cells could be 
caused by a loss of transcription of GFP. This transcriptional silencing could be caused by 
a progressive silencing of transgenes or genetic background effects (Allen et al., 1990; 
Opsahl et al., 2002) or loss of homology created by heterozygous knock-in (Rose et al., 
2000). Immunoglobulin loci carry strain differences in sequence and number of V, D and 
J genes (Koflerz et al., 1989; Solin and Kaartinen, 1992; Solin and Kaartinen, 1993), which 
have been successfully used to allow allele identification (Singh et al., 2003). Such 
differences could cause a loss of homology during replication which is enhanced by the 
introduction of the GFP cassette, or could result in misregulation of the targeted allele 
during development. Regeneration of the transgenic mice onto a known background and 
analysis in early generations may overcome these issues and restore expression of GFP 
protein at the pre-BII stage of development. 
We rederived the kappa-GFP+/- reporter line to determine if progressive silencing had 
caused the absence of GFP expression in pre-BII cells. ES cells containing the GFP-
neomycin cassette targeted at the immunoglobulin kappa locus (courtesy of Prof M.S. 
Schlissel, UCLA) were electroporated with a CRE expressing vector to delete the loxp-
neomycin-loxp cassette. In-vitro deletion avoided breeding through constitutive CRE 
expressing lines thereby reducing generation number. Following electroporation, 
individual colonies were picked and screened by PCR for loss of the neomycin gene 
(Figure 3.4a). Blastocyst injection using the kappa-GFP+/- ES cells generated four chimeric 
mice which were backcrossed onto three genetic backgrounds, C57BL/6, 129S/V and 
FVB/N (Blastocyst injection performed by J. Godwin, Transgenics and Embryonic Stem 
Cell Laboratory). These backgrounds were chosen as an FVB/N background was used in 
the initial study for the constitutive Cre deletion line, and C57BL/6 and 129S/V have been 
shown to silence transgenes to different extents (Schweizer et al., 1998). The first three 
generations of kappa-GFP+/- backcrossed mice were analysed by flow cytometry for GFP 
expression during development. In all generations and all strains, developmental 
regulation of kappa-GFP was observed (Figure 3.3). Histograms representing the 
percentage of GFP+ cells in each developmental stage demonstrate a gradual increase in 
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the GFP+ population during development. However, no GFP+ population at the small 
pre-BII stage could be detected on any background for three generations, demonstrating 
strain and transgene silencing artefacts were not the cause for the absence of GFP protein 
in pre-BII cells. 
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Figure 3.3 Genetic background or generation dependent silencing is not responsible 
for absence of GFP in small pre-BII cells. 
(a) ES cells harbouring the GFP-neomycin knock-in cassette at the Igκ-J1 locus were 
transiently transfected with pTURBO-CRE to delete the floxed neomycin gene. Screening 
of genomic DNA form wild type, untransfected and transfected kappa-GFP+/- ES cells by 
PCR demonstrated loss of the neomycin cassette. Position of PCR primers is indicated in 
the scheme. (b) Chimeric mice were generated using ES cells containing the kappa-GFP 
cassette. GFP expression was analysed in developing B cells from the first three 
generations of backcrosses onto different genetic backgrounds. GFP expression was 
monitored by flow cytometry defining development as described in figure 3.2. 
Percentage GFP+ population at each stage is shown (mean+SD, n=3).  
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3.2.4 Coding potential of Igκ germline transcripts from kappa-GFP+/- pre-B and mature B 
cells. 
Regulation of protein expression can occur at the transcriptional stage to block 
transcription or degrade transcripts, at the translational stage to prevent translation of 
mRNA or at the protein level to prevent folding and maturation or induce degradation. 
To determine if the absence of GFP protein in pre-BII cells was reflected by the absence of 
transcription, polyadenylated (poly(A)) mRNA was purified from wild type and kappa-
GFP+/- pre-B cultures and mature kappa-GFP+/- B cells. Mature ex-vivo kappa-GFP+/- B cells 
were activated for 24 hour by CD40 stimulation to enhance RNA recovery. The RNA was 
analysed by northern blotting using an antisense riboprobe for GFP (Figure 3.4a). Four 
GFP transcripts were found in the pre-B and mature B kappa-GFP+/- cells (lanes 2 and 3 
respectively, transcripts labelled A-D), with no equivalent transcripts seen in the wild 
type pre-B cell RNA (lane 1). Interestingly, pre-B and mature B cells showed different 
predominating transcripts, with Transcript C as the major species in pre-B cells and 
Transcript D as the major species in mature cells. A probe for HPRT allowed 
densitometric normalisation of the GFP transcripts. Estimation of the transcript intensity 
from the normalised profile suggested Transcript C was two-fold higher in pre-B cultures 
whereas Transcript D was 6.8 fold higher in mature cells.  
The different sized transcripts identified could represent differential transcriptional start 
sites or splicing of GFP transcripts. To determine the transcriptional start site, RNA-
Linker mediated rapid amplification of cDNA ends (RLM-RACE) was used to analyse 
RNA from wild type and kappa-GFP+/- pre-B cells and kappa-GFP+/- activated mature B 
cells (Figure 3.4b). An internal control to this technique was provided by skipping an 
enzymatic decapping step which selects for fully mature mRNA (for detailed discussion 
see Chapter 2.5.13). Three GFP containing RNA species were detected from the pre-B 
(lane 2) and mature B kappa-GFP+/- (lane 3) RNA, with the two predominant forms 
showing a similar estimated total transcript size found by northern analysis and were 
hence labelled Transcript C and D. The third intervening band was labelled C’. No 
equivalent bands were detected in the wild type control (lane 1). Sequencing determined 
Transcript C to be transcribed from the 5’κ˚, whilst Transcript D was the product of the 
3’κ˚. Band C’ also originated from the 5’κ˚ but had lost the first 99bp, which could 
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represent degradation during processing or a downstream start site. The kappa-GFP 
knock-in should only generate a GFP transcript from the 3’κ˚ (Transcript D) as transcripts 
from the 5’κ˚ should be spliced to the Igκ-C gene, removing the intervening GFP 
sequence. The insertion of the SV40 intron and poly(A) sequence downstream of the GFP 
could cause early termination of the transcripts produced from the 5’κ˚, leaving a large 
3’6kb 5’UTR. Such a large UTR would be expected leave the GFP untranslatable due to 
potential upstream start and stop codons. However, Transcript C contained an aberrant 
splice product, where the splice donor, located 394bp downstream of the 5’κ˚ start site, 
spliced to an acceptor within the GFP sequence, removing the first 54bp of the GFP open 
reading frame (Sequences of the transcripts are shown in Appendix I).  
We next wanted to test the translatability of the identified transcripts. Predicted open 
reading frames of the transcript (red arrows in Figure 3.4b) suggested transcripts C and 
C’ contained upstream translation initiation and stop codons, which could prevent 
translation of a full GFP protein. Transcript D contained a single open reading frame 
coding for a full and in-frame GFP sequence. Transcripts C and D were cloned into the 
mammalian expression vector, pcDNAIII, under the control of the CMV promoter and 
transient transfection of the 239T cell line was used to assess their translation competence 
(Figure 3.4c). Ectopic expression of the empty vector or vector expressing Transcript C 
for 48 hours failed to produce GFP protein as detected by flow cytometry. Ectopic 
expression of Transcript D produced detectable GFP after 48 hours. Cells were co-
transfected with a DsRED-Express expressing vector as a transfection control, and semi-
quantitative RT-PCR showed equivalent expression of Transcript C and D in transfected 
cells.  
The presence of a transcript does not guarantee a mature protein as correct processing of 
transcripts and naive proteins can depend on developmental and activation state of a cell 
(Vasudevan and Steitz, 2007; Yu et al., 2007). Ectopic expression of Transcript D in pre-B 
cell cultures was used to assess the ability of this stage of development to translate and 
produce a mature GFP protein. Nucleofection allows introduction of plasmid DNA but 
causes a high loss of cell viability. We used pre-B cultures from mice expressing the anti-
apoptosis Bcl2 gene to enhance survival. Ectopic expression of Transcript D minus the 
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SV40 intron in Bcl2 transgenic pre-B cultures resulted in detectable GFP fluorescence 
after 48 hours (Figure 3.4d, green line). No GFP was detected in cells treated with an 
empty vector control (black line). Pre-B cells are therefore competent to translate an 
ectopic Transcript D and mature the subsequent GFP protein. 
We next wanted to examine the competency of the endogenous germline transcripts as 
the orthologous transcripts from human cells have been shown to produce a kappa like 
protein (Frances et al., 1994). 293T cells were transiently transfected with either an empty 
vector or a vector expressing the endogenous 1.1kb or 0.8kb sterile transcripts. 48 hours 
post transfection, cells were analysed by semi-quantitative RT-PCR which demonstrated 
equivalent expression of vectors in the cells (Figure 3.4e upper panel). Western analysis 
of cells transfected with an empty vector control or the vector expressing the 1.1kb 
transcript did not produce proteins recognisable by anti-Igκ antibodies (lane 1 and 3). 
Expression of the 0.8kb transcript did result in a protein detectable by anti-Igκ antibodies 
(lane 2). This 15kDa protein is smaller than the 25kDa mature Igκ protein as 
demonstrated by the signal from splenocyte extracts from C57BL/6 wild type mice (lane 
4). The size of this kappa-like protein agrees with the study by Frances et al., who 
suggested this kappa-like protein could form an alternative pre-BCR in place of λ5 
(Frances et al., 1994). Equal loading of the protein extracts was demonstrated by Western 
analysis with antibodies to the nuclear envelop protein, Lamin. 
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Figure 3.4 Transcription of GFP in early B cells correlates with alternative promoter usage, 
splicing events and a loss of coding potential. 
(a) Northern analysis of poly(A) RNA from wild type BM pre-B culture (lane 1), kappa-GFP+/- 
BM pre-B culture (lane 2) and kappa-GFP+/- mature B cells (lane 3). A probe for GFP detected 
four transcript species (A-D). Densitometric normalisation of the GFP signal by Hprt detection is 
shown in the right hand graph. (b) RLM-RACE for GFP transcripts from cells described in (a). 
Detected GFP transcripts corresponded in size to Transcripts C and D. The PCR products were 
sequenced and results summarised in right hand panel. Transcript C codes from the 5’κ˚ and 
contained an aberrant splice site within the GFP coding sequence. Transcript C‘ has lost the first 
99bp from the 5’κ˚ promoter. Transcript D emanated from the 3’κ˚ and contained a full GFP 
coding sequence. Predicted open reading frames are shown in red. (c) Ectopic expression of 
Transcript C and D in 293T by transient transfection. GFP signal and DsRed transfection control 
were detected by flow cytometry after 48 hours. Lower panel shows semi-quantitative RT-PCR 
for total GFP, 3’κ˚-GFP, 5’κ˚-GFP, and Hprt transcripts. Representative of 2 independent 
experiments. (d) Bcl2 transgenic pre-B cultures were nucleofected with 20μg of an Empty vector 
or vector expressing Transcript D. Expression of GFP was assessed by flow cytometry after 48 
hours. (e) Ectopic expression of endogenous sterile transcripts in 293T cells. Upper panel shows 
semi-quantitative RT-PCR from transfected cells. Lower panel shows Western analysis with 
anti-Igκ and anti-lamin antibodies.  
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3.2.5 Mechanisms of translational control of kappa-GFP transcripts. 
Transcript C was the predominant GFP encoding transcript at the pre-B stage but the 
translational competent Transcript D is expressed (Figure 3.4a lane 2). We have 
demonstrated the absence of GFP protein at the pre-B stage was not caused by low 
protein levels (Figure 3.2) implying an alternative mechanism prevents translation at this 
developmental stage. A translational block could be caused by incorrect processing of the 
transcript, so we began by attempting to understand the splicing events occurring on 
GFP transcripts. We first assessed transcript levels by qRT-PCR on wild type (lane 1) and 
kappa-GFP+/- pre-B (lane 2) cultures and ex-vivo kappa-GFP+/- mature B cells (lane 3, 
Figure 3.5a). Total GFP transcripts were approximately twofold lower in pre-B cells by 
qRT-PCR. Abundance of Transcript C by qRT-PCR agrees with the northern analysis but 
showed a greater difference of 7.5 fold higher levels in pre-B cells, possibly due to the 
higher sensitivity of qRT-PCR over northern analysis. Abundance of Transcript D 
showed only a 2 fold increase in mature B cells. The primers used to amplify Transcript 
D will also amplify unspliced products from the 5’κ˚ and may therefore over represent 
the actual levels. No equivalent signal was detected in RNA from wild type pre-B 
cultures. The GFP cassette used in the knock-in contained the SV40 intron which 
enhances transcription (Choi et al., 1991; Clark et al., 1993; Duncker et al., 1997). 
Quantification of GFP transcripts spliced at the SV40 intron, using a primer which spans 
the splice site, revealed that splicing occurred to a much higher degree in mature B cells 
than in the pre-B cells. Failure to splice the SV40 intron could lead to destabilisation of 
the transcript, as the SV40 sequence has been found to induce nonsense mediated decay 
(Metzstein and Krasnow, 2006). Alternatively, failure to splice could signify that the 
correct complement of splicing factors are not present at this stage. Such stage specific 
splicing is known to occur at the CD45 locus in the T cell lineage (Oberdoerffer et al., 
2008). This could have resulted in transcript which is not fully processed and thus not 
translationally competent, even though these cells were capable of expressing an 
ectopically expressed GFP from a vector without the SV40 intron (Figure 3.4d). 
The poly(A) tail of a transcript stabiles the RNA molecules allowing translation. To 
determine whether stage dependent changes in polyadenylation of the GFP transcripts 
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would explain changes in translation, we assessed the poly(A) tail length by rapid 
amplification of cDNA ends poly(A) test (RACE-PAT) (Salles et al., 1999). This method 
uses an oligo-d(T) primer with a 3’ anchor during reverse transcription that anneals 
along the length of the poly(A) tail to produce cDNA with all possible lengths of the 
poly(A) tail. PCR from this template can then be used to assess the length of the poly(A) 
tail by the size of the smear of PCR products (Figure 3.5b). Assessment of poly(A) tail 
length from total GFP transcripts (not specifically transcript C or D) either spliced or 
unspliced at the SV40 intron did not find differences between pre-B cultures and ex-vivo 
mature B kappa-GFP+/- cells, suggesting a shortening of tail length at the pre-B stage was 
not preventing translation (Figure 3.5c). No equivalent band was seen in the wild type 
RNA control. 
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Figure 3.5 Reduction of splicing correlates with absence of GFP but poly(A) tail length 
does not. 
(a) qRT-PCR analysis using cDNA from wild type (1) and kappa-GFP+/- (2) pre-B culture 
and ex-vivo kappa-GFP+/- mature B cells (3). All samples are normalised to Ywhaz and Ube 
(average = 1) (mean+SD, n=3). (b) Scheme of RACE-PAT PCR, showing reverse 
transcription with the oligo-d(T)-Anchor primer (orange) to give multiple length 
products. PCR using a gene specific primer (blue) and the anchor (orange) give a range of 
product sizes dependent on poly(A) tail length. (c) RACE-PAT PCR using RNA from wild 
type (1) and kappa-GFP+/- (2) pre-B culture and ex-vivo kappa-GFP+/- mature B cells (3). 
Gene specific primers to the SV40 intron (upper panel) and spanning the SV40 splice site 
(lower) show no difference in poly(A) tail length.  
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Ribosome association of mRNA controls translation in a number of systems (Vasudevan 
and Steitz, 2007; Yu et al., 2007). Highly translated mRNAs are associated with multiple 
ribosomes – termed polysomes - whereas untranslated mRNAs will have no associated 
ribosomes. To determine whether differential ribosome association prevented translation 
of Transcript D at the pre-B stage we measured the polysome profile of various 
transcripts from activated mature and pre-B cells from kappa-GFP+/- mice. Sucrose 
gradients were used to separate RNA into fractions containing free RNA or RNA 
associated with increasing numbers of ribosomes. Cycloheximide was added to cells to 
block ongoing translation and lock the ribosomes onto mRNA. EDTA was added to 
cytoplasmic extracts to disrupt the ribosome subunits and dissociate the mRNA-
ribosome complex to verify ribosomal complexes. Monitoring of optical density during 
fractionated provided density profiles with peaks corresponding to free RNA, RNA 
associated with the 40S and 60S ribosome subunits, the 80S monosome and polysomes 
(Figure 3.6a) and RNA abundance of resultant fractions was measured by qRT-PCR 
(Figure 3.6b). Ribosome association with the housekeeping gene Hprt demonstrated that 
highly transcribed mRNAs were contained in the higher fractions, corresponding to large 
numbers of associated ribosomes. Primers specific for total GFP, Transcript C, Transcript 
D or total GFP spliced at the SV40 intron all gave a broad peak across the gradient 
suggesting a wide distribution of ribosome association. No difference was seen between 
pre-B and mature cell profiles for the analysed transcripts, suggesting changes in 
polysome association between these stages does not account for the absence of GFP 
protein. Comparison of sterile transcript (total GFP) with a mature kappa transcript 
expressed from a rearranged locus and detected using degenerate Vκ primers, showed a 
large difference in profile. The mature transcripts were predominately associated with 
large numbers of ribosome with a single main peak, compared to the broad profile of the 
GFP sterile transcript which was associated with low number of ribosomes. Disruption of 
the ribosome complex by EDTA shifted all profiles to the early fractions containing free 
protein and RNA, verifying the ribosomal nature of the measured profiles. 
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Figure 3.6 Polysomal association of GFP transcripts in pre-B and mature B cells. 
(a) Representative example of cytoplasmic extracts separated on a sucrose gradient and 
monitored at A254. Cycloheximide (left) preserved polysomal fractions and addition of 
EDTA (right) disrupted ribosomes leading to loss of mono- and polysomes. (b) RNA 
abundance across the sucrose gradient was measured by qRT-PCR of each fraction. RNA 
abundance is shown as a percentage of the total across all fractions (cycloheximide 
gradients show mean+SD n=3, EDTA gradients show mean+range, n=2). 
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3.2.6 Transcriptional usage of promoters during development 
GFP protein was first detected in immature B cells (Figure 3.2) so we used models of 
early B cell differentiation to assess the capacity to form GFP protein. Pre-B cultures can 
be differentiated towards the immature stage by IL7 withdrawal and/or LPS stimulation, 
which arrest the cell cycle and promote rearrangement of light chain genes (Schlissel and 
Baltimore, 1989). Further differentiation was not possible as IL7 withdrawal caused 
complete cell death by 72 hours (data not shown).  Analysis of differentiated cells by flow 
cytometry showed a continued absence of GFP expression using IL7 withdrawal with or 
without LPS stimulation for 48 hours differentiation (Figure 3.7a). Analysis of GFP 
transcripts during differentiation revealed that the both Transcript C and D increased 10-
20 fold during this time window.  
To determine the developmental control of the sterile transcription promoters during 
development, we assessed GFP message levels in FACS purified cell populations from 
kappa-GFP+/- mice (Figure 3.7c). Total GFP shows a gradual increase in expression during 
development, with a peak at the immature cell stage, followed by gradual repression. 
Subdivision of GFP into Transcript C and D showed the expected pattern from the wild 
type counterpart. However, Transcript C was established early in development and 
strongly repressed following rearrangement in small pre-BII cells whereas Transcript D 
underwent delayed expression kinetics with a peak at the immature stage, followed by a 
twofold downregulation and stabilisation in the following stages. Message levels of Cd43, 
Igll1 and Igκ-C were used to verify purity of isolated populations. 
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Figure 3.7 Development of kappa-GFP B cells correlates with alternative promoter 
usage but induced differentiation does not. 
Kappa-GFP+/- pre-B cell cultures were differentiated by IL7 withdrawal with or without 
30µg/ml LPS stimulation and assessed by flow cytometry after 48 hours for (a) GFP 
fluorescence and by qRT-PCR (b) for transcript abundance with RNA normalised to 
Ywhaz and Ube (mean+SD, n=3).  
(c) Developing B cells were isolated from kappa-GFP+/- 4-12 week old mice using the 
FACS strategy shown in figure 3.1 and 3.2. qRT-PCR analysis of the cells shows 
developmental regulation of the GFP encoding transcripts. Histograms show RNA 
abundance normalised to Ywhaz and Ube (average = 1) (mean±range, n=2). 
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3.2.7 Germline transcript promoter activity during pre-BCR signalling. 
Developmental regulation of germline transcripts suggested activity of the promoters 
reflected a passive or potentially active role in these developmental events. We wanted to 
assess whether pre-BCR signalling was important in controlling the differential promoter 
activity and so used a transgenic model system where pre-BCR signalling is blocked by 
loss of the pre-BCR signalling complex adaptor protein, SLP65 (Jumaa et al., 1999). In this 
system, SLP65 activity can be restored through induction of an ERt-SLP65 transgenic 
protein (Meixlsperger et al., 2007). The transgenic SLP65 protein is fused to the modified 
estrogen receptor (ERt2), so that under normal conditions heat shock proteins bind this 
receptor and prevent its activity. On induction with 4-hydroxytamoxifen (4-HT), the heat 
shock proteins release the ERt2-Slp65 fusion, allowing its relocation to the membrane and 
consequent activity. SLP65-/-ERt2-Slp65 pre-B cultures proliferate indefinitely at the large 
pre-BII stage as they fail to respond to pre-BCR signalling. Induction of SLP65 activity by 
4-HT treatment restores the pre-BCR signalling complex, resulting in downregulation of 
Igll1 and the pre-BCR, arrest of the cell cycle and expression of rearranged Igκ at the cell 
surface effectively reconstituting large pre-BII to immature B cell differentiation 
(Meixlsperger et al., 2007; Thompson et al., 2007). Slp65-/- ERT2-Slp65 pre-B cultures 
(courtesy of Dr H. Jumaa, MPI, Freiburg) were treated with 4-HT or Ethanol (EtOH) as a 
carrier control, in either IL7hi conditions or IL7lo conditions. The use of the four 
conditions allows analysis of the role of pre-BCR signalling and cell cycle withdrawal on 
promoter activity. Induction of SLP65 by 4-HT treatment, in IL7lo conditions results in 
induction of surface kappa expression by 48 hours (Figure 3.8a). Cell cycle withdrawal 
alone did not induce surface Igκ at 72 hours (Figure 3.8b, black hatched bar), but did 
contribute to surface expression when combined with pre-BCR (red hatched bar). Both 
the 1.1kb and 0.8kb transcript increase 50-100 fold on induction of pre-BCR signalling 
(Figure 3.8c, red bars). Cell cycle arrest without pre-BCR signalling resulted in a modest 
10 fold increase of either transcript (hatched black bars). Both pre-BCR signalling and cell 
cycle arrest resulted in an additional increase in transcription (hatched red bars), 
suggesting both pathways are involved in these events, with pre-BCR signalling 
comprising the major component. However, the ratio between the transcripts was not 
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altered, suggesting pre-BCR signalling does not induce differential regulation of 
promoter activity. 
  
 
 
Figure 3.8 Inducible pre-BCR signalling correlates with activity of both germline 
promoters. 
Slp65-/- cells with an ERt2-Slp65 fusion transgene were cultured in IL7hi+EtOH, IL7hi+4-HT, 
IL7lo+EtOH or IL7lo+4-HT conditions for 72 hours. (a) Induction of surface Igκ expression 
over time by IL7lo+4-HT conditions (black line), with staining control (grey line) and 
percentage Igκ+ shown (mean±SD, n=3). (b) Percentage of surface Igκ+ cells by flow 
cytometry in each condition at 72 hours (mean+SD, n=3). (c) RNA level of the 1.1kb and 
0.8kb germline transcripts by qRT-PCR in each condition at 24, 48 and 72 hours (RNA 
level shown relative to Ywhaz and Ube, mean+SD, n=3). 
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3.2.8 Germline transcript promoter activity during BCR signalling. 
The activity of the 3’κ˚ promoter peaks at the immature stage of development (Figure 
3.7c), suggesting a role of this activity at this cell stage. Self-reactivity of the assembled 
BCR is tested at the immature stage with self-stimulation of the BCR resulting in receptor 
editing, characterised by a withdrawal from the cell cycle and return to a pre-B stage of 
transcriptional activity to allow further IgL rearrangements (Tze et al., 2000; Tze et al., 
2005). To investigate the activity of the germline promoters during receptor editing, we 
utilised the 3-83 BCR transgenic model systems. 3-83 BCR transgenic mice contain 
transgenes expressing functionally rearranged heavy and light chains, which negates 
endogenous IgH and IgL rearrangement allowing cells to bypass the preB-I and pre-BII 
stage for direct progression to the immature stage (Nemazee and Burki, 1989). The 
transgenic receptor has mono-specificity for the MHC H-2KKDK, allowing uniform 
stimulation by BCR engagement. Bone marrow cells from 3-83 transgenic mice were 
FACS purified for B220lo immature and B220hi mature recirculating B cells. These 
populations were confirmed by post isolation staining with IgM, demonstrating isolation 
of B220loIgM+ immature cells and B220hiIgM+ mature cells (Figure 3.9a). Cells were co-
cultured for 24 hours with mouse embryonic fibroblasts (MEFs) expressing the neutral 
MHC H2d or stimulatory MHC H2b in the absence of IL7 to allow cell cycle withdrawal. 
After 24 hours, cells were removed and analysed by flow cytometry for surface 
expression of IgM and CD69 (Figure 3.9b) and qRT-PCR for RNA abundance (Figure 
3.9c). Stimulation of the BCR resulted in downregulation of surface IgM at both 
developmental stages, which occurs on both activation and receptor editing (Tze et al., 
2000). Stimulation of mature cells was found to be associated with upregulation of the 
activation marker CD69 and downregulation of the 1.1kb transcript. Surprisingly, no 
major affect was seen on Rag transcription or abundance of the 0.8kb transcript at the 
mature B cell stage. Stimulation of the immature cells and induction of receptor editing 
was associated with an increase in both Rag1 and Rag2 transcription, and also a small 
drop in levels of both the 1.1 and 0.8kb transcripts. Receptor editing does not appear to 
be associated with differential promoter usage, whereas activation of mature B cell does. 
The higher levels of germline transcripts in the mature cells compared to the immature 
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cells, which contrasts with relative levels in non-trangenic and kappa-GFP bone marrow 
cells (Fig 3.1c and 3.7c), may reflect their enforced advancement in stage caused by 
expression of the Igµ and Igκ transgene which imposes an immature identity on a pre-BI 
cell. 
 
Figure 3.9 Activity of germline promoters in response to receptor editing or activating 
stimuli. 
(a) Bone marrow cells from 3-83 Tg mice were stained for surface B220 and isolated by 
FACS into B220lo and B220hi  populations. Post sort surface IgM staining demonstrated the 
populations were immature B220loIgM+ B cells and mature B220hiIgM+ B cells respectively. 
Isolated populations were co-cultured on a layer of H2d or H2b expressing MEFs to 
provide neutral or stimulatory conditions respectively. Cells were analysed after 24 hours 
for surface expression of IgM and CD69 (b) and by qRT-PCR for RNA abundance (c), with 
RNA normalised to Ywhaz and Ube (average=1) (mean±range, n=2). 
111 
 
3.3 DISCUSSION 
The experiments here describe the developmental activity of the two Igκ-J region sterile 
transcript promoters. Activity of these promoters has been used to suggest stochastic 
allele choice for rearrangement. Using the kappa-GFP model system, an absence of 
stochastic activation was found which correlated with differential promoter activity, an 
aberrant splice event and transgene splicing misregulation. Developmental regulation of 
the sterile transcript promoters suggests a role of these promoters beyond chromatin 
events in early B cell development. We have yet to identify the mechanisms generating 
differential promoter usage. We investigated pre-BCR signalling and development to the 
immature B cell stage but did not find differential promoter usage associated with these 
events. Neither do we see differential activity in models of receptor editing, the stage at 
which 5’κ˚ begins downregulation and the activity of the 3’κ˚ peaks. Differential activity 
was observed upon activation of mature cells. 
3.3.1 Sterile transcription and stochastic activation. 
To date, studies of Igκ sterile transcription have focused on their role during 
rearrangement at the pre-BII stage of development, with only one study detailing 
suppression of transcription during activation of mature B cells (Schlissel and Baltimore, 
1989; Engel et al., 1999; Skok et al., 2001). Here, we analysed the activity of the sterile 
transcript promoter throughout development. We demonstrate the early activation and 
repression of the 5’κ˚ and later activation of the 3’κ˚ with more stable expression in 
mature stages. Transcription from these promoters is thought to reflect the chromatin 
status of the locus rather than being essential for rearrangement (Sikes et al., 2002). The 
developmental regulation suggests rather than being equivalent these promoters may 
have distinct roles or reflect distinct events.   
To dissect the function of these promoters we employed the kappa-GFP reporter model. 
This system was thought to have answered the enigma of allele exclusion during pre-B 
development. However, we found an absence of the stochastically activated small pre-BII 
population which formed the basis of the probabilistic model. GFP protein could not be 
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detected at this stage using Western analysis or immunofluorescence. Rederivation of 
these targeted mice did not restore the phenotype, suggesting that epigenetic silencing 
caused by transgene silencing or genetic background were not responsible for the 
absence at this stage. Having been unable to replicate the phenotype, a detail study of the 
absence of GFP at this stage was undertaken. Absence of GFP protein at the pre-BII stage 
was not reflected by GFP encoding transcripts. The finding that transcripts from the 3’κ˚ 
are competent for translation whereas transcripts from the 5’κ˚ are aberrantly spliced into 
the GFP open reading frame suggested a mechanism for the loss of translation at the pre-
B stage, a stage characterised by high activity of the 5’κ˚ and low activity of the 3’κ˚. 
However, northern analysis and qRT-PCR demonstrate that transcripts from the 3’κ˚ are 
present, suggesting either translation from this transcript is too low to detect or 
translation is somehow blocked. The normalised profile from the northern analysis 
showed an almost 7 fold increase in Transcript D in mature cells, whereas qRT-PCR 
showed a two fold increase. The larger unidentified fragments from the northern analysis 
(band A and B) could code for unspliced read through transcripts from the 5’κ˚. These 
would contain the 3’κ˚ sequence and be detected by the PCR for Transcript D, leading to 
an overestimation of this transcript using this method. At the pre-B stage, the limited 
amount of Transcript D may therefore drive translation of GFP protein below detection 
levels. Alternatively, we may not have as yet identified all the transcripts produced from 
this region. 
A second mechanism for absence of GFP protein is suggested by the failure to splice the 
SV40 intron. The SV40 sequence has been found to direct nonsense mediated decay 
(NMD) of some transcripts (Metzstein and Krasnow, 2006). If such a phenomenon was 
occurring here, failure to remove the SV40 intron would enhance NMD on the transcript, 
reducing the potential GFP translation available. Although these studies found that it 
was sequences other than the intron which were responsible for NMD, it is also possible 
that the failure to splice reflect an absence of correct transcriptional and possibly 
translational machinery. To determine the translational competency of transcripts 
containing the SV40 intron, a similar approach to determine translational competency of 
Transcript C and D could be used. Ectopic expression of transcripts in which the SV40 
intron cannot be splice due to mutations of the splice donor or acceptor would determine 
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whether such transcripts are competent for translation or whether translational efficiency 
was reduced.  
Alternative mechanisms of translational control were investigated but did not reveal 
clues about lack of GFP protein translated from Transcript D. Polyadenylation of 
transcripts occurred equally in pre-B cultures and mature cells and the polysomal 
distribution does not appear different at the two stages. It is interesting that all detected 
transcripts are associated with an equivalent broad polysome profile, suggesting 
equivalent ability of both Transcript C and D to undergo translation.  
We detect low levels of Transcript D in pre-B cultures and at the large pre-BII stage of 
development. The absence of GFP protein may reflect levels that are too low to detect by 
the methods employed. Maturation and correct folding of GFP does not appear to be a 
problem, as the antibodies used in the immunofluorescence and Western analysis 
recognises both folded and unfolded protein and ectopic expression demonstrated that 
pre-B cells could produce GFP protein from Transcript D. Our finding that pre-B cultures 
induced to differentiate towards immature stage upregulate Transcript D but do not 
produce detectable GFP suggests other translational blocks are occurring or maturation 
and accumulation may require longer than 48 hours. It is also possible that the qRT-PCR 
method used may overestimate the level of Transcript D due to the presence of, as yet, 
unidentified transcripts. However, to extend the time window of viability of cells 
undergoing IL7 withdrawal, apoptosis during differentiation could be blocked, for 
instance by introduction of the anti-apoptotic Bcl2 gene. This would allow more time for 
protein maturation and accumulation and would answer whether translational inhibition 
was occurring in these cells.  
Whether or not low level translation of GFP occurs in pre-B cells, sterile transcription is 
occurring as early as pre-BI cells, with robust transcription from the 5’κ˚ occurring in 
large pre-BI cells before rearrangement events. Although this study does not exclude 
stochastic activation for the mechanism of allele choice, or probe the question of mono or 
biallelic expression of these transcripts in the cell populations, it does conclude that 
probabilistic models of allelic exclusion based on stochastic activation of sterile 
transcription cannot be supported by the kappa-GFP model.  
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Further studies will be of interest to determine whether the germline transcripts detected 
during development originated in a monoallelic or biallelic manner. RNA-FISH 
experiments using probes for transcripts containing either GFP or wild-type germline 
sequences would allow these questions to be answered, although previous reports have 
address these questions using FACS sorted populations and found biallelic expression at 
early stages of development (Singh et al., 2003). Additionally, a single cell PCR approach 
could be informative about whether the different kinetics of promoter activation 
represent transcription from the same or different alleles. Results from these experiments 
may suggest whether differential promoter activation may cooperate in cis to regulate 
stage specific rearrangement, or whether there is a competition in trans between the 
alleles for promoter activation. 
3.3.2 Sterile transcript promoter activity during developmental processes. 
We sought to determine the role of the differential promoter activity observed during 
development. Development in wild type and kappa-GFP mice show early activation of 
the 5’κ˚ and later activation of the 3’κ˚ at the small pre-BII stage, suggesting these 
differential activities could be important for rearrangement itself. To probe this step in 
greater detail, the Slp65-/- ERT2-Slp65 system allowed dissection of stages of pre-B to 
immature development. Unlike pre-B cultures Slp65-/- cells are arrested at the large pre-
BII stage due to the inability to signal through the pre-BCR, providing a homogenous cell 
population (Meixlsperger et al., 2007). Differentiation of these cells to the immature stage 
drives upregulation of both the 5’κ˚ and 3’κ˚, as confirmed by qRT-PCR. This method 
does leave the possibility of overestimation of the activity of the 3’κ˚ promoter through 
detection of read through transcripts coded by 5’κ˚ promoter. With this caveat in mind, 
we did not detect differential activity in this model system suggesting pre-BCR signalling 
and events during Igκ rearrangement do not contribute to the detected differential 
regulation. 
The developmental profiling demonstrated the 3’κ˚ activity peaks in immature B cells. 
Receptor editing occurs at the immature stage as a way of removing self reactive BCRs 
from the repertoire. The 3-83 transgenic BCR model system was used to investigate 
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receptor editing (Nemazee and Burki, 1989). Engagement of the 3-83 BCR in immature 
cells caused the associated aspects of receptor editing, such as downregulation of IgM 
and induction of RAG genes (Tze et al., 2000). Cells preparing to undergo another round 
of rearrangement would be expected to reactivate the Igκ locus, by upregulating sterile 
transcripts. However, induction of receptor editing resulted in a decrease in activity of 
both the 5’κ˚ and 3’κ˚. Without DNA analysis of the locus at this time point it is 
impossible to state whether the reduction in the abundance of these transcripts was due 
to repression of promoter activity or due to rearrangement events at the unrearranged 
loci resulting in loss of the promoters. Previous studies have assessed rearrangement 
after 48 hours and seen only a two-three fold increase in rearrangement at the Igκ locus, 
suggesting rearrangement events are far from rapid (Tze et al., 2000). However, an 
extended time course in conjunction with DNA analysis would determine whether 
engagement of the BCR at the immature stage resulted in differential regulation of the 
germline promoters.  
Engagement of receptors in mature cells causes a signalling cascade resulting in 
activation, anergy or apoptosis, dependent on context and antigen. Activation of the cells 
was confirmed by upregulation of activation markers and downregulation of IgM, and 
event associated with internalisation of the BCR-antigen complex. Engagement caused a 
specific repression of the 5’κ˚ whilst the 3’κ˚ remains active. Previous RNA-FISH studies 
have shown that after 4 days activation, mature cells repress sterile transcripts (Skok et 
al., 2001), suggesting that while downregulation of 5’κ˚ activity occurs rapidly in 
response to receptor engagement, repression of the 3’κ˚ promoter may occur at a later 
time point, possibly reflecting the different factors required to drive these promoters. The 
role and importance of continued 3’κ˚ activity on BCR stimulation is interesting and is 
under continued investigation. 
Knockout and mutation models would provide excellent systems to investigate the role 
and importance of the promoter regions in various aspects of B cell biology. However, no 
idea system is as yet available. A mutation of the KI and KII regions upstream of the 3’κ˚ 
has been described (Ferradini et al., 1996). Although rearrangement was impaired by 
these mutations, no effect on the 0.8kb transcript was observed, suggesting these sites are 
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not involved in the 3’κ˚ promoter. A deletion of the region encompassing the 5’κ˚ to just 
upstream of the 3’κ˚ has also been reported (Cocea et al., 1999). Rearrangement was also 
impaired in this system, and when combined with the KI KII mutation, a cumulative 
effect was observed in-vivo but not in in-vitro model systems. This demonstrates the 
importance of the 5’κ˚ during rearrangement. Cells from the deletion model could be 
used understand the role of the 5’κ˚ in receptor editing situation and whether there is any 
link between activity of the 5’κ˚ and activity of the 3’κ˚ promoters. An additional genetic 
manipulation which may prove insightful would be to follow the approach used by 
Mark Krangel, and insert a transcription stop codon directly downstream from the 
germline transcription promoters (Abarrategui and Krangel, 2006; Abarrategui and 
Krangel, 2007). This could be achieved using either transgenes which mimic lineage or 
stage specific regulation and show production of germline transcripts, or at the 
endogenous locus, and the small size of the knock-in would not be expected to induce 
aberrant events. By blocking the ability of the promotes to drive transcription through 
the locus, we should be able to establish the role of transcriptional activity originating 
from each promoter during rearrangement and later developmental events.  
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Chapter 4: Factors involved in Igκ rearrangement 
4.1 INTRODUCTION 
Rearrangement of Igκ is regulated by lineage and stage specific alterations in the 
chromatin structure of the locus. Signalling through the pre-BCR drives changes in 
expression and activity of transcription factors which promote chromatin modifying 
enzymes to open the locus and allow RAG access prior to rearrangement. While multiple 
transcription factors have been shown to bind the locus, no clear picture has emerged as 
to which factors are responsible for guiding changes in chromatin and histone 
modifications associated with induction of rearrangement. We used a candidate based 
approach to overexpress potentially relevant transcription factors in developing pre-B 
cells and assessed their involvement in regulation of Igκ rearrangement.  
We selected Ikaros and IRF4 for initial study, as we have previously shown that pre-BCR 
signalling results in upregulation of Irf4 and Ikzf3 (which encodes Aiolos), a member of 
the Ikaros family of transcription factors. Aiolos competes with EBF for binding sites 
within the promoter of the Igll1 locus (which encodes λ5), leading to downregulation of 
the pre-BCR and developmental progression to the small pre-BII stage (Thompson et al., 
2007). Our laboratory has shown that the Igκ locus undergoes monoallelic relocalisation 
to Ikaros heterochromatic foci in the mature stage (Skok et al., 2001). Bergman and 
colleagues extended these findings to show at the pre-BII stage preceding Igκ 
rearrangement there is monoallelic recruitment of an Igκ allele to Ikaros containing 
centromeric heterochromatic regions, further implicating Ikaros in control of the locus 
and allelic exclusion (Goldmit et al., 2005). 
We present evidence that Ikaros is implicated in regulating rearrangement of the Igκ 
locus, and that it has a dual role of suppression and activation of rearrangement, with the 
latter effect in the same genetic network as IRF4. We also present evidence for a role of 
LEF1 in chromatin changes at the locus, with its actions dependent on the activity of the 
β-interaction domain and the HMG DNA binding domain. We also find a novel effect of 
β-catenin on locus activation. 
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4.2 RESULTS 
4.2.1 IRF4 can drive Igκ rearrangement whilst Ikaros may have a bipartite role. 
Previous studies have demonstrated that pre-BCR signalling led to upregulation of Irf4 
and Ikzf3, and that monoallelic relocalisation of one allele occurs to Ikaros-
heterochromatic foci. IRF4 and Ikaros were therefore chosen for further investigation. To 
understand the role of these factors in Igκ rearrangement, we used the Slp65-/-ERt2-Slp65 
pre-B culture system as a model. Induction of Igκ rearrangement using this system has 
been discussed in Chapter 3.1.7. Briefly, cells deficient for Slp65 are blocked at the large 
pre-BII stage of development. Induction of SLP65 activity through treatment with 4-HT, 
completes the pre-BCR signalling complex and allows progression to the small pre-BII 
stage and subsequent Igκ rearrangement. By controlling levels of IL7 and 4-HT in the 
media, the cell cycle and pre-BCR signalling can be separated, allowing assessment of the 
contribution of these events to developmental progression and Igκ rearrangement. We 
transduced Slp65-/- ERt2-Slp65 pre-B cells with retroviruses to allow ectopic 
overexpression of candidate genes, and assessed rearrangement at the Igκ locus by 
surface expression of Igκ protein.  
Retroviral infection is a well established method of gene transfer in lymphocytes and the 
vector used was a modification of the pMSCV vector, where the candidate gene was 
expressed upstream from an Internal Ribosome Entry Site (IRES) and Cyan Fluorescent 
Protein (CyFP). CyFP was used as the ERt2-Slp65 fusion is coexpressed with GFP 
(Meixlsperger et al., 2007). The IRES allows expression of the candidate gene and CyFP 
from the same transcript, so that CyFP fluorescence is directly related to expression of the 
candidate gene. This cassette was inserted into the pMSCV vector between the viral long 
terminal repeat (LTR) elements which drive high level expression in lymphocytes, and is 
referred to as pMICy (Figure 4.1a). Virus particles were produced by co-transfection of 
293T cells with pMICy vectors and the pCL-Eco helper vector, which expressed the Gag, 
Pol and Env proteins required for virus production (Hawley et al., 1994). 
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Irf4 was cloned into the pMICy vector with a double FLAG epitope fused 5’ of the start 
site. HA epitope tagged Ikaros and Ikaros dominant negative (DN) were cloned into 
pMICy (Cobb et al., 2000). Ikaros DN contained a point mutation of asparagine to alanine 
at residue 159 in the second zinc finger. This mutation disrupts the DNA binding ability 
of the protein. Dimerisation is still possible which allows the mutant to bind endogenous 
Ikaros and Ikaros family members and disrupt their function by preventing dimeric 
DNA binding. 
Overexpression of Ikaros causes arrest of both 3T3 cell lines and primary lymphocytes in 
G1 phase (Gomez-del Arco et al., 2004). Igκ rearrangement can only occur in arrested 
cells as RAG1 is susceptible to cell cycle mediated degradation (Li et al., 1996). To dissect 
the role of the candidate genes involvement on Igκ rearrangement during these events, 
transduced cells were cultured in different conditions to allow pre-BCR signalling and/or 
induce cell cycle arrest. IL7hi conditions promoted cell cycle though IL7 receptor 
stimulation (Rolink et al., 1991) while IL7lo conditions induced cell cycle arrests. 
Treatment with 4-HT induced the activity of transgenic ERt2-SLP65 to allow SLP65 
mediated pre-BCR signalling. EtOH provided a solvent control. Slp65-/- ERt2-Slp65 pre-
BII cells were transduced with virus particles and after 24 hours the cells were cultured 
in EtOH-IL7hi, 4-HT-IL7hi, EtOH-IL7lo or 4-HT-IL7lo conditions. After 72 hours in these 
conditions, cells were analysed by flow cytometry. Treatment in IL7lo conditions resulted 
in a loss of cell viability, so dead cells were excluded from the analysis by propidium 
iodide (PI) staining (Figure 4.1b). PI negative (live) cells were assessed for surface 
expression of Igκ (Figure 4.1c) and cell cycle status was estimated by cell size based on 
Forward Scatter (FSC) (Figure 4.1e). The percentage of surface Igκ positive transduced 
cells from 6 independent experiments are shown (Figure 4.1d) 
Induction of pre-BCR signalling and cell cycle arrest appear to be required for an increase 
in rearrangement and expression of surface Igκ protein, as was seen in the vector control 
cells (Figure 4.1c and e). EtOH-IL7hi conditions gave a low frequency of surface Igκ 
positive cells (16% of the population) and cells were of a uniform large size, indicating 
continuation of the cell cycle. 4-HT-IL7hi conditions, which allowed pre-BCR signalling, 
resulted in a small increase in cells expressing Igκ, with 23% of the population Igκ 
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positive, and a partial arrest of the cell cycle as seen by a reduction in FSC. EtOH-IL7lo 
gave a robust cell cycle arrest shown by uniformly small cells, but no increase in Igκ 
detection. In fact, cell cycle arrest alone resulted in a reduction in the frequency of Igκ 
positive cells, with only 8% of cells showing surface Igκ. 4-HT-IL7lo conditions gave an 
equally robust cell cycle arrest, and a larger two fold upregulation of cells expressing Igκ, 
with 32% of cells Igκ positive, suggesting, although a modest increase, both IL7 
withdrawal and SLP65 reconstitution are required for efficient Igκ rearrangement and 
expression. 
While overexpression of Ikaros resulted in upregulation of surface Igκ in all conditions 
regardless of IL7 concentration or SLP65 reconstitution, IRF4 overexpression promoted 
upregulation in all conditions except 4-HT-IL7lo conditions. This suggested these factors 
act downstream of pre-BCR signalling and may play a role in cell cycle regulation, as 
each factor induced an equivalent arrest of the cell cycle in all conditions, independently 
of pre-BCR signalling or cell cycle stimulation by IL7. However, compared to IRF4, the 
upregulation if Igκ was greater with Ikaros transduction in all conditions, with 35-42% 
cells Igκ positive with IRF4 overexpression and 60-74% with Ikaros overexpression. The 
density profiles demonstrate a linear correlation of the level of Ikaros expression 
(assessed by CyFP) with the level of Igκ expression, suggesting a direct correlation 
between these factors. IRF4 transduction does not produce a linear correlation, which 
could suggest IRF4 is not limiting, which is supported by the finding that IRF4 and 
vector control gave similar upregulation of Igκ in 4-HT-IL7lo conditions.  
The density plot for Ikaros and IRF4 overexpression in IL7hi conditions suggested a lower 
infection rate compared to other conditions, with more CyFP negative cells. However, 
IRF4 and Ikaros overexpression resulted in a cell cycle arrest, and so in these conditions, 
uninfected cells will continue to proliferate and overtake arrested infected cells. It is also 
possible that overexpression of a particular factor will result in selection of a 
subpopulation for survival, rather than actual induction of surface expression of Igκ. 
Whilst the experiments shown here do not differentiate between the two possibilities, 
SLP65 inactivation should generate a relatively homogenous starting population of cells, 
blocked at the large pre-BII stage and thereby reducing the possibility of subpopulations.  
121 
 
Disruption of Ikaros family member activity by overexpression of Ikaros DN resulted in 
a surprising profile of surface Igκ expression. Overexpression in EtOH-IL7hi conditions 
resulted in a statistically significant increase in Igκ detection as compared to the vector 
control from 16% Igκ positive in vector control samples to 27% Igκ positive in Ikaros DN 
samples. However, pre-BCR signalling or cell cycle arrest in conjunction with disruption 
of Ikaros activity gave a suppression of Igκ surface expression, with only 7-8% of the 
population showing surface Igκ in these conditions. The effects of Ikaros DN were not 
due to a continuation of the cell cycle in IL7lo conditions, as suggested by the reduction in 
cell size. However the partial arrest of the cell cycle in 4-HT-IL7hi conditions was not 
observed, suggesting repression of the cell cycle by pre-BCR signalling requires Ikaros or 
Ikaros family members.  
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Figure 4.1 Retroviral induction of Slp65-/- ERT2-Slp65 pre-B cultures.  
(a) Scheme of the retroviral vector used for cell infection. A cassette containing the 
candidate gene-IRES-CyFP was inserted between retroviral LTRs.  
Slp65-/- ERt2-Slp65 pre-B cells were infected with either empty vector control or vector 
expressing IRF4, Ikaros or Ikaros DN. Cells were cultured for 24 hours and then recultured 
in EtOH IL7hi, 4-HT IL7hi, EtOH IL7lo or 4-HT IL7lo conditions. 96 hours post infections cells 
were analysed by flow cytometry. (b) Live cells were gated by PI exclusion and forward 
and side scatter. Live cells were analysed for (c) CyFP fluorescence and surface Igκ, with (d) 
showing percentage CyFP+ Igκ+ in each culture condition (mean+SD, n=6) with significance 
compared to vector control for each condition (t-test, p<0.05, **p<0.005, ***p<0.0005 (e) 
showing cell cycle assessed by FSC profile. 
 
123 
 
The separation of developmental pathways in the Slp65-/- ERt2-Slp65 system allowed 
dissection of gene expression changes influenced by cell cycle arrest and/or pre-BCR 
signalling. We used this system to assess whether changes in the levels of candidate 
transcription factors brought about by pre-BCR signalling and/or cell cycle arrest 
correlated with observed changes in rearrangement and expression of Igκ. The 
transcription factors assessed were Ikaros, Aiolos, IRF4 and PU.1 (encoded by Sfpi1). 
PU.1 was included as binding with IRF4 can modulate transcriptional activity of Eκ3’ 
reporters and the binding site in the Eκ3’ increases occupancy during pre-BI to pre-BII 
transition, implicating it in Igκ regulation (Pongubala et al., 1992; Shaffer et al., 1997). We 
also assessed how these conditions affected the transcription of the recombinase 
machinery. We have previously used this system to give an indication of the influence of 
the conditions on chromatin structure at the Igκ locus, assessed by the level of Igκ 
germline transcription and found that while cell cycle exit induced germline 
transcription, pre-BCR signalling gave a much more robust increase (Figure 3.8). Message 
levels were measured by qRT-PCR every 24 hours over a 72 hours culture period in 
EtOH-IL7hi, 4-HT-IL7hi, EtOH-IL7lo or 4-HT-IL7lo (Figure 4.2). Pre-BCR signalling induced 
by 4-HT alone was responsible for suppression of the pre-BCR component Igll1. Ikzf1 and 
Ikzf3 were upregulated three to five fold by 4-HT or IL7lo conditions, and Ikzf3 levels were 
dramatically upregulated 25 fold by the combination of IL7lo and 4-HT, which correlated 
with maximal Igκ surface expression. Irf4 was only induced by 4-HT mediated pre-BCR 
signalling and Sfpi1 levels changed only slightly in response to IL7lo induced cell cycle 
arrest. Rag1,2 genes were induced specifically by IL7lo conditions and pre-BCR signalling 
had little effect on Rag1,2 expression. In conclusion, Irf4 levels follow the same pattern of 
Igκ surface expression, directly implicating it in developmental control, and Ikzf1 and 
Ikzf3 both show upregulation coincident with rearrangement suggesting changes in 
expression of these factors during development may also influence events at the Igκ 
locus. The finding that these factors undergo increased transcription during development 
supports the idea that overexpression of these factors mimics’ developmental 
progression and results in induction of Igκ rearrangement and surface expression, rather 
than stabilisation of a subpopulation. 
124 
 
4.2.2 Ikaros may suppress premature Igκ rearrangement through the Eκ3’.  
The Slp65-/-ERt2-Slp65 system suggested IRF4 and Ikaros can drive rearrangement 
independently of pre-BCR signalling and that Ikaros can promote rearrangement above 
effects on the cell cycle. However, the finding that disruption of Ikaros activities can also 
enhance rearrangement before induction of pre-BCR signalling and suppress 
rearrangement after pre-BCR signalling suggested that Ikaros may play a dual role at the 
 
 
Figure 4.2 Gene expression profiling of Slp65-/- ERT2-Slp65 cells. 
Cells were cultured in EtOH-IL7hi, 4-HT-IL7hi, EtOH-IL7lo or 4-HT-IL7lo for 72 hours and 
RNA was extracted every 24 hours. RNA abundance was assessed by qRT-PCR and 
levels normalised to control genes Ywhaz and Ube (average=1) and shown relative to 24 
hour EtOH-IL7hi treated sample (mean+SD, n=3-4).  
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Igκ locus during development. To further define the role of these candidate genes and 
identify their target sites within the Igκ locus, we analysed a panel of transgenic mice 
harbouring Igκ transgenes with cis-acting mutations in collaboration with Dr J. Boyes 
(FBS, Leeds). 
Hiramatsu and colleagues demonstrated an Igκ reporter transgene which undergoes 
correct lineage and developmental stage specific rearrangement, as discussed in Chapter 
1.2.3.4 (Hiramatsu et al., 1995). This study also demonstrated that deletion of the entire 
Eκ3’, or mutation of 6bp in the Eκ3’ across a PU.1 binding site, caused deregulation of 
rearrangement with rearranged Igκ detected in pre-BI cells and T cells. We analysed mice 
with the wild type version of the Igκ reporter transgene (WT Eκ3’) and two new variants; 
mPUlo Eκ3’ which has a mutation of the PU.1 consensus site within the Eκ3’ core (PU.1 
consensus sequence GAGGAA (Klemsz et al., 1990)) and mIkPU Eκ3’ where the mutation 
covered the same PU.1 site and an overlapping putative Ikaros binding site defined by 
sequence analysis (Ikaros consensus sequence GGAA (Georgopoulos et al., 1992)) (Figure 
4.3a).  
Electrophoretic mobility shift assay (EMSA) was used to determine the ability of Ikaros 
and PU.1 to bind the mutated Eκ3’ sequences. Purified recombinant full length Ikaros-
GST or extracts from 293T cells which had been transfected with a PU.1 expressing vector 
(PU.1) or mock transfected (Neg) were assessed for binding to 32P labelled probes 
covering the PU.1 and putative Ikaros binding site from the WT Eκ3’, mIkPU Eκ3’ and 
mPUlo Eκ3’ transgenes (EMSAs performed by Dr J. Boyes, figure 4.3). The probes alone 
(P) or incubated with Neg extract showed no retardation of probe migration, suggesting 
293T cells do not express proteins which could bind the Eκ3’ probes. Incubation of the 
WT Eκ3’ probe with Ik-GST or PU.1 extracts resulted in retardation of the probe 
migration, indicating the ability of these proteins to bind the probe. The mIkPU Eκ3’ 
probe showed no Ikaros or PU.1 band, suggesting this mutation prevented their binding. 
The mPUlo Eκ3’ probe supported Ikaros binding to the same level as the WT Eκ3’ probe. 
However, PU.1 binding was severely compromised, leading to a much weaker band. 
These results suggest Ikaros and PU.1 are both able to bind the Eκ3’ in-vitro and that 
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while the mIkPU Eκ3’ mutation block binding of both of these proteins, the mPUlo Eκ3’ 
mutation reduced the ability of only PU.1 to bind. 
We next wanted to determine how the loss of the Ikaros and PU.1 binding sites affected 
lineage and stage specificity of rearrangement. The Igκ transgene contains a single V 
gene, whereas 140 V genes are present in the endogenous locus (Brekke and Garrard, 
2004). The transgenic Vκ21C is one of the least frequently used V genes, so that specific 
detection of the transgene can be made by assessing rearrangements to this one V gene 
(Hiramatsu et al., 1995). This was confirmed by PCR using primers specific for Vκ21C 
and Jκ5 and Southern blotting using a Vκ21C specific probe (Figure 4.3c). Using genomic 
DNA from FACS sorted immature B cells, rearrangement was only seen from WT Eκ3’ 
and mIkPU Eκ3’ transgenic samples (lane 2 and 3) with no signal seen from non-
transgenic (NTG) cells (lane 1). Equivalent amounts of DNA were used, as assessed by 
picogreen DNA quantification and qPCR for genomic control loci (data not shown).  
To assess tissue specificity of rearrangement, genomic DNA from kidney (K), spleen (S) 
and thymus (T) tissue were analysed by PCR and Southern blotting (experiments 
performed by Dr J. Boyes). Equal loading of DNA was demonstrated by detection of β-
globin, allowing direct comparison of levels of rearrangement. Two to four transgenic 
founders were analysed for each transgenic line to ensure that the detected effects were 
not caused by the integration site of the transgene. DNA from WT Eκ3’ transgenic mice 
from all transgenic founders showed tissue specific rearrangement, with signals only 
detected in spleen (Figure 4.3d, courtesy of Dr J. Boyes). The mIkPU Eκ3’ mutation 
demonstrated functional derestriction of rearrangement, as Vκ21C-J1-4 products were 
detected in thymus extracts. Stage specificity of rearrangement was assessed in FACS 
sorted pre-BI and pre-BII cells. The WT Eκ3’ transgene underwent predominant 
rearrangement at the pre-BII stage whereas the mIkPU Eκ3’ mutation allowed almost 
complete rearrangement in the pre-BI stage, mirroring the Hiramatsu mutation (Figure 
4.1d lower panel, courtesy of Dr J. Boyes).  
The identification of an Ikaros binding site in the Eκ3’ allows new interpretation of the 
Hiramatsu study, and suggests that it may be Ikaros rather than PU.1 targeting of the 
Eκ3’ which is important for suppression of Igκ rearrangement. Transgenic mice 
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harbouring the mPUlo Eκ3’ transgene were studied for rearrangement of the transgene in 
the tissues and cell stages discussed above (Figure 4.1d courtesy of Dr J. Boyes). We 
found that loss of PU.1 binding but retention of Ikaros binding by the mPUlo Eκ3’ 
transgene allowed restoration of correct tissue and lineage specificity of rearrangement, 
supporting the idea that Ikaros rather than PU.1 suppresses rearrangement in alternative 
lineages and developmental stages. 
A qPCR method was developed to allow rapid and more sensitive detection of 
rearrangement. To detect rearrangement of the transgene, primers specific for Vκ21C and 
Jκ1 were used. Rearrangement of the endogenous locus were detected using a degenerate 
Vκ primer which recognises V II family members (of which Vκ21C is not a member) 
(Diss et al., 2002) and the Jκ1 primer. Levels of rearrangement were then normalised to 
two genomic control regions, provided by primers for PU.1 and Amylase. Analysis of 
FACS isolated pre-BI and pre-BII populations from WT Eκ3’ and mIkPU Eκ3’ transgenic 
mice demonstrated a similar pattern of rearrangement detected in the Southern analysis 
(Figure 4.3e). Pre-BI cells from the WT Eκ3’ transgene had very low levels of 
rearrangement whereas mIkPU Eκ3’ had much higher levels. The Southern analysis 
suggested almost equal levels of rearrangement of the transgene in mIkPU Eκ3’ pre-BI 
and pre-BII cells whereas the qPCR results suggested a two-fold higher levels in pre-BII 
cells. The difference could be due to the increased sensitivity of qPCR over Southern 
analysis. Importantly, levels of rearrangement of the endogenous loci were equivalent in 
cells from the two transgenic lines, demonstrating specific amplification of the 
endogenous and transgenic locus. 
qPCR with Vκ21C and Jκ1 primers gave no product from NTG control samples, further 
demonstrating this strategy can specifically detect rearrangement of the transgene over 
the endogenous loci (Figure 4.3f). Detected rearrangements of the mIkPU Eκ3’ transgene 
were greater than the WT Eκ3’ transgene, and correlate well with the Southern analysis 
figure 4.3c. While both transgenes are integrated in multicopy arrays, the derestriction of 
rearrangement of the mIkPU Eκ3’ transgene will mean that each copy has an increased 
frequency of rearrangement which will result in an exponential increase in detection by 
PCR.  
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Figure 4.3 The loss of the Ikaros but not the PU.1 binding site in Eκ3’ caused derestriction of Igκ 
rearrangement.  
(a) Scheme of Igκ transgene showing location of major elements. Mutations at the Eκ3’ are 
indicated. (b) EMSA using purified recombinant Ikaros-GST or nuclear extracts from 293T cells 
transfected with a PU.1 expressing vector (PU.1) or mock transfected (Neg) using a WT Eκ3’, 
mIkPU Eκ3’, or mPUlo Eκ3’ transgene probe. Free probe (P) was run as a negative control. (c) 
Immature B cell DNA from NTG and WT Eκ3’ and mIkPU Eκ3’ transgenic mice was assessed by 
PCR and Southern blot for Vκ21C-Jκ5 rearrangements. (d) Kidney (K), thymus (T) and spleen (S) 
(upper panel) and pre-BI and pre-BII (lower panel) were isolated from WT Eκ3’, mIkPU Eκ3’ and 
mPUlo Eκ3’ transgenic mice and analysed for rearrangement of the transgene (courtesy of Dr J. 
Boyes). (e) Pre-BI and pre-BII cells from WT Eκ3’ and mIkPU Eκ3’ transgenic mice were assessed by 
qPCR for rearrangements of the transgene and endogenous Igκ locus. Rearrangement normalised 
to PU.1 and Amylase genomic loci and shown relative to pre-BII levels (mean+SD, n=3). (f) 
Detection of Vκ21C-Jκ1 products by qPCR from NTG, WT Eκ3’ and mIkPU Eκ3’ transgenic pre-BII 
cells, with levels normalised to PU.1 and Amylase (mean+SD, n=3).  
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4.2.3 Overexpression of Ikaros does not implicate the Eκ3’ binding site. 
To determine whether Ikaros exerts its activity at the Igκ locus through the potential 
binding site in the Eκ3’, we overexpressed Ikaros and Ikaros DN by retroviral 
transduction of primary pre-B cultures using the pMIG vector which has an IRES-GFP 
downstream of the candidate factor. This system allows use of primary cells rather than 
the Slp65-/- cell line, and importantly, allows probing of transcription factor binding sites 
by the cis-acting mutations. Detected effects on rearrangement of the WT Eκ3’ transgene 
should be absent in the mIkPU Eκ3’ transgene if Ikaros targets the loci through this site. 
Pre-B cultures were established from bone marrow or foetal livers of transgenic mice and 
maintained in culture until over 90% were expressing CD19, a pan B cell marker. FACS 
isolation of transduced cells on the basis of GFP fluorescence (Figure 4.4a) and 
subsequent staining with CD19 demonstrated purity of the cell cultures (Figure 4.4b). 
We have seen in the Slp65 system that Ikaros can promote Igκ rearrangement. To 
determine whether Ikaros effects on the transgene are related to the cell cycle, after 48 
hours transduced cells were grown in conditions to promote continued cell cycle (IL7+ 
conditions) or conditions to induce cell cycle arrest and promote Igκ rearrangement 
(IL7ˉLPS+ conditions). Growth conditions were changed at 48 hours, which did not alter 
the outcome compared to the Slp65-/- system, but was important to allow the primary 
pre-B cells extra time for expression of the ectopic proteins. The IL7ˉLPS+ conditions were 
used as they gave a stronger induction of rearrangement that IL7ˉ alone (data not 
shown). 96 hours post transduction, cells were purified by FACS on the basis of GFP 
fluorescence. 
Before examining rearrangement, we first characterised ectopic protein expression in the 
transduced cells. In addition to detecting ectopic Ikaros expression by GFP, we confirmed 
expression of full length protein by western analysis from cell extracts (Figure 4.4c). 
Probing for Lamin B demonstrated equal loading of protein extracts, allowing direct 
assessment of protein concentration. Using an Ikaros antibody, levels of the full length 
Ikaros-1 isoform were higher in cells infected with Ikaros and Ikaros DN compared to 
vector control. Expression of the transgenic Ikaros was confirmed by probing with an 
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anti-HA antibody. Culture of cells in IL7ˉLPS+ conditions resulted in an increase in 
Ikaros-1 abundance, as can be seen in the vector control samples. This suggests cell cycle 
arrest and developmental progression is normally accompanied by an increase in Ikaros 
protein levels. A faint lower molecular weight band of was also detected by the Ikaros 
antibody which correlated to the Ikaros-2 isoform.  
To confirm that Ikaros remained centromeric when overexpressed, and that Ikaros DN 
interfered with centromeric localisation of the endogenous Ikaros protein, we performed 
immunofluorescence staining on purified transduced cells using Ikaros (red) and HA 
(green) antibodies (Figure 4.4d) (Immunofluorescence performed by Dr I. Ferreiros-
Vidal, MRC, CSC). Cells infected with the empty vector had low levels of Ikaros staining 
and no staining with the HA antibody. Cells infected with Ikaros expressing vector show 
a higher level of Ikaros which localised with DAPI bright heterochromatin. HA detection 
in these cells overlapped with these Ikaros-DAPI bright foci. Cells infected with Ikaros 
DN gave an HA signal which was diffuse throughout the nucleus at DAPI low 
euchromatic regions. Staining with the Ikaros antibody showed both ectopic and 
endogenous protein had redistributed to the DAPI low euchromatic regions, 
demonstrating disruption of Ikaros function in these cells. Growth in IL7ˉLPS+ conditions 
resulted in arrest of cell cycle and reduction in cell size, which is reflected in the 
immunofluorescence images, but did not alter activity of endogenous Ikaros or the 
ectopic proteins.  
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Figure 4.4 Functional characterisation of Ikaros and Ikaros DN overexpression in pre-
B cultures. 
Pre-B cultures from mice harbouring the WT Eκ3’ transgene were transduced with 
empty vector control, Ikaros or Ikaros DN expressing vectors. 48 hours after 
transduction, cells were re-cultured in IL7+ or IL7ˉLPS+ conditions. (a) 96 hours post 
infection, cells were FACS purified on GFP expression. (b) Isolated cells were stained 
with CD19 to demonstrate over 98% of cells were CD19+. (c) Cell extracts from isolated 
cells were probing for Ikaros, HA and Lamin B loading control by western analysis. (d) 
Isolated cells were also analysed by immunofluorescence using antibodies for Ikaros 
(red) and HA (green) and DNA was stained with DAPI (blue) (Immunofluorescence 
performed by Dr I. Ferreiros-Vidal). 
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Transgene and endogenous rearrangements were assessed by qPCR using genomic DNA 
from FACS isolated transduced cells. Overexpression of Ikaros resulted in an almost 
three fold induction of rearrangement of both the WT Eκ3’ and mIkPU Eκ3’ transgene 
under IL7+ conditions compared to vector control cells, which agrees with the Slp65-/- 
results (Figure 4.5a). The endogenous Igκ locus underwent similar changes in both cell 
types, suggesting equal Ikaros activity between the two cell cultures (Figure 4.5b). This 
suggests that the detected Ikaros effects are not directed through the Eκ3’, and so could 
be through an alternative site or be indirect effects, such as via the cell cycle. 
Overexpression of Ikaros DN resulted in no change in levels of rearrangement in either 
WT Eκ3’ or mIkPU Eκ3’ transgenic cells suggesting Ikaros does not suppress 
rearrangement, which are in contrast to results from the Slp65-/- system and mPUlo Eκ3’ 
transgenic mice. Alternatively, levels of expression may not be high enough to block 
activity of all endogenous Ikaros, which is supported by the increased transduction rate 
of the Slp65-/- cells (data not shown). Additionally, the Slp65-/- model suggested Ikaros 
suppresses rearrangement prior to pre-BCR signalling and activates rearrangement after 
signalling. Cultured pre-B cells naturally downregulate the pre-BCR, and so these cells 
may be at a later stage compared to the Slp65-/- cells which may also influence events 
(Rolink et al., 1991). 
As shown previously, overexpression of Ikaros resulted in small cell size suggestive of 
cell cycle arrest, which will promote stabilisation of RAG proteins and Rag transcription. 
We therefore used PI staining of purified transduced cells to provide a more accurate and 
quantitative assessment of the cell cycle (Figure 4.5d and e). Overexpression of Ikaros 
resulted in a reduction of the number of G2/M cells from 26% to 12% whereas 
overexpression of Ikaros DN had no effect on the cell cycle.  
The absence of an effect of Ikaros DN may be due to these cells not actively undergoing 
rearrangement due to continued cell cycle. To address this, we assessed whether Ikaros 
DN could block rearrangement at loci induced to rearrange, by transducing WT Eκ3’ 
transgenic cells with Ikaros DN and enforcing cell cycle arrest and rearrangement by re-
culture in IL7ˉLPS+ conditions. We also performed the same experiment but transduced 
Ikaros to give an indication of the effects of Ikaros separated from the cell cycle. Arrest of 
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the cell cycle was confirmed by PI analysis which showed only a fraction of cells in S and 
G2/M phase for Vector control, Ikaros and Ikaros DN, and that the arrest was more 
complete than that seen with Ikaros transduction in IL7+ conditions (Figure 4.5e). Vector 
control cells confirmed that enforced cell cycle arrest resulted in an increased 
rearrangement of both the transgene and endogenous locus compared to cells 
maintained in IL7+ conditions. Disruption of endogenous Ikaros by Ikaros DN 
overexpression had no effect on rearrangement, with the detected levels identical to 
vector control cells in both conditions. However, overexpression of Ikaros increased the 
level of both transgenic and endogenous rearrangement above the vector control in both 
conditions, suggesting Ikaros can affect rearrangement independently of the cell cycle. 
The absence of effect on Ikaros DN expression may suggest that Ikaros cannot suppress 
rearrangement in this system, is not required for the increase in rearrangement seen on 
cell cycle withdrawal and that the effects seen on Ikaros overexpression could be indirect 
through other factors influenced by Ikaros overexpression. However, the absence could 
also be due to insufficient protein levels to influence the locus. 
To determine whether the effects on rearrangement could be mediated by Ikaros family 
members, WT Eκ3’ transgenic cells were transduced with a vector expressing Aiolos 
(Figure 4.5c). Assessment of rearrangement of the transgene by qPCR demonstrated 
Aiolos was able to induce Igκ rearrangement, confirming that these effects are not 
specific for Ikaros, but are common to the Ikaros family of proteins. 
The effects of Ikaros on rearrangement and the cell cycle could be caused by alterations 
in the level of other transcription factors. To assess this, we analysed transcript levels 
from WT Eκ3’ transgenic cells transduced with either Ikaros or Ikaros DN and cultured 
in IL7+ conditions for 96 hours. We measured levels of transcription factors known to be 
important for early B cell development (Figure 4.5f). Levels of Ikzf1 transcript were 30-70 
fold higher in Ikaros and Ikaros-DN cells compared to vector control, which is much 
higher than the two fold increase in protein levels, suggesting that translation efficiency 
or protein stability must be altered. 
The level of the transcription factors Irf4, Sfpi1, Pax5, Lef1 and Ebf1 were slightly raised by 
overexpression of Ikaros. However, overexpression of Ikaros DN did not give a 
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reciprocal repression, suggesting Ikaros may not directly induce these transcription 
factors and that their upregulation is indirect possibly through the cell cycle effects. 
Alternatively, that the level of Ikaros DN in the cells may not be enough to block all 
Ikaros activity or the basal expression level at this stage may not be dependent on Ikaros, 
so that reduction of Ikaros activity would have little effect on expression. Ikzf3 levels 
were unaffected by Ikaros activity, which is surprising as the Slp65 system suggested 
developmental progression is accompanied by an upregulation of Aiolos. It is possible 
that the increased Ikaros activity prevents the need for Aiolos upregulation. 
Additionally, CD43, a marker of pre-BI cells which would be expected to undergo 
repression following developmental progression, was not affected by Ikaros or Ikaros 
DN overexpression. The level of Igκ germline transcription gives an assessment of 
chromatin structure at the locus, and overexpression resulted in a 100 fold increase, 
which correlated with the increase in rearrangement. However, Ikaros DN had little 
effect on the levels, so that no direct relationship between Ikaros activity and events at 
the locus could be suggested. It is also possible that basal Ikaros levels at this stage are 
not involved in rearrangement and that it is the increasing Ikaros or Ikaros family 
members which promote rearrangement.  
Rag1,2 genes showed an increase in expression in Ikaros transduced cells and also a 
lesser increase in Ikaros DN infected cells which was, however, not sufficient to affect 
rearrangement. Myc is associated with proliferation in B lymphocytes and provides a 
marker of the cell cycle activity (Smeland et al., 1985). Overexpression of Ikaros caused 
three fold repression of Myc RNA levels which may be a cause or consequence of Ikaros 
activity. Myc levels were unchanged in Ikaros DN transduced cells, suggesting an 
indirect effect of Myc regulation. The changes to the transcription profile suggest either 
Ikaros or the cell cycle arrest induced by Ikaros result in an upregulation of the 
transcription factors IRF4, PU.1, PAX5, LEF1 and EBF. Ikaros, or one of these factors, 
could drive an increase in accessibility and germline transcription of the Igκ locus. This, 
and the increase in Rag1,2 transcription may result in the increased rearrangement 
detected. 
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Figure 4.5 Ikaros and Ikaros DN effects on rearrangement, cell cycle and transcription. 
WT Eκ3’ and mIkPU Eκ3’ transgenic cells were transduced with vector control, Ikaros or 
Ikaros DN expressing vectors and maintained in IL7+ or IL7ˉLPS+ conditions 48 hours after 
transduction. Rearrangement of the (a) transgene or (b) endogenous locus from 
transduced WT Eκ3’ transgenic (grey) and mIkPU Eκ3’ transgenic (blue) pre-B cells was 
assessed by qPCR and normalised to Amylase and PU.1 and shown relative to vector 
control IL7+ (mean+SD, n=3). (c) Assessment of rearrangement in WT Eκ3’ cells 
transduced with Aiolos expressing vectors under IL7+ conditions (mean+SD, n=3). (e) Cell 
cycle profile (with doublets removed from analysis (d)) of transduced pre-B cultures. (f) 
Gene expression analysis of WT Eκ3’ transgenic pre-B cultures transduced with Ikaros 
(grey) or Ikaros DN (black) and cultured for 96 hours in IL7+ conditions. Expression was 
normalised to Ywhaz and Ube and shown relative to vector control on log scale (mean+SD, 
n=3-5).  
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4.2.4 IRF4, PU.1 and Igκ rearrangement 
We have demonstrated that IRF4 can induce rearrangement in the Slp65 model system 
(Figure 4.1). We have also demonstrated that PU.1 may not function as the suppressor of 
rearrangement at the Eκ3’ (Figure 4.3), and that both these factors are induced by Ikaros 
overexpression and induction of Igκ rearrangement (Figure 4.5). We therefore wanted to 
further investigate the role of these candidates during rearrangement using the 
transgenic pre-B system to allow analysis of direct interactions on cis-acting sequences. 
WT Eκ3’ and mIkPU Eκ3’ transgenic pre-B cultures were therefore transduced with IRF4 
and PU.1 expressing pMIG vectors.  
Protein levels were determined by western blotting (Figure 4.6a). While endogenous 
IRF4 protein levels were equivalent in IRF4 and vector control transduced cells, the 
FLAG-tagged IRF4 could be detected as a higher molecular weight band and was 
equivalent in strength, suggesting a doubling of IRF4 protein load. Lamin B 
demonstrated slight under-loading of the IRF4 transduced cells. A faint endogenous 
PU.1 band was detected in both PU.1 transduced and vector control samples, but two 
much stronger higher molecular weight bands were also detected in PU.1 transduced 
extracts. These were confirmed as the FLAG-tagged PU.1 by probing with anti-FLAG 
antibodies. These products might represent degraded forms, alternative translational 
start sites or post translational modification which are known to control the ability of 
PU.1 to interact with transcriptional coactivators such as IRF4 (Pongubala et al., 1993). 
Levels of α-tubulin demonstrated equal loading of these protein extracts. 
The cell cycle was analysed in transduced cells and showed that overexpression of IRF4 
resulted in a reduction of cells in S and G2/M phase from 32% in vector control to 15% in 
IRF4 samples (Figure 4.6b upper panel). PU.1 overexpression resulted in an even greater 
arrest of the cell cycle with only 8% of cells in S or G2/M phase. Treatment with IL7ˉLPS+ 
resulted in arrest of all transduced cells (Figure 4.6b lower panel). The difference in cell 
cycle status between vector control cells of these and the Ikaros experiments reflects the 
biological variability in cultures of pre-B cells. 
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WT Eκ3’ cells overexpressing PU.1 had an almost 8 fold increase in the rearrangement of 
the transgene and 4 fold increase in rearrangement of the endogenous Igκ locus (Figure 
4.6c and e). The endogenous loci of mIkPU Eκ3’ cells underwent a similar increase in 
rearrangement as WT Eκ3’ transgenic cells demonstrating equivalent activity of PU.1 
(Figure 4.6e, blue bar). The mIkPU Eκ3’ transgene also showed increased rearrangement 
in response to PU.1, but to a lesser extent with only a 3.3 fold rise (Figure 4.6c, blue bar). 
However, the PU.1 transduced mIkPU Eκ3’ cells did not respond to IL7ˉLPS+ treatment 
with a greater increase in rearrangement (Figure 4.6f), which could be due to all copies of 
the transgene having already undergone rearrangement, such that no difference could be 
detected. Therefore, the 3.3 fold increase is the maximum detectable in these cells, so that 
the reduced increase in rearrangement compared to the WT Eκ3’ transgene may not be 
related to the Eκ3’ mutation. Equally, these results cannot rule out that the mutation 
could cause such an effect.  
IRF4 overexpression resulted in 4-5 fold higher levels of rearrangement of the WT Eκ3’ 
transgene (Figure 4.6c). The endogenous locus from both WT Eκ3’ and mIkPU Eκ3’ 
transgenic cells also increased 4 fold in response to IRF4, suggesting equal levels of IRF4 
activity in these cells (Figure 4.6e). IRF4 transduction of the mIkPU Eκ3’ cells also 
promoted rearrangement with a 2.5 fold increase. As this increase did not seem to cause 
the maximal increase detectable suggested by PU.1 transduction, the finding that the 
increase was lower than seen at the WT Eκ3’ transgenes could suggest that IRF4 targets 
the Eκ3’ for specific effects 
The fact that PU.1 overexpression could induce rearrangement of WT Eκ3’ and mIkPU 
Eκ3’ transgenes suggests PU.1 either targets a non-consensus binding site in the 
transgene or the induction of rearrangement is caused by other non-specific effects, 
possibly due to the dramatic effect on the cell cycle. However, assessment of the effects of 
these factors in arrested cells by IL7ˉLPS+ treatment determined that both IRF4 and PU.1 
could promote rearrangement of the WT Eκ3’ transgene above vector control cells, 
suggesting effects are distinct from the cell cycle (Figure 4.6d). 
We next assessed how overexpression of PU.1 and IRF4 affected message levels of B cell 
specific genes (Figure 4.6g). Overexpression of either factor did not influence expression 
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level of the other. However, overexpression of IRF4 or PU.1 gave a similar increase of B 
cell transcription factors, such as Ikzf1, Ikzf3, Lef1 and Pax5. This suggested PU.1 and IRF4 
either function in the same regulatory network with these factors as downstream targets, 
or that these increases are indirect, possibly through the cell cycle effects. What is 
interesting to note is the dramatic increase in germline transcription from the Igκ locus 
seen with IRF4 overexpression which was also seen with Ikaros overexpression. PU.1 
overexpression did not drive a similar increase in germline transcription, suggesting that 
upregulation of transcription is dependent on IRF4/Ikaros pathways and not general cell 
cycle mechanisms, or that PU.1 can specifically suppress germline transcription without 
preventing rearrangement.  
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Figure 4.6 Overexpression of IRF4 and PU.1 in pre-B cultures.  
WT Eκ3’ and mIkPU Eκ3’ transgenic pre-B cultures were transduced with vector control, IRF4 
or PU.1 expressing vectors and were maintained in IL7+ or IL7ˉLPS+ conditions after 48 hours. 
96 hours post transduction, cells were isolated by FACS purification and assessed for (a) 
protein level by western analysis for cells maintained in IL7+ conditions and (b) cell cycle 
profile. Rearrangement was assessed for the transgene in cells maintained in (c) IL7+ or (d) 
IL7ˉLPS+ conditions and (e) the endogenous loci under IL7+ conditions. Rearrangement was 
normalised to Amylase and PU.1 (specific for the endogenous locus) and is shown relative to 
vector control (mean+SD, n=3-6). (f) Rearrangement of mIkPU pre-B cells transduced with 
vector control, PU.1 IL7+ or PU.1 IL7ˉLPS+ (mean+SD, n=3). (g) Gene expression profile was 
analysed in transduced WT Eκ3’ transgenic cells by qRT-PCR. RNA abundance was normalised 
to Ywhaz and Ube and is shown as log fold change over vector control (mean+SD, n=3-5).  
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4.2.5 The role of LEF1 in Igκ rearrangement  
To determine whether other factors were involved in regulation through the Eκ3’ cis-
acting sites, we screened nuclear extracts from pre-B cell lines by EMSA to identify 
potentially novel interaction partners (EMSAs performed by Dr J. Boyes). Using nuclear 
extracts from the 122-1 pre-B cell line (Sabbattini et al., 1999) we detected four complexes 
forming on the Eκ3’ probe as compared to the probe alone (Figure 4.7a lane 1 and 2). One 
complex ran with the same mobility as the PU.1 complex previously seen (Figure 4.3b) 
and agreed with competition and supershift assays (data not shown) and is therefore 
labelled PU.1. 
Transcription factor binding site analysis of the Eκ3’ using the sequence analysis 
programme, TESS (Transcription Element Search System), suggested the presence of a 
LEF1 binding site at the sequence CTTTG. LEF1 is an architectural protein which can 
form multi—component complexes and has been implicated in B cell development as 
null mice have a partial block in the pre-BI to pre-BII transition (Giese et al., 1995; 
Lnenicek-Allen et al., 1996; Reya et al., 2000). We confirmed LEF1 binding to the Eκ3’ 
using an unlabelled LEF1 consensus binding site probe (Gustavson et al., 2004) which 
was able to compete away one of the protein complexes formed between the nuclear 
extracts and the 32P labelled Eκ3’ probe (lane 3-5, band labelled LEF1), while a mutated 
version of the LEF1 consensus probe did not compete with this band (lane 6-8). To 
further demonstrate in-vitro LEF1 binding, addition of a LEF1 antibody resulted in a 
supershift of this band (lane 10 and 11) whilst no supershift was seen on addition of an 
isotype control antibody (lane 12 and 13).  
Having demonstrated the ability of LEF1 to bind the Eκ3’ in-vitro, we sought to 
determine whether it was involved in regulation of Igκ rearrangement. A potential 
model would involve the architectural function of LEF1 stabilising a repressive complex 
at the Eκ3’. Destabilisation of the complex during development would then relieve 
repression of the locus allowing rearrangement to occur. To determine whether LEF1 
could play such a role, LEF1 protein levels were modulated by retroviral transduction of 
WT Eκ3’ and mIkPU Eκ3’ transgenic pre-B cultures using a cloned FLAG epitope tagged 
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LEF1 and LEF1 dominant negative (LEF1DN) construct in the pMIG vector (Figure 4.7b). 
A naturally occurring LEF1DN  is generated endogenously by an alternative transcription 
start site resulting in loss of the first two exons (Hovanes et al., 2001). The resultant N-
terminal truncated protein has lost the β-catenin interaction domain (β-ID) and a portion 
of the context dependent transcriptional activation domain (CAD) but retains the HMG 
DNA binding domain and nuclear localisation signal sequence (HMG) (Figure 4.7b). 
Studies have demonstrated in-vitro that LEF1DN can bind DNA but cannot cause β-
catenin induced transcriptional activation (Hovanes et al., 2001; Tutter et al., 2001).  
Two to three fold overexpression of LEF1 and LEF1DN was confirmed in transduced pre-B 
cultures using antibodies specific to LEF1 and FLAG (Figure 4.7c). The FLAG epitope 
increasing the size of transduced LEF1 while the truncation of LEF1DN resulted in an 
expected decrease in size. Endogenous LEF1 remained stable in all cells grown in IL7+ 
conditions, whereas levels were reduced two to three fold in cells cultured in IL7ˉLPS+ 
conditions, suggesting LEF1 levels are downregulated during development from the 
large to small pre-BII stage. Lamin B showed equal protein loading. 
Unlike Ikaros, IRF4 and PU.1, overexpress of LEF1 had no effect on the cell cycle while 
overexpression of LEF1DN induced a modest reduction of cells in S+G2/M phase from 
32% to 26% (Figure 4.7d). Therefore, any effects on Igκ rearrangement are not via the cell 
cycle. Furthermore, IL7ˉLPS+ treatment caused cessation of the cell cycle in all transduced 
cells, demonstrating overexpression of LEF1 or LEF1DN has no effect on exit of the cell 
cycle.  
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Figure 4.7 LEF1 interacts with Eκ3’ sequences. 
(a) EMSA using a 32P labelled WT Eκ3’ sequence (lane 1) with protein extracts from the 
122-1 pre-B cell line (lane 2). The probe and protein extract were pre-incubated with an 
unlabelled LEF1 competitor probe (lane 3-5), mutated competitor (lane 6-8), LEF1 
antibody (lane 10 and 11) or isotype matched control antibody (lane 12 and 13). The PU.1 
mobility band has been previously determined (courtesy of Dr J. Boyes). (b) Scheme of 
FLAG-LEF1 constructs used for retroviral transduction. Wild type LEF1 contained the β-
catenin interaction domain (β-ID), context-dependent activation domain (CAD) and the 
HMG DNA binding domain and nuclear localisation sequence (HMG). LEF1DN codes 
from an alternative start site within exon 3 causing loss of the β-ID and a portion of the 
CAD. WT Eκ3’ and mIkPU Eκ3’ pre-B cultures were transduced with vector control, LEF1 
or LEF1DN and recultured in IL7+ or IL7-LPS+ conditions after 48 hours. 96 hours post 
transduction cells were sorted for GFP expression. Transduced cells were assessed for 
protein abundance by (c) western analysis with FLAG, LEF1 and Lamin B antibodies and 
(c) for cell cycle by PI staining and detection by flow cytometry. 
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Rearrangement was assessed in transduced cells and overexpression of LEF1 showed no 
significant effect on the WT Eκ3’ or mIkPU Eκ3’ transgene or the endogenous locus 
under IL7+ conditions (Figure 4.8a and b). To determine whether LEF1 could stabilize a 
repressive complex at the Eκ3’, WT Eκ3’ and mIkPU Eκ3’ pre-B cultures were induced to 
rearrange by culturing in IL7ˉLPS+ conditions. Stabilisation of a repressive complex by 
overexpression of LEF1 should prevent rearrangement occurring in these conditions. 
However, overexpression of LEF1 did not cause a statistically significant effect on 
rearrangement levels of either the WT Eκ3’ or mIkPU Eκ3’ transgene in these cells 
(Figure 4.8c). Rearrangement of the endogenous locus (Figure 4.8d) mirrored this with no 
significant effect on rearrangement in either cell type.  
Disruption of LEF1 activity by overexpression of LEF1DN did cause an effect on 
rearrangement, with a twofold increase in the level of rearrangement at the endogenous 
locus and the WT Eκ3’ transgene under IL7+ conditions, while the mIkPU Eκ3’ was 
unaffected. Therefore, this effect is dependent on the Ikaros/PU.1 binding site (Figure 
4.8a and b). Under IL7ˉLPS+ conditions LEF1DN had no effect on rearrangement at either 
transgene or the endogenous locus (Figure 4.8 b and d).  
Disruption of LEF1 activity by overexpression of LEF1DN could have many off target 
effects which give increased rearrangement. We therefore assessed candidate 
transcription factors to determine whether they had undergone altered transcriptional 
regulation which may explain the effects observed (Figure 4.8e). All the transcripts 
measured showed similar expression between vector control, LEF1 or LEF1DN transduced 
cells. Small effects were observed on germline transcripts but these do not appear 
significant and do not correlate with rearrangement. Rag1,2 genes showed a small LEF1 
dependent response and appear to require the β-IM domain or an intact CAD domain for 
expression. However, these effects are small and do not correlate with changes seen in 
Igκ rearrangement.  
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Figure 4.8 LEF1DN but not LEF1 can effect Igκ rearrangement. 
Vector control, LEF1 or LEF1DN transduced cells grown in IL7+ or IL7ˉLPS+ conditions were 
assessed by qPCR for rearrangement of (a and c) the WT Eκ3’ or mIkPU Eκ3’ transgene or (b 
and d) the endogenous Igκ locus. Rearrangement was normalised to Amylase and PU.1 
control loci and are shown relative to vector control (mean+SD, n=3-5). (e) Gene expression 
profile of transduced cells grown in IL7+ conditions by qRT-PCR. RNA was normalised to 
Ywhaz and Ube and shown as fold change over vector control (mean+SD, n=3-4). 
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4.2.6 LEF1 knockdown in WT Eκ3’ transgenic cells 
Rearrangement of Igκ can be induced by overexpression of LEF1DN, which is not 
dependent on cell cycle changes or alteration in the gene expression profile of the 
analysed genes. The induction is also dependent on the presence of an Ikaros and/or 
PU.1 binding sites in the Eκ3’, suggesting an interaction with one or both of these factors. 
LEF1DN disrupts protein interactions but retains the DNA binding/bending activity of the 
protein. To determine whether this DNA binding/bending activity is important for 
regulation of the locus, we used siRNA knockdown to deplete LEF1 protein from the WT 
Eκ3’ transgenic cells. If only the β-ID/complete CAD is required for the suppression of 
rearrangement, knockdown should have no effect past that seen with LEF1DN. However, 
if we see an additive effect, this suggests DNA binding activity is also important for 
regulation.  
Four synthetic siRNAs were screened and two were chosen for greatest reduction of 
LEF1 protein level (data not shown). siRNAs were introduced into the cells by 
nucleofection and maximal protein reduction occurred 72 hours post nucleofection (data 
not shown). Dead cells were removed by FACS on the basis of PI uptake. Compared to 
non-specific control siRNA, LEF1 siRNAs resulted in a two to three fold reduction of 
LEF1 protein (Figure 4.9a). Reduction of LEF1 protein had little effect on the cell cycle as 
assessed by PI profile of isolated cells (Figure 4.9b).  
A reduction of LEF1 protein resulted in a surprising decrease in rearrangement of both 
the WT Eκ3’ transgene and endogenous Igκ loci, which is inconsistent with LEF1 
involvement in a repressive complex at the Igκ locus (Figure 4.9c and d). LEF1 null mice 
show a partial block in pre-BI to pre-BII transition (Reya et al., 2000). Removal of LEF1 
protein from the cultures could have caused a selection of earlier pre-BI cells in the 
culture. The cell surface markers Heat Stable Antigen (HSA), BP-1, CD43 and CD25 can 
be used to differentiate early and late populations of pre-BI and pre-BII cells (Hardy et al., 
1991), and surface staining with these markers revealed no differences between the 
control siRNA and LEF1 siRNA treated cells (Figure 4.9d). Therefore, these cells were at 
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the same developmental stage and that the decrease in rearrangement is not due to a 
selection event.  
We next used chromatin accessibility using real time PCR (CHART-PCR) to determine 
whether the reduction in rearrangement was caused by a change of the chromatin status 
of the Igκ locus. The Eκ3’ has a nuclease hypersensitive site (HSS) containing an NcoI 
restriction site, which undergoes increased accessibility during B cell development 
(McDevit et al., 2005). Following treatment of nuclei with restriction enzymes, the 
abundance of the Eκ3’ HSS was determined by qPCR using primers spanning the 
restriction site and was normalised to the abundance of genomic control loci which do 
not contain a restriction site. To control for non-specific degradation during processing, 
the normalised value is shown relative to normalised Eκ3’ HSS abundance from samples 
treated with the restriction enzyme SpeI, which has no target sites in the Eκ3’ HSS or 
control loci. 
Reduction of LEF1 protein resulted in a small increase in detection of the Eκ3’ HSS 
compared to control siRNA treated cells over all concentration of NcoI tested (Figure 
4.9f). This suggests there is a decrease in chromatin accessibility of the locus on LEF1 
depletion, which agrees with the decrease in rearrangement seen in these cells.  
We analysed transcript abundance to determine whether we could correlate the 
reduction in rearrangement and accessibility with alterations in transcription factors 
(Figure 4.9g, note change to linear scale). In confirmation of the protein analysis, Lef1 
message was reduced compared to control siRNA. Of the other genes analysed, only 
Ikzf3 and Cd43 showed upregulation. CD43 is a marker of pre-BI cells, and upregulation 
could suggest a selection event discussed above. However, Ikzf3 is upregulated on the 
large to small pre-BII transition and the absence of change of Igll1 argues against such a 
selection. Rag1,2 were not affected by the loss of LEF1, demonstrating the reduction in 
rearrangement was not caused by loss of components necessary for rearrangement and 
disagrees with the data suggesting LEF1 involvement in Rag1,2 expression. Germline 
transcripts from the Igκ locus were reduced substantially, which correlated with the 
decrease in rearrangement and chromatin accessibility, and suggests LEF1 DNA binding 
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activity is important for locus accessibility during development, while the protein 
interaction domain mediates a repressive effect.  
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Figure 4.9 LEF1 protein depletion reduces chromatin accessibility and rearrangement at the Igκ 
locus. 
WT Eκ3’ transgenic pre-B cultures were nucleofected with either control siRNA or two LEF1 
siRNAs and cultured for 72 hours. Live cells were isolated by FACS on the basis of PI exclusion 
and protein levels determined by western analysis (a) and cell cycle status assessed (b). 
Rearrangement of the WT Eκ3’ transgene (c) and endogenous Igκ locus (d) was assessed in 
purified cells by qPCR. Rearrangement was normalised to Amylase and PU.1 control loci and is 
shown relative to control siRNA (mean+SD, n=2). (f) CHART-PCR assessment of chromatin status 
of the Eκ3’ hypersensitive region in control and LEF1 siRNA treated cells. Abundance of the Eκ3’ 
HSS was normalised to PU.1 and β-2 macroglobulin loci which have no restriction sites and are 
shown relative to SpeI treated cells which controls for non-specific degradation of the nuclei 
(mean+SD, n=2, statistical significance by students T test indicated). (g) Control and LEF1 siRNA 
treated live cells were assessed for gene expression by qRT-PCR. RNA was normalised to Ywhaz 
and Ube and is shown relative to control siRNA treated cells (mean+SD, n-2). 
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4.2.7 A role for β-Catenin in Igκ rearrangement 
The results from the previous sections suggested both a positive and negative role for 
LEF1 in Igκ rearrangement. Depletion of LEF1 protein correlates with reduced 
rearrangement and decreased chromatin accessibility at the Igκ locus, suggesting LEF1 is 
necessary for rearrangement. Conversely, LEF1DN overexpression caused an increase in 
the level of rearrangement, suggesting the activity of the β-ID/intact CAD could suppress 
rearrangement which was dependent on the presence of an Ikaros/PU.1 binding site in 
the Eκ3’. β-catenin, a member of the Wnt signalling pathway, is one of the main 
interacting partners of the LEF1 β-ID. There are reports which implicate β-catenin in BCR 
signalling and pre-BI to pre-BII developmental progression, which are further expanded 
in the discussion (Christian et al., 2002; Ranheim et al., 2005). In the absence of signalling, 
β-catenin is continually phosphorylated by glycogen synthase 3 (GSK3), which targets it 
for ubiquitin mediated degradation. Wnt signalling blocks GSK3 activity, preventing β-
catenin phosphorylation and the resultant stabilised β-catenin accumulates in the 
cytoplasm from where it can translocate to the nucleus and interact with LEF1/TCF 
transcription factors to cause transcriptional activation (Dale 1998; Huelsken and Behrens 
2002; Nusse 2005).  
To investigate the role of β-catenin during Igκ rearrangement, a stabilised form was 
cloned and tagged with the double FLAG epitope. Stabilisation is achieved through 
deletion of exon 3, which contains the phosphorylated regulatory domain to give β-
cateninΔex3 (Iwao et al., 1998; Harada et al., 1999) (Figure 4.10a). Stabilisation of β-catenin 
was confirmed by retroviral transduction of a pre-B cell line. Immunofluorescence using 
β-catenin antibodies in transduced cells showed much higher levels of β-catenin in the 
cytoplasm of the cells compared to vector control (Figure 4.10b). Although ectopic β-
cateninΔex3 was predominantly in the cytoplasm, higher levels were also present in the 
nucleus compared to vector control.  
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Overexpression of β-cateninΔex3 in WT Eκ3’ transgenic pre-B cultures was confirmed by 
western analysis using anti-β-catenin and anti-FLAG antibodies, which showed 
significant overexpression (Figure 4.11a). Cell cycle analysis showed β-cateninΔex3 
overexpression resulted in cell cycle arrest inversely proportional to the protein load 
(assessed by GFP fluorescence, figure 4.11b). While β-cateninΔex3 overexpression resulted 
in arrest of the cell cycle, cells isolated for GFPlo fluorescence showed greater cell cycle 
arrest than those isolated for GFPhi fluorescence.  
 
 
Figure 4.10 Stabilisation of β-catenin.  
(a) Scheme of the β-catenin transcript showing location of major domains including exon 
3 which undergoes phosphorylation, the armadillo repeats and the transactivation 
domain. X marks the translational stop site.  
Double FLAG tagged β-cateninΔex3 was cloned into the pMIG vector allowing retroviral 
transduction of cells. (b) Immunofluorescence on B3 pre-B cells transduced with vector 
control or β-cateninΔex3 expressing vectors, showing β-catenin (red) and DNA stained 
with DAPI (blue). Staining control shows cells stained without the primary antibody. 
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β-cateninΔex3 overexpression resulted in an increase in rearrangement of the WT Eκ3’ 
transgene that was independent of protein load. GFPhi and GFPlo cells showed a similar 
1.5-2 fold increase over vector control GFPhi cells (Figure 4.11c). The endogenous locus, 
however, underwent much more dramatic change. GFPlo cells underwent a 12 fold 
increase in rearrangement, whereas GFPhi cells underwent a more modest 6 fold increase. 
The differences between the endogenous locus and transgene may be caused by the 
absence of regulatory elements in the transgene (further expanded in the discussion). The 
difference between the GFPhi and GFPlo cells could be explained by the greater cell cycle 
arrest in GFPlo cells and also by the gene expression changes (only measured in GFPhi 
cells, figure 4.11e). The germline transcripts are dramatically upregulated on β-catenin 
induction, suggesting β-catenin activity can influence accessibility of the Igκ locus, either 
indirectly or perhaps directly through LEF1 interactions. Rag1,2 underwent dramatic 
repression on β-catenin overexpression, which may be a consequence of the detected 
reduction in Pax5, as PAX5 has been implicated in regulating Rag2 expression (Jin et al., 
2002). Although the Igκ locus would be expected to have greater accessibility in the GFPhi 
than GFPlo cells, Pax5-Rag1,2 repression would be greater, reducing the potential for 
rearrangement. Upregulation of Irf4 and Ikzf3 occurs on pre-BCR signalling and the 
detected upregulation upon β-catenin overexpression could suggest a link between this 
signalling and β-catenin activity.   
To determine whether β-catenin can influence the Igκ locus at endogenous protein levels, 
we used lithium chloride (LiCl), which inhibits GSK3 activity resulting in stabilisation of 
β-catenin (Ryves and Harwood, 2001) and asked whether treatment could affect Igκ 
germline transcription. Wild type pre-B cells were treated for 24 hours with varying 
concentrations of LiCl or KCl (Figure 4.11a). KCl was included as a control for addition of 
a small positively charged ions. A 5-fold induction of germline transcription was 
observed on treatment of cells with high levels of LiCl, with no equivalent induction seen 
with KCl, suggesting endogenous β-catenin activity can influence the Igκ locus. The 
absence of a graded effect of LiCl may suggest a high threshold β-catenin activity is 
required to drive chromatin changes in these cells.  
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Figure 4.11 β-catenin can promote Igκ germline transcription and rearrangement. 
(a) Western analysis of vector control and β-cateninΔex3 transduced WT Eκ3’ transgenic pre-B 
cultures after 72 hours. Probing for β-catenin showed roughly equal levels of the endogenous 
β-catenin protein while ectopic β-cateninΔex3 was detected as a larger protein and was 
confirmed by probing with anti-FLAG antibodies. Probing for α-tubulin demonstrated equal 
protein loading. (b) Cell cycle profile of GFPhi vector control transduced cultures and GFPhi or 
GFPlo β-cateninΔex3 transduced cultures, representative of two experiments. Rearrangement at 
the transgene (c) and endogenous (d) locus was assessed by qPCR. Levels normalised to 
Amylase and PU.1 and are shown relative to vector control (mean+SD, n=2-3). (e) Gene 
expression profiling of GFPhi β-cateninΔex3 transduced cells. RNA abundance normalised to 
Ywhaz and Ube and shown relative to vector control (mean+SD, n=3). (f) Non transgenic pre-B 
cultures were treated with LiCl or KCl for 24 hours and Igκ germline transcription assessed by 
qRT-PCR (mean+SD, n=2). 
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4.3 DISCUSSION 
The experiments here described a role for multiple transcription factors in regulation of 
Igκ rearrangement. Ikaros demonstrated an ability to both suppress and enhance 
induction of rearrangement above indirect effects through the cell cycle. IRF4 also 
demonstrated an ability to induce rearrangement, as did PU.1. The effect on germline 
transcription of Ikaros and IRF4 suggest they are related and possibly function in the 
same pathway. PU.1 appears to function through an alternative pathway as seen by 
differing effects on germline transcription. LEF1 was also implicated in direct regulation 
through the β-catenin interaction domain to suppress rearrangement, which required 
factors binding the PU.1 or Ikaros sites in the Eκ3’. Further, the LEF1 DNA binding 
activity appeared required to maintain accessible chromatin. The role of β-catenin was 
investigated and multifaceted effects on development were noted. Changes to the gene 
expression profile led to an inversely related dose dependent effect on rearrangement, 
influenced by alterations in the gene expression profile of cells. 
4.3.1 IRF4 and a bipartite Ikaros  
The results presented here suggest a model whereby prior to pre-BCR signalling and cell 
cycle withdrawal, Ikaros is involved in a suppressive complex at the Igκ locus. After 
these events, Ikaros changes in nature to activate rearrangement.  
The suppressive role of Ikaros was demonstrated by overexpression of Ikaros DN which 
caused modest upregulation of Igκ rearrangement in the Slp65-/- system. This effect was 
only observed in cells that were not undergoing SLP65 induced pre-BCR signalling or 
IL7lo dependent cell cycle withdrawal. The inability of the cells to undergo pre-BCR 
mediated withdrawal from the cell cycle was suggested by the absence of the partially 
arrested cell size in Ikaros DN 4-HT IL7hi treated cells. Treatment of Ikaros DN 
transduced cells in IL7lo condition resulted in cell cycle arrest, demonstrating that 
disruption of Ikaros activity alone is not sufficient to maintain proliferation.  
The role of Ikaros as a suppressor protein at the locus was also supported by the in-vivo 
findings using the Eκ3’ transgenic reporter system. Here we refined the previous in-vivo 
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study (Hiramatsu et al., 1995) and showed that loss of both Ikaros and PU.1 binding in-
vitro causes complete deregulation of rearrangement in-vivo. We then demonstrated that 
by preservation of the Ikaros site but reduction in the binding capacity of the PU.1 site in-
vitro, lineage and stage specificity is restored in-vivo, placing Ikaros as a regulator of 
specificity.  
However, the suppressive role of Ikaros could not be confirmed using ex-vivo pre-B cells 
harbouring the Eκ3’ transgenes. Overexpression of Ikaros DN in these cells had no effect 
on levels of rearrangement, even when rearrangement was promoted by cell cycle arrest. 
Overexpression of Ikaros DN did not influence the cell cycle but did disrupt endogenous 
Ikaros activity and delocalise both transduced and endogenous Ikaros away from 
pericentromeric heterochromatin, effects which were in accordance with our previous 
studies (Thompson et al., 2007). It is possible that while the use of LPS enhanced 
rearrangement in these cells, the effects of LPS induced NF-κB activity in the cells may 
have masked effects caused by Ikaros DN. The confliction between the ex-vivo Eκ3’ 
transgenic cells and results from the Slp65-/- cells could also be due to levels of 
overexpression of Ikaros DN. Although protein levels were not determined in 
transduced Slp65-/- cells, overexpression on the basis of transduction efficiency and 
fluorescence suggested a higher level of retroviral activity (data not shown). This would 
also agree with our findings that cell lines tolerate higher levels of transduced proteins 
than primary ex-vivo cells. Alternatively, the Slp65-/- system suggests that Ikaros functions 
as a suppressor until pre-BCR signalling occurs. Wild type pre-B cultures naturally 
express and then downregulate surface pre-BCR over time (Rolink et al., 1991), so the 
cultures of transgenic cells may reflect a different developmental stage. 
The activatory role of Ikaros and IRF4 was demonstrated by overexpression in both the 
Slp65-/- system and ex-vivo Eκ3’ transgenic cells. These effects do not appear to be caused 
by the cell cycle arrest induced by these factors, and the Slp65-/- system showed the effects 
of overexpression were independent of pre-BCR signalling and therefore place IRF4 and 
Ikaros downstream of this cascade. The upregulation driven by IRF4 overexpression was 
no greater than the increase seen on cells with enforced cell cycle withdrawal and SLP65 
induced pre-BCR signalling. This suggested that overexpression in these cells reaches 
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only the physiological levels induced by pre-BCR signalling or that whilst IRF4 
upregulation is fundamental to Igκ rearrangement, it is not limiting. Ikaros however, did 
promote Igκ rearrangement and surface expression beyond that seen in equivalent 
control cells. The fact that under all conditions tested, Ikaros promoted equivalent levels 
of rearrangement, suggesting its role as a limiting factor in the final stages of the 
signalling cascade. The suggestion of an IRF4–Ikaros cascade parallels our findings of 
control of the Igll1 locus (Thompson et al., 2007) and would provide a mechanism for 
integrating signalling events through the pre-BCR with the Igκ locus. A functional 
cascade between these factors is also supported by the similar effects on levels of 
germline transcripts seen on their overexpression.  
The question of how per-BCR signalling may control the effects of Ikaros at the Igκ locus 
is intriguing. We observed increased levels of Irf4 caused by both pre-BCR signalling and 
Ikaros overexpression, which may indicate changes in IRF4 levels are involved in 
promoting an activatory rather than suppressive Ikaros complex. Aiolos was also able to 
induce rearrangement, which provides an alternative mechanism for integrating pre-BCR 
signalling with downstream events through the upregulation of Ikzf3. The activatory 
Ikaros effects do not appear to be targeted through the Eκ3’, as the mIkPU Eκ3’ transgene 
responded equally well to Ikaros overexpression. This may suggest suppressive and 
activatory Ikaros complexes may occur at different sites in the locus, controlled through 
differing interaction partners at these locations, which is supported by ChIP results that 
demonstrated Ikaros binding at multiple sites across the locus (Liu et al., 2006). However, 
there is a suggestion that IRF4 effects are targeted through the Eκ3’. The derestricted 
rearrangement pattern of the mIkPU Eκ3’ transgene indicates that rearrangement takes 
place whenever RAG proteins are present. Increased rearrangement of the mIkPU Eκ3’ 
transgene on ectopic expression of factors may simply reflect an indirect increase in 
rearrangement potential in these cells, which may mask any direct involvement at the 
locus.  
Gene expression profiling of Slp65-/- ERt2-Slp65 cells grown in different conditions 
agreed well with other studies. We found that Rag1,2 expression is induced by IL7 
withdrawal rather than pre-BCR signalling events, which was the conclusion reached by 
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Johnson and colleagues on a study of IRF4,8-/- pre-B cells (Johnson et al., 2008).  IRF4,8-/- 
cells are blocked at the pre-BII stage and have sustained pre-BCR expression and no Igκ 
rearrangement. Two pathways required for Igκ rearrangement were identified in these 
cells, the first was an IRF4 pathway which caused Ikzf3 induction for Aiolos mediated 
Igll1 silencing, direct activation of the Eκ3’ and Igκ germline transcription and 
upregulation of the CXCL12 receptor which drove migration away from IL7 producing 
stromal cells. The second pathway was induced by the resultant reduction in IL7 
signalling, and caused upregulation of Rag1,2 genes and Tcfe2a (which encodes E2A 
isoforms E12 and E47) which induced activation of Igκ at the Eκi. We found that Irf4 is 
upregulated rapidly only after pre-BCR signalling. Ikzf1 levels were upregulated 
moderately by IL7 withdrawal or pre-BCR signalling. The IRF4 driven Ikzf3 upregulation 
previously reported by us appeared less direct here, as pre-BCR induction or IL7 
withdrawal alone (without Irf4 upregulation) increased in Ikzf3 levels. IL7 withdrawal 
coupled with pre-BCR signalling, however, caused a more than cumulative effect. 
However, these cells do express IRF4, which may already be at sufficient levels to 
upregulate Ikzf3 on pre-BCR signalling. Importantly, Igll1 was only strongly 
downregulated by pre-BCR signalling. Downregulation by IL7 withdrawal alone was not 
observed even though Ikzf3 occurred in these cells, suggesting both Irf4 and Ikzf3 
upregulation are required for full Igll1 silencing.  
While overexpression of Ikaros, PU.1 or IRF4 increased Igκ rearrangement, they also 
arrested the cell cycle. The gene expression profile demonstrated that all factors caused 
modest upregulation of Ikzf1, Ikzf3 and Irf4. Germline transcripts were only substantially 
increased on overexpression of Ikaros or IRF4, whilst PU.1 had only modest effects. The 
effects of all these factors on Igκ rearrangement may be a reflection of the indirect cell 
cycle effects caused by overexpression. Attempts to separate these effects by culture in 
IL7ˉLPS+ conditions demonstrated overexpression of these factors were also able to 
promote rearrangement above controls, suggesting effects beyond control of cell cycle.  
The finding that IRF4 and Ikaros cause functionally identical effects has to be reassessed 
following the study of B cell development in IRF4,8-/- cells (Ma et al., 2006; Ma et al., 2008). 
Overexpression of IRF4, Ikaros or Aiolos in IRF4,8-/- cells was capable of inducing cell 
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cycle arrest and λ5 downregulation, which parallels our previous study (Thompson et al., 
2007). IRF4 transduction was also capable of inducing Igκ rearrangement whereas Ikaros 
and Aiolos had no effect on Igκ rearrangement (Ma et al., 2008). Disruption of Ikaros 
function by an Ikaros DN was sufficient to block IRF4 induced pre-BCR downregulation, 
but not to block IRF4 induced Igκ rearrangement. According to this study, IRF4 mediates 
the effects at the Igκ locus, whereas Ikaros and Aiolos are dispensable. Our study 
demonstrated that IRF4, Ikaros or Aiolos induction resulted in Igκ rearrangement. 
Transduction of Ikaros in the Eκ3’ transgenic pre-B cells caused an upregulation of Irf4. 
This may have been the result of Ikaros mediated pre-BCR downregulation and cell cycle 
arrest or direct activation. The observed effects of Ikaros could therefore be a 
consequence of this IRF4 upregulation and would explain why Ikaros DN failed to cause 
any changes to levels of rearrangement on transduction of transgenic pre-B cultures. 
It would then follow that the Ikaros DN block of Igκ rearrangement in the Slp65-/- cells 
undergoing pre-BCR signalling would be the result of a failure to downregulate the pre-
BCR and upregulate Irf4. However, the transcriptional analysis of these cells 
demonstrated that a complete pre-BCR complex is essential for Irf4 induction. Our kinetic 
experiments and substitution experiments by Lu and colleagues place IRF4 upstream of 
Ikzf1 and Ikzf3 upregulation (Thompson et al., 2007; Ma et al., 2008). According to this 
model, disruption of Ikaros/Aiolos activities would be expected to prevent pre-BCR 
downregulation, but should not block IRF4 induction or activity. Pre-BCR signalling 
induced by 4-HT treatment should therefore cause Irf4 induction and activity at the Igκ 
locus in addition to Ikzf1 and Ikzf3 induction. Disruption of Ikaros activity would prevent 
Igll1 repression but not events at the Igκ locus. However, this conflicts with our results, 
questioning how Ikaros DN is able to suppress (supposedly IRF4 induced) Igκ 
rearrangement in Slp65-/- ERt2-Slp65 cells under 4-HT IL7lo conditions.  
A positive feedback loop may exist between Ikaros/Aiolos and IRF4 such that their 
activity is required for sustained Irf4 expression. Alternatively, continued pre-BCR 
signalling may prevent Igκ locus activation through an alternative mechanism. Double 
Igll1 and VpreB1 transgenic mice which express the pre-BCR throughout development, 
however, undergo normal B cell development with only a block at the immature B cell 
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stage (van Loo et al., 2007). These transgenic mice showed that while sustained pre-BCR 
expression and signalling caused constitutive internalisation of surface Igκ protein, 
which was responsible for the block at the immature stage, enforced expression of the 
SLC did not prevent rearrangement of the kappa locus and development of a mature 
BCR. There is some controversy over this study however, as the transgenic Igll1 and 
VpreB1 are under control of the CD19 promoter. CD19 purportedly undergoes 
transcriptional downregulation on the large to small pre-BII transition, suggesting 
possible downregulation of the transgenes used in this system could occur (personal 
communication, Prof T. Grundström, DMB, Umeå). Another explanation is that IRF4 and 
Ikaros function in partnership at the Igκ locus, even though Ma et al., demonstrated that 
Ikaros DN blocks IRF4 mediated pre-BCR downregulation but not Igκ induction. Further 
analysis of Ikaros DN transduced cells will determine whether Irf4 is induced in these 
cells and if pre-BCR signalling is maintained under all conditions. IRF4 upregulation in 
Ikaros DN 4-HT treated cells would suggest continued pre-BCR signalling prevents Igκ 
locus activation. A block in IRF4 upregulation would suggest Ikaros is involved in IRF4 
transcription.  
The discrepancy between our results and the Ma study could also be due to the Ikaros 
DN used. Ma et al., used a truncated Ikaros which lacks the DNA binding domain. Trinh 
et al., 2001, demonstrated that a similar truncated Ikaros isoform lacking the DNA 
binding domain did not preferentially heterodimerise with full length Ikaros isoforms 
(Trinh et al., 2001). The truncated isoform could homodimerise and multimerise with full 
length Ikaros homodimers at pericentromeric foci and may therefore be able to disrupt 
multimerisation of Ikaros rather than disrupting dimeric Ikaros activity. Although the 
Ma study shows an effect of the dominant negative Ikaros on Igll1 expression, they do 
not give any indication of how the dominant negative affects endogenous Ikaros activity. 
We and others have shown that the 159A point mutation disrupts endogenous Ikaros 
activity by heterodimerisation to block DNA binding and pericentromeric localisation 
(Cobb et al., 2000). Therefore, the 159A mutant Ikaros in our study may act as a stronger 
dominant negative than the isoform used in the Ma study. 
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4.3.2 The role of PU.1 
To follow the overexpression study in the Slp65-/- system, we used reporter transgenes to 
probe cis-acting binding sites. IRF4 involvement in Igκ regulation has now been 
demonstrated by us and others and while the activity of PU.1 on extrachromosomal 
constructs has been studied intensively, the in-vivo role is not fully elucidated. 
Identification of multiple factor binding sites at the Eκ3’ lead to ideas of an PU.1-IRF4 
complex responsible for activation at this site (Pongubala et al., 1992; Pongubala and 
Atchison, 1995; Pongubala and Atchison, 1997). However, several studies have suggested 
that PU.1 cannot drive changes at the Igκ locus, but rather binds once the locus is in an 
open state and is then involved in activation (Marecki et al., 2004; McDevit et al., 2005; 
McDevit and Nikolajczyk, 2006). 
Our study clarifies the conflicting data showing PU.1 as an in-vitro activator, but in-vivo 
suppressor suggested by the Hiramatsu et al., 1995, study. The separation of the Ikaros 
and PU.1 binding site showed that the Ikaros, rather than the PU.1 site, suppresses the 
locus during development. In agreement with the PU.1 binding data, Pongubala et al., 
demonstrated two 3bp mutations in the Eκ3’, one within the mPUlo Eκ3’ mutation and 
one overlapping the 3’ terminus of this mutation, which both showed weak binding of 
the PU.1-IRF4 complex (Pongubala et al., 1992). Our study showed PU.1 overexpression 
caused effective arrest of the cell cycle, which agrees with previous findings (Schweitzer 
and DeKoter, 2004). We then determined that overexpression caused an increase in Igκ 
rearrangement which was not dependent on the cell cycle status of the cells. PU.1 
overexpression caused modest upregulation of germline transcription which agrees with 
the transactivation domain not to be essential for Igκ activation (DeKoter and Singh, 
2000; Marecki et al., 2004). The ability of PU.1 to promote Igκ rearrangement without 
substantially enhancing germline transcription suggests the two processes are not as 
intimately linked as previously thought. Germline transcription may only need to reach a 
certain threshold before enough chromatin accessibility is reached to promote RAG 
mediated rearrangement. Our study shows PU.1 can drive rearrangement but we could 
not clarify whether this was though the Eκ3’ due to the limitations of the mIkPU Eκ3’ 
cells, leaving open the possibility for alternative PU.1 target site or indirect effects. IRF4 
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was not upregulated on PU.1 overexpression, suggesting the increase in Igκ 
rearrangement is not driven by this factor. It would be interesting to look at locus 
activation by ChIP to see if PU.1 overexpression causes alterations of epigenetic marks at 
the Eκ3’ associated with development of pre-BI to pre-BII cells, and whether these 
alterations are similar to any effects caused by overexpression of IRF4 or Ikaros.  
While we demonstrate an ability for PU.1 to drive Igκ rearrangement, assessment of Igκ 
rearrangement in PU.1-/-SpiB-/- cells with an IL7 transgene disagrees, as these cells  show a 
more repressed locus at the pre-BII stage, but the locus was more than capable of 
undergoing rearrangement following IL7 withdrawal (Schweitzer and DeKoter, 2004). It 
is clear from our studies and those of the IRF4,8 and PU.1,SpiB deficient cells that there is 
functional redundancy of factors involved in Igκ rearrangement, as loss of PU.1 or IRF4,8 
blocked rearrangement, but this block was not complete and either of these factors is 
capable of promoting rearrangement (Schweitzer and DeKoter, 2004; Johnson et al., 
2008). E2A is emerging as a possible master regulator or rearrangement and future work 
will need to consider this factor. E2A binding sites have been identified at both the Eκi 
and Eκ3’ (Pongubala and Atchison, 1991; Greenbaum and Zhuang, 2002). Deletion of 
E2A binding sites in the Eκi were shown to cause the same reduction of Igκ 
rearrangement as deletion of the entire Eκi (Inlay et al., 2002; Inlay et al., 2004). E2A null 
mice show a block at the pre-BII stage and cannot be induced to rearrange the Igκ locus 
(Lazorchak et al., 2006), although further investigation is required as PU.1 expression was 
also reduced in these cells, which could explain the reduced germline transcription 
identified. Additionally, the inability of E2A null cells to rearrange Igκ when induced is 
perhaps not a total block, but could be similar to IRF4,8-/- cells where rearrangement can 
occur under certain conditions (Ma et al., 2006; Johnson et al., 2008). E2A binding to the 
Eκ3’ and Eκi has recently been shown to increase on induction of rearrangement in wild 
type cells, which correlated with an E2A and IRF4 dependent increase in histone 
acetylation and germline transcription, suggesting E2A and IRF4 function in partnership 
with other factors at the enhancers to promote chromatin modifications (Lazorchak et al., 
2006). However, E2A is expressed and bound at the Eκi and Eκ3’ at the pre-BI stage 
(Shaffer et al., 1997; Zhuang et al., 2004), but the functional interaction with IRF4, which is 
upregulated on pre-BCR signalling and promotes E2A binding at the Eκ3’ (Lazorchak et 
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al., 2006), suggests alterations in partner interactions as a mechanism of control of E2A 
activity. Finally, overexpression of E2A with RAG allows rearrangement of the Igκ locus 
in non B cells (Romanow et al., 2000). It would therefore be interesting to determine 
whether the repressive effects of Ikaros identified at Eκ3’ were involved in regulating 
E2A binding and how the loss of the Ikaros site influences E2A binding at the locus. ChIP 
studies on the transgenic locus from mIkPU Eκ3’ mice would provide a suitable model 
system for these studies. It would also be interesting to determine whether E2A is 
involved in the Ikaros/IRF4 activation pathway at the Igκ locus. Also, the BOSC 23 
embryonic kidney cells used in the Romanow study do not express Ikaros, and so it 
would be revealing to see if ectopic Ikaros expression in these cells would affect Igκ 
rearrangement induced by RAG and E2A expression. 
4.3.3 LEF1 and β-catenin in Igκ rearrangement 
LEF1 null mice show a block at the pre-BI stage caused by an inability to proliferate, 
demonstrating an essential role for this factor during B cell development (Reya et al., 
2000). LEF1 functions as an architectural protein to structure DNA and provide binding 
sites for co-activators. While LEF1 binding sites have been suggested at the Eκ3’ (Meyer 
and Ireland, 1994), we are the first to show in-vitro binding of LEF1 in the Eκ3’ region. 
The western analysis of IL7ˉLPS+ treated pre-B cultures demonstrates reduction of LEF1 
protein on IL7 withdrawal of pre-B cell cultures, which agrees with previous studies 
showing LEF1 is downregulated during development (Travis et al., 1991; Reya et al., 
2000). We investigated the possibility of LEF1 playing a role in stabilisation of a 
repressive complex during development, which could collapse on LEF1 downregulation 
at the small pre-BII stage. However, overexpression in cycling or arrested cells had no 
effect on rearrangement of the endogenous loci or the reporter transgenes. Either LEF1 
plays no role in rearrangement, its levels are saturating or post translational 
modifications/interaction partners are important. Disruption of the β-catenin interaction 
domain did however, promote rearrangement. There are multiple target sites of LEF1 
and so this effect could have been indirect. Gene expression analysis failed to identify 
any targets with altered expression on overexpression of LEF1 or LEF1DN, however this 
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was only a limited candidate based approach. Microarray analysis would allow complete 
identification of possible targets of LEF1 during development. The reporter transgenes 
determined the Ikaros/PU.1 binding site to be essential for the LEF1DN effect. The 
enhancement of rearrangement on disruption of this domain suggests LEF1 does play a 
repressive role, which could therefore be through interactions with Ikaros in the Eκ3’. 
Further studies are important to verify whether LEF1 can functionally interact with 
Ikaros and whether the β-ID/intact CAD is important for this interaction, and ChIP 
experiments would allow us to directly test LEF1 binding to the Eκ3’. Increased 
rearrangement in the absence of substantially increased germline transcription is 
reminiscent of effects of PU.1 overexpression. Thus, disruption of LEF1 activity may 
allow PU.1 mediated enhancement of rearrangement. Here, ChIP studies using stage 
specific populations of cells would allow the identification of the temporal order of 
factors binding the locus and EMSA would allow identification of competition between 
these factors binding to the Eκ3’. Using Eκ3’ reporter constructs, the ability of LEF1 to 
interfere with transcriptional activation by PU.1 and other factors shown to drive 
transcriptional activity, could allow a clear validation of the repressive role of this factor. 
Further definition of the LEF1 role was made by gene knock-down. Surprisingly we 
found reduction of LEF1 protein levels by this method led to a decrease in 
rearrangement, which was backed by a decrease in germline transcription and chromatin 
accessibility at the locus. Reya et.al, demonstrated LEF1 null cells had a block in 
proliferation and increased apoptosis (Reya et al., 2000). Our knockdown cells underwent 
normal proliferation, did not appear selected for earlier stages and had few changes in 
gene expression, however in these cells, LEF1 protein depletion was not complete. It 
would therefore appear that LEF1 is required for rearrangement and may therefore 
function as an intermediary to maintain open chromatin, but also stabilise a repressive 
complex to prevent premature rearrangement at the pre-BI stage. It would be interesting 
to combine the LEF1 knock-down with overexpression of IRF4 and other candidate 
factors, to determine whether this intermediary complex is essential for rearrangement.  
In addition to the architectural role of LEF1, it is also involved in the Wnt signalling 
pathway, whereby Wnt signals cause stabilisation of cytoplasmic β-catenin which then 
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translocates to the nucleus to interact with LEF1 through the β-ID and alters the 
transcriptional program of the cell (Behrens et al., 1996). β-catenin can also displace 
Groucho (a transcriptional repressor which binds LEF1 through the CAD) from LEF1 to 
convert a repressor complex to an activator (Levanon et al., 1998; Brantjes et al., 2001). The 
role of the β-catenin interaction domain was investigated by overexpression of a 
stabilised form of β-catenin. Expression of this form caused dramatic changes on pre-B 
development. Germline transcription and rearrangement of the endogenous locus was 
enhanced by β-catenin activity. The upregulation of germline transcription was also 
shown to occur by endogenous levels of β-catenin through stabilisation by LiCl 
treatment, which suggests these effects could occur in-vivo. Although overexpression of 
β-catenin caused an increase in Igκ rearrangement, the maximal increase was observed 
with limited β-catenin activity. β-catenin has many transcriptional targets, and gene 
expression analysis determined that Rag1,2 transcription was responsive to β-catenin 
activity. PAX5 is required for Rag2 transcription (Jin et al., 2002), and this was also 
suppressed by β-catenin activity. β-catenin regulation of Pax5 was demonstrated in 
similar experiments on lymphoid progenitors which showed downregulation of Pax5 in 
response to stabilisation of β-catenin (Baba et al., 2005). This suggests a direct correlation 
between β-catenin, Pax5 repression and loss of Rag transcription. Although higher levels 
of β-catenin activity will cause greater locus accessibility, rearrangement will be 
prevented by Pax5-Rag repression. Interestingly, β-catenin overexpression did not 
upregulate Myc which is a known target of β-catenin/TCF-4 complexes and which 
induces proliferation (He et al., 1998). The reason for this isn’t clear but the reduction of 
cell cycle also agrees with lower Myc levels. Lower levels of β-catenin caused a greater 
arrest of the cell cycle than higher levels, which may also help explain the increase in 
rearrangement in these cells. 
The Igκ transgene was less sensitive to β-catenin activity than the endogenous locus. The 
transgene is lacking the SIS regulatory site between the Vκ and Jκ genes which may 
harbour a β-catenin responsive site. ChIP experiments to determine β-catenin binding 
sites and which areas undergo alterations in histone modification would help target the 
sites of β-catenin activity and determine whether it functions through the LEF1 binding 
site in the Eκ3’ or alternative sites.  
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Several studies have shown involvement of β-catenin during B cell development. β-
catenin regulates generation of multipotent progenitors, and enforced expression has 
also been shown transdifferentiate restricted myeloid and lymphoid progenitors into 
multipotent progenitors (Willert et al., 2003; Baba et al., 2005; Baba et al., 2006). 
Proliferation of HSC in-vitro was enhanced by transduction of stabilised β-catenin (Reya 
et al., 2003). Transduced HSCs show less differentiation and enhanced ability to 
reconstitute B, T and myeloid lineages of irradiated recipients. Disruption of β-catenin 
activity prevented such reconstitution, demonstrating β-catenin activity does not prevent 
and is essential for development of a B cell compartments. Further, mice null for Frizzled, 
a Wnt signalling receptor showed a block at the pre-BI to pre-BII transition (Ranheim et 
al., 2005), demonstrating Wnt signalling and β-catenin activity are required beyond 
development of HSCs. Christian and colleagues demonstrated β-catenin activity was 
induced on engagement of the mature B cell receptor (Christian et al., 2002). Signalling 
caused upregulation of phospholipase Cγ2 activity which activated protein kinase C 
which caused phosphorylation of GSK3 at an inhibitory domain, blocking its activity. 
The pre-BCR could support such a signalling network, which could provide a burst of β-
catenin activity which could allow alterations of the Igκ locus to promote rearrangement. 
Due to the rapid downregulation of the pre-BCR this burst would be short-lived and self 
terminating, preventing the large scale alterations of the RNA landscape which would 
prevent rearrangement occurring and generation of self-renewing multipotent 
progenitors driven by the loss of Pax5. Effects in normal cells would be more modest, as 
transduction of β-catenin caused a far greater increase in β-catenin protein levels than 
those detected in vector control cells. However, although a seductive pathway to induce 
rapid chromatic changes, IRF4,8-/- cells have no block in pre-BCR signalling but show 
reduced Igκ germline transcripts and no downregulation of the pre-BCR (Lu et al., 2003). 
It would be interesting to see if LiCl treatment of IRF4,8-/- pre-BII cells could cause 
upregulation in germline transcription. Upregulation of germline transcription by LiCl 
treatment in this system may suggest that pre-BCR signalling does not lead to β-catenin 
stabilisation whilst a inability to affect transcription would suggest β-catenin functions 
through interactions with IRF4 or its downstream effectors. However, the role of β-
catenin in lymphocyte development is not unequivocal. β-catenin and γ-catenin (a close 
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β-catenin homolog) double knock out multipotent progenitor cells can reconstitute 
complete lymphoid, myeloid and erythroid compartments of irradiated recipients (Cobas 
et al., 2004; Koch et al., 2008). However, as the authors highlight, mice null for TCF1, a 
second target of β-catenin, show defects in T cell development which are not replicated 
by the β- and γ- catenin knockout cells, suggesting either alternative functions of TCF, or 
an as yet unknown pathway that could compensate for loss of β- and γ- catenin. 
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Chapter 5: Ikaros as a modulator of B cell differentiation 
5.1 INTRODUCTION 
Our lab has previously demonstrated that activation of mature B cells drives an increase 
in Ikaros protein levels, which redistributes to heterochromatic foci that are important for 
stabile gene silencing (Brown et al., 1999). Activation is also characterised by an increase 
in level of repressive histone modifications which colocalise with these heterochromatic 
foci (Baxter et al., 2004).  
Genetic reduction of Ikaros protein levels in mature B cells causes a reduced threshold of 
activation (Kirstetter et al., 2002). A similar Ikaros control on the activation threshold has 
been found in T cells (Wang et al., 1996; Wang et al., 1998; Avitahl et al., 1999; Winandy et 
al., 1999). Mice null for the Ikaros family member Aiolos, also demonstrate hyper-
responsiveness to stimulation (Wang et al., 1998). Additionally, Aiolos deficient mice 
show an absence of the marginal zone (MZ) subset of B cells. Generation of this subset 
required cells with low BCR signalling, and the absence of MZ B cells was proposed to be 
caused by increased BCR signal strength in the absence of Aiolos (Cariappa et al., 2001).  
MZ B cells are responsible for mounting rapid responses to blood born bacterial 
infections (Martin et al., 2001). MZ B cells have a lower threshold of activation compared 
to follicular (FO) B cells, so that they undergo rapid activation at low levels of antigen 
and differentiate into antibody secreting plasma cells more readily than FO B cells 
(Oliver et al., 1999). The ability to undergo activation and differentiation at lower levels of 
stimulation compared to FO B cells could suggest an involvement of Ikaros or Aiolos. We 
therefore sought to use retroviral transduction to determine whether Ikaros family 
members were involved in the regulation of plasma cell differentiation. 
167 
 
5.2 RESULTS 
5.2.1 Gene expression analysis of MZ and FO B cell activation. 
FO B cells comprise 80-90% of the splenic B cell population while MZ B cells are 5-10% of 
the population, and these populations can be separated on the basis of surface expression 
of CD21 and CD23 (Oliver et al., 1997). We began this study by determining the gene 
expression profile of MZ and FO B cells undergoing activation to determine whether 
alterations in significant transcription factors would account for their different activation 
and differentiation kinetics. Splenocytes were isolated by FACS to give pure populations 
of B220+CD21hiCD23lo MZ B cells and B220+CD21+CD23+ FO B cells (Figure 5.1a).  
After 96 hour of stimulation with 30µg/ml LPS, plasma cell differentiation was assessed 
by downregulation of surface B220 and upregulation of surface CD43 (Gulley et al., 1988). 
This concentration of LPS is saturating and an LPS titration has demonstrated cells are 
activated by much lower concentrations of LPS (personal communication, Dr D. Liberg). 
These titration experiments also showed that over a wide range of concentrations, MZ B 
cells differentiated to a greater extent than FO B cells, suggesting that unlike activation, 
there is not a threshold of LPS stimulation for differentiation. In agreement with these 
data, we see that plasma cell differentiation was more pronounced in MZ B cells, with 
58.6% of MZ B cells compared to 14% of FO B cells showing plasma cell surface 
phenotype (Figure 5.1b). 
168 
 
 
To understand the transcriptional kinetics of differentiation, MZ and FO B cell transcript 
levels were assessed every 24 hours by qRT-PCR during the time course (Figure 5.2). 
Stimulation sets off a series of transcriptional events to ultimately downregulate factors 
which enforce B lineage identity and upregulate factors to promote plasma cell 
development. As discussed in Chapter 1.2.4, B cell stimulation causes a transcriptional 
cascade which initiates with degradation of BCL6 (encoded by the Bcl6 gene), allowing 
transcriptional upregulation of Prdm1 (which encodes BLIMP1). BLIMP1 represses Pax5, 
 
Figure 5.1 Isolation and activation of MZ and FO B cells. 
(a) Splenocytes were surface stained and FACS isolated for MZ B cells 
(B220+CD21hiCD23-) and FO B cells (B220+CD21+CD23+). (b) Differentiation to plasma 
cells was followed by downregulation of B220 and upregulation of CD43 surface 
markers before and after 96 hours activation with 30µg/ml LPS. 
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which relieves repression of Xbp1. BLMIP1 also represses Myc, which allows cell cycle 
exit for terminal differentiation, and also represses Bcl6, to create a self-enforcing 
feedback loop. Transcription factors which enforce B cell identity, such as PAX5 and PU.1 
(encoded by Sfpi1) undergo repression on plasma cell differentiation while the 
transcription factors Irf4 and Pou2af1 (which encodes OBF-1) are important for terminal 
differentiation.  
Assessment of Ikzf1 and Ikzf3 (which encodes Aiolos) transcripts showed that levels were 
roughly equal with no statistically significant differences in resting MZ and FO B cells, 
suggesting that differentiation is not controlled by initial levels of these factors. Upon 
LPS stimulation of either MZ or FO B cells, Ikzf1 levels were reduced two fold and 
remained stable during the time course. The reduction of Ikaros transcription is 
surprising given the reported increase in protein levels (Brown et al., 1999). Ikzf3 levels 
were also reduced on activation, with a more pronounced suppression in FO B cells.  
Transcript levels of Bcl6 were 3.5 fold higher (p<0.005) in resting FO than MZ B cells, 
which may partially explain the lower threshold for activation of MZ B cells. Bcl6 
underwent rapid and almost complete repression after just 24 hours LPS induction in 
both cell types. Prdm1 and Xbp1 were gradually upregulated on stimulation. Resting 
levels were higher in MZ than FO B cells, which may reflect the enhanced activation in 
these cells. Both factors also underwent a 24 hour lag of upregulation in FO compared to 
MZ B cells. Pax5 downregulation in both cell types was observed after 24 hours. Sfpi1 
underwent rapid and stable repression in both cell types, and marginally higher levels 
were found in resting FO than MZ B cells. Irf4 underwent almost two fold repression in 
MZ B cells, followed by restoration of levels at 96 hours. FO B cells however, underwent 
greater repression with less restoration of transcript levels. Pou2af1 (which encodes OBF-
1) underwent gradual upregulation in both cell types. 
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Figure 5.2 Gene regulation during MZ and FO B cell differentiation. 
MZ B (blue) and FO B (black) cells were isolated by FACS and activated with LPS. 
Transcript levels were assessed every 24 hours by qRT-PCR, normalising to the 
housekeeping genes, Hprt and Hmbs. Normalised values are shown as scatter plot with 
the mean indicated. 
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5.2.2 Effect of Ikaros on plasma cell differentiation 
Having identified transcriptional differences between MZ and FO B cell activation 
pathways, we sought to determine whether modulating the activity of Ikaros would 
influence the ability of cells to differentiate. Resting MZ and FO B cells were FACS 
isolated, activated with LPS and after 24 hours activation were transduced with either 
vector control, Ikaros or Ikaros DN expressing vector. Retroviral transduction was 
performed after 24 hours as viral integration only occurs in cycling cells. After a further 
72 hours activation, transduced cells were FACS isolated on the basis of GFP fluorescence 
and stained for B220 and CD43 to determine plasma cell differentiation (Figure 5.3a and 
b). As seen previously, LPS stimulation caused greater plasma cells differentiation in MZ 
compared to FO B cells. Overexpression of Ikaros resulted in reduced plasma cell 
differentiation in both MZ and FO B cells. These effect were more pronounced in MZ B 
cells, most probably due to the enhanced transduction of MZ B cells which can be seen in 
figure 5.3a. Disruption of Ikaros activity by Ikaros DN enhanced plasma cell 
differentiation in both cells types, and again the effect was greater in MZ B cells. 
Quantification of the mean fluorescence intensity (MFI) demonstrated the effect of Ikaros 
on CD43 protein levels in three independent experiments (Figure 5.3c) 
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To determine whether Ikaros was able to influence differentiation to the plasma cell fate 
by alterations in the gene expression profile, transduced cells were analysed for RNA 
abundance by qRT-PCR (Figure 5.4a and b). Expression of the surface markers CD43 and 
Syndecan1 (encoded by Sdc1) undergo upregulation on differentiation to the plasma cell 
fate. Overexpression of Ikaros reduced both Cd43 and Sdc1 message levels whereas 
disruption of Ikaros activity by Ikaros DN resulted in reciprocal upregulation. Effects 
were greater in MZ than FO B cells, possibly due to gene dosage. This again suggests the 
 
 
Figure 5.3 Modulation of Ikaros affects plasma cell differentiation. 
FACS purified MZ and FO B cells transduced with vector control, Ikaros or Ikaros DN 
expressing vectors after 24 hour LPS stimulation. 72 hour post transduction, cells were 
isolated on the basis of (a) GFP expression and (b) stained for B220 and CD43 and 
analysed by flow cytometry for plasma cell differentiation. (c) The MFI of CD43 
expression of GFP+ MZ (blue) and FO (black) B cells is shown normalised to vector control 
samples (mean+SD, n=3). 
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ability of Ikaros to influence development to the plasma cell stage. This influence could 
be an indirect effect through other regulators of plasma cell differentiation which in turn 
control expression of Cd43 and Sdc1. It is also possible, however, that Ikaros acts directly 
on the Cd43 and Sdc1 locus. This could mean that Ikaros has multiple targets during 
plasma cell development or that the manipulation of Ikaros activity resulted in an altered 
surface phenotype which may or may not reflect the true state of the cell. 
To determine gene dosage of MZ and FO B cells, overexpression of Ikaros and Ikaros DN 
was assessed by Ikzf1 level. MZ B cells had an 80-90 fold overexpression whereas FO B 
cells had 20-40 fold overexpression of Ikaros and Ikaros DN. This could have been 
caused by the enhanced activation of MZ B cells by LPS which would allow greater 
retroviral transduction. This would also explain the reduced effects on protein and RNA 
levels of plasma cell surface markers in FO B cells. 
Assessment of transcription factor RNA levels showed stronger effects in MZ B cells than 
FO B cells, again due to the gene dosage effects. Bcl6 message levels underwent minor 
changes on transduction of Ikaros or Ikaros DN. Bcl6 is repressed rapidly in response to 
LPS in both FO and MZ B cells (Figure 5.2) and this would have occurred before ectopic 
Ikaros or Ikaros DN protein levels accumulate. However, this does suggest that Ikaros 
does not control plasma cell differentiation through regulation of Bcl6. Ikaros 
transduction caused a slight increase in Pax5 levels in MZ B cells whilst disruption 
caused downregulation. This pattern was also seen with Ikzf3 and Sfpi1 levels in MZ B 
cells.   
Of the factors which undergo transcriptional upregulation during activation, Prdm1 
levels showed no statistically significant change on overexpression of Ikaros or Ikaros 
DN. This is surprising as BLIMP1 is required for plasma cell differentiation and we 
would have expected an upregulation as a result of Ikaros DN transduction and 
downregulation on Ikaros overexpression. Xbp1 was also repressed by both Ikaros and 
Ikaros DN in MZ B cells. XBP1 is absolutely required for terminal plasma cell 
differentiation (Reimold et al., 2001), so suppression is unexpected. Pou2af1 is also 
suppressed by both Ikaros and Ikaros DN whereas IRF4 shows marginal effects in MZ B 
cells, but strong repression by Ikaros DN in FO B cells.  
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Figure 5.4 Ikaros modulation affects gene expression. 
(a) MZ and (b) FO B cells were transduced with vector control, Ikaros (orange) or Ikaros 
DN (black) expressing vectors 24 hours after LPS activation. 72 hours post transduction 
cells were FACS purified on GFP fluorescence and RNA abundance measured by qRT-
PCR. Abundance is shown relative to vector control (mean+SD, n=3-4). 
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5.2.3 Genome wide analysis of the effects of Ikaros disruption on plasma cell 
differentiation. 
The gene expression analysis described above identified small changes in the 
transcriptional network occurring during plasma cell differentiation in response to 
modulation of Ikaros activity. We decided to take a genome wide approach to allow 
identification of all factors affected by Ikaros during differentiation. Rather than looking 
at late stages of activation, we used a transgenic model system to allow disruption of 
Ikaros activity at early stages of differentiation. We took advantage of a transgenic line 
generated in the lab, which expressed Ikaros DN from an IgG promoter. MZ B cells from 
these mice undergo enhanced differentiation to plasma cells on activation with LPS, in 
concordance with the retroviral transduction experiments (personal communication, Dr 
D. Liberg). The first major surface marker changes appear at 72 hours of activation, 
which reflect alterations in the transcriptional activity at earlier times. We therefore used 
these cells to assess the transcriptional profile at 24 and 48 hours while the transcriptional 
program is being established and before the surface markers highlight the cell fate 
decisions these programs have made. 
To verify transcription of the transgene during early time stages of activation, we 
assessed RNA levels in isolated MZ B cells from wild type and transgenic littermates 
over the first 48 hours of activation. Cells were activated using a limiting concentration of 
LPS (1µg/ml), determined to generate the greatest variation in differentiation (data not 
shown). RNA levels were assessed using primers which amplify both the endogenous 
and transgenic Ikaros and showed overexpression of Ikzf1 at all time points in transgenic 
compared to wild type cells (Figure 5.5b). Wild type cells showed downregulation of 
Ikzf1 by 24 hours, while the transgenic mice show an initial downregulation of Ikzf1 RNA 
at 24 hours, followed by restoration to the resting level by 48 hours. The reduction in 
Ikzf1 specifically affects the endogenous locus as quantification using primers which 
specifically amplify the transgenic Ikaros HA epitope, showed upregulation of the 
transgene occurred at 48 hours coinciding with the increase in total Ikzf1 levels in these 
cells (Figure 5.5b). The primers failed to detect any transcript in wild type controls, 
demonstrating specificity of detection.   
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Figure 5.5 Activation of wild type and Ikaros DN transgenic MZ B cells. 
MZ B cells were FACS isolated from wild type and Ikaros DN transgenic mice and 
activated with LPS for 96 hours. (a) Flow cytometry analysis of CD43 and B220 surface 
expression over 96 hours of activation (courtesy of Dr D. Liberg).  
(b) Abundance of Total Ikzf1 and transgenic Ikzf1 (HA-Ikaros) was determined by qRT-
PCR from resting, 24 hour and 48 hour activated cells (b). RNA levels were normalised 
to Hprt and Hmbs and are shown relative to resting Ikaros DN transgenic cells for 
transgenic Ikaros (mean+SD, n=3). 
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For the microarray experiments, we used independent duplicates of RNA from 48 hour 
time point experiments shown in Figure 5.5, which used transgenic and wild type 
littermates. We also performed arrays using RNA from independent experiments where 
transgenic and aged matched wild type C57BL/6 MZ B cells were activated for 24 hours. 
Overexpression of Ikzf1 was confirmed in these samples (data not shown). Total RNA 
from the wild type and transgenic MZ B cells was amplified using the Affymetrix two-
cycle amplification kit and hybridised to Affymetrix GeneChip Mouse Genome 430 2.0 
Arrays. Quality control analysis showed RNA amplification and hybridisation were 
within normal parameters (data not shown).  
The threshold we used for determining differential gene expression between wild type 
and transgenic MZ B cells was set at a fold change of log2(0.5) at either time point and a 
p-value of less than 0.05. The low threshold of fold change was chosen as the 
overexpression experiments demonstrated small modulations of gene expression on 
transduction with Ikaros or Ikaros DN. We did not use adjusted p-values, which provide 
a more rigorous multiple testing statistical analysis, as very few genes showed statistical 
significant by these criteria. This could be due to the small changes in gene expression we 
observed or the small sample size (n=2 for each time point). Increasing the number of 
replicates would increase the statistical power and provide a more suitable multiple 
testing statistic. 
As a control for Ikaros expression, the probe set 1421303_at hybridised to both the ectopic 
and endogenous Ikaros transcripts and demonstrated expected overexpression of Ikaros 
at both time points (Table 5.1). Importantly, the 1436312_at probe set hybridised to the 3’ 
UTR of the endogenous Ikaros transcript which is not present in the transgene, and 
showed disruption of Ikaros activity did not cause altered expression of endogenous 
Ikaros. The differences in mean intensity between the probe sets could be caused by 
differing hybridisation efficiencies.  
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The 24 hour time point showed only small numbers of genes differentially regulated 
compared to the 48 hour time point. At 24 hours, 45 genes were upregulated and 26 
genes were repressed in transgenic cells compared to wild type controls. At 48 hours, 467 
genes were upregulated and 154 genes were repressed in transgenic cells compared to 
control cells. The majority of genes overexpressed at 24 hours were also overexpressed at 
48 hours, as indicated by the intersection in figure 5.6. Surprisingly, the differentially 
expressed genes did not include any of the candidate transcription factors or surface 
markers we had assessed in the previous experiments, or any other B cell and plasma cell 
specific transcription factors. The most strongly differentially regulated genes at 48 hours 
are shown in table 5.2.  
 
 
Probe ID 24 hours 48 hours 
 
Log2 
mean 
WT 
Log2 mean 
IkarosDN 
Log2 
fold 
change 
p-
value 
Log2 mean 
WT 
Log2 mean 
IkarosDN 
Log2 
fold 
change 
p-
value 
1421303_at 6.07 11.78 5.71 
1.18E-
07 
6.91 12.81 5.895 
1.15E-
06 
1436312_at 12.21 12.21 -0.001 0.996 12.87 12.88 0.007 0.974 
 
 
Table 5.1 Ikaros probe detection 
Verification of Ikaros probes on array showing fold change between wild type and Ikaros 
transgenic MZ B cells at 24 and 48 hours activation. 
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To identify key features in the up and downregulated clusters, we used GO TERM 
enrichment analysis using the DAVID Bioinformatics resource (Dennis et al., 2003). The 
38 genes overexpressed at both time points showed no term enrichment. GO TERM 
enrichment for all genes overexpressed and repressed at 48 hours are shown in Table 5.3 
and 5.4 respectively. Interestingly, the repressed genes were enriched for B cell activation 
markers, suggesting that surface morphology of the cell may not accurately reflect their 
transcriptional activity. Overexpressed genes contains many GO TERMS related to 
Probe ID 
Gene 
Symbol 
24 hours 48 hours 
Log2 
mean 
WT 
Log2 mean 
IkarosDN 
Log2 
fold 
change 
p-
value 
Log2 
mean 
WT 
Log2 mean 
IkarosDN 
Log2 
fold 
change 
p-
value 
1437201_at 
Lrrc4c/ 
NGL1 
3.42 5.72 2.29 
9.48E
-06 
4.13 8.30 4.17 
1.45E-
04 
1418004_a_at Tmem176b 6.29 8.59 2.31 
4.57E
-05 
6.24 9.40 3.17 
1.74E-
05 
1426174_s_at Ighg 4.90 6.54 1.64 
2.57E
-05 
6.27 8.81 2.54 
6.84E-
04 
1417679_at Gfi1 3.71 3.60 -0.11 0.47 6.99 5.46 -1.53 
4.89E-
03 
1449465_at Reln 3.72 3.78 0.06 0.74 7.51 5.62 -1.89 
3.97E-
03 
1439036_a_at Atp1b1 3.37 3.29 -0.08 0.57 8.36 6.14 -2.22 
3.97E-
03 
 
Table 5.2 Most strongly differentially regulated genes between activated wild type and 
Ikaros DN MZ B cells. 
 
 
Figure 5.6 Differentially expressed genes from the microarray analysis of wild type and 
Ikaros DN transgenic MZ B cells at 24 and 48 hours activation. 
Differentially expressed genes were determined by a fold change of at least log20.5 and 
p<0.05. 
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metabolism, including glucose metabolism, which is expected for lymphocytes 
undergoing activation (Doughty et al., 2006). Two other interesting enriched terms were 
gene expression (GO TERM:0010467) and intracellular signalling cascade (GO 
TERM:0007242). In addition, KEGG pathways were analysed and overexpressed genes 
showed enrichment for antigen processes and presentation pathways (KEGG 
PATHWAY: mmu04612).  
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 GO Term Count % Pop Hits % 
Fold 
Enrich. 
Benjamini 
B
io
lo
g
ic
al
 P
ro
ce
ss
es
 
0008152~metabolic process 238 49.6 8036 53.7 1.26 2.30E-04 
0007242~intracellular signaling cascade 54 11.2 1209 8.1 1.91 7.70E-03 
0006006~glucose metabolic process 13 2.7 110 0.7 5.04 1.00E-02 
0065007~biological regulation 146 30.4 4607 30.8 1.35 1.10E-02 
0002376~immune system process 40 8.3 859 5.7 1.99 3.00E-02 
0048519~negative regulation of 
biological process 
45 9.4 1029 6.9 1.87 3.40E-02 
0050789~regulation of biological process 132 27.5 4204 28.1 1.34 3.30E-02 
0006464~protein modification process 61 12.7 1648 11.0 1.58 6.90E-02 
0010467~gene expression 95 19.8 3216 21.5 1.26 4.10E-01 
 
       
C
el
lu
la
r 
co
m
p
ar
tm
en
t 0005737~cytoplasm 206 42.9 5672 35.8 1.54 3.30E-12 
0043229~intracellular organelle 242 50.4 7528 47.5 1.37 1.70E-09 
0043231~intracellular membrane-bound 
organelle 
217 45.2 6646 41.9 1.39 2.40E-08 
0044444~cytoplasmic part 119 24.8 3379 21.3 1.50 1.50E-04 
0005634~nucleus 137 28.5 4207 26.6 1.38 1.00E-03 
0044464~cell part 366 76.2 14779 93.3 1.05 9.30E-04 
0005856~cytoskeleton 41 8.5 957 6.0 1.82 1.80E-02 
0005783~endoplasmic reticulum 33 6.9 744 4.7 1.88 4.30E-02 
 
       
K
E
G
G
 P
at
h
w
ay
s 
mmu00860:Porphyrin and chlorophyll 
metabolism 
10 2.1 34 0.8 8.39 2.80E-04 
mmu00040:Pentose and glucuronate 
interconversions 
7 1.5 20 0.5 9.98 4.00E-03 
mmu04612:Antigen processing and 
presentation 
12 2.5 91 2.2 3.76 1.70E-02 
mmu00150:Androgen and estrogen 
metabolism 
8 1.7 45 1.1 5.07 3.80E-02 
mmu00500:Starch and sucrose 
metabolism 
9 1.9 60 1.5 4.28 3.70E-02 
mmu00030:Pentose phosphate pathway 6 1.2 25 0.6 6.85 4.60E-02 
 
Table 5.3 DAVID GO TERM analysis for all upregulated genes in Ikaros transgenic 
MZ B cells compared to wild type B cells after 48 hours activation. 
Count and % show the number of terms in the gene list with this GO TERM. Pop hits and 
% shows the number of terms in the background list of total genes. Fold Enrich. shows the 
fold enrichment in the gene list over the background list and Benjamini gives a corrected 
p-value for enrichment.  
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The GO TERMS gene expression, protein kinase cascade and lymphocyte activation and 
KEGG PATHWAY Antigen processing and presentation were further analysed (Figure 
5.7, 5.8 and 5.9 respectively). Multiple transcription factors show upregulation, including 
several chromatin modifying enzymes (highlighted with red stars). The alterations in 
gene expression could be either direct or indirect through secondary factors. The 
signalling cascade group showed several members of the protein kinase family (Figure 
5.8a). In addition, many members of this group were specific for the MAP kinase 
pathway (Figure 5.8b) suggesting overactivation of this pathway in Ikaros DN cells.  
The downregulated genes in the lymphocyte activation GO TERM (Figure 5.9) correlate 
with Ikaros DN enhancing plasma cell differentiation as many of these factors are in fact 
found to be suppressed during differentiation. Some of these genes reportedly undergo 
rapid transcriptional upregulation followed by rapid suppression, such as Erg1 which is  
upregulated and suppressed within 6 hours of cell stimulation (Seyfert et al., 1990). Other 
markers such as CD21/Cr2 are downregulated upon activation and lost at the plasma cell 
stage (Tedder et al., 1984). 
 
GO Term Count % 
Pop 
Hits 
% 
Fold 
Enrich. 
Benjamini 
B
io
lo
g
ic
al
 
P
ro
ce
ss
es
 
0046649~lymphocyte activation 10 6.5 215 1.4 6.90 3.40E-02 
0002252~immune effector process 8 5.2 148 1.0 8.02 7.40E-02 
 
Table 5.4 DAVID GO TERM analysis for all downregulated genes in Ikaros transgenic 
MZ B cells compared to wild type B cells after 48 hours activation. 
Count and % show the number of terms in the gene list with this GO TERM. Pop hits and % 
shows the number of terms in the background list of total genes. Fold Enrich. shows the 
fold enrichment in the gene list over the background list and Benjamini gives a corrected p-
value for enrichment.  
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Figure 5.7 Upregulated members of the GO TERM: 0010467 Gene expression group. 
Genes upregulated in Ikaros DN transgenic cells over wild type cells at 24 and 48 hours of 
activation are shown with fold change and p-value. Heat maps show fold change over wild 
type cells with upregulated in red and downregulated in green. Red stars indicate members 
of the GO TERM: 0006325~establishment and/or maintenance of chromatin architecture.  
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Figure 5.9 Overexpression of (a) Protein kinases and (b) MAP Kinase pathway members 
within the signalling kinase pathway cascade GO TERM and members of the (c) Antigen 
processing and presentation KEGG PATHWAY. 
Genes upregulated in Ikaros DN transgenic cells over wild type cells at 24 and 48 hours of 
activation are shown with fold change and p-value. Heat maps show fold change over wild 
type cells with upregulated in red and downregulated in green. 
 
 
 
Figure 5.8 Repressed genes in the Lymphocyte Activation GO TERM. 
Genes upregulated in Ikaros DN transgenic cells over wild type cells at 24 and 48 hours of 
activation are shown with fold change and p-value. Heat maps show fold change over 
wild type cells with upregulated in red and downregulated in green. 
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5.3 DISCUSSION 
Several transcription factors have been previously identified as essential for plasma cell 
differentiation, including BCL6, BLIMP1 and XBP1. In this study we have characterised 
expression differences between MZ and FO B cells to understand the different kinetics of 
differentiation between these cells. We observed reduced expression of Bcl6 and slightly 
enhanced levels of Prdm1 in MZ compared to FO B cells which may be responsible for the 
decreased threshold of activation and increased differentiation of these cells. The lower 
Bcl6 and higher Prdm1 level in MZ B cells agrees with two recent studies investigating 
the differences between B cell subsets (Fairfax et al., 2007; Kin et al., 2008). However, 24 
hours after activation, Bcl6 levels in both cell types are equally suppressed. This 
highlights the differences between activation threshold and differentiation as both these 
cell types undergo activation at the saturating concentrations of LPS used, as shown by 
Bcl6 suppression. However, MZ B cells show enhanced differentiation suggesting 
activation and differentiation are not directly linked and that the mechanisms which 
suppressed differentiation in FO B cells are either reduced or absent in MZ B cells.  
Xbp1 and Prdm1 were both more strongly upregulated in MZ than FO B cells, which 
agrees with their enhanced commitment to plasma cells. We also found accelerated 
upregulation of Pou2af1. Although OBF1 has been associated with initial suppression of B 
cell activation, it is also important for eventual commitment to the plasma cell fate as 
genetic deletion can prevents Prdm1 upregulation (Corcoran et al., 2005).  
We have extended the findings that Ikaros family members are able to control 
development of the MZ B cells by demonstrating that Ikaros modulates the 
differentiation of both MZ and FO B cells to plasma cell fate. We find enhancement of 
Ikaros activity blocked differentiation to plasma cells whereas disruption of Ikaros and 
Ikaros family member activity enhanced differentiation. The effects were greatest in MZ 
B cells and correlated with the increased proliferation response to LPS and subsequent 
enhanced retroviral transduction, which was confirmed by Ikzf1 message levels; MZ B 
cells showed an almost 90 fold increase in message levels compared to a 20-35 fold 
increase in FO B cells. 
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These findings agree with work demonstrating Ikaros and its family members can set the 
threshold of cell activation and limit differentiation. For instance, Ikaros or Aiolos 
deficient B cells have enhanced background BCR signalling with a stronger and longer 
lived response to antigen stimulation (Wang et al., 1998; Cariappa et al., 2001; Kirstetter et 
al., 2002). In some settings, activation triggers differentiation which can be suppressed by 
Ikaros, exemplified by early thymocytes development, where the absence of Ikaros 
allowed development of mature T cells driven by signalling through an incomplete pre-
TCR (Winandy et al., 1999). In other settings, activation does not trigger differentiation, 
such as in LPS activation of FO and MZ B cells, where the differences in differentiation 
remain over a wide range of LPS concentrations (personal communication, Dr D. Liberg). 
The question of how Ikaros is able to control differentiation in this setting remains 
unanswered.  
Differentiation was induced by LPS stimulation which activates B cells through the TLR4 
receptor (Chow et al., 1999). This suggests that the Ikaros control of signal strength could 
be through shared pathways between TLR4 signalling and BCR signalling, such as PI3K, 
MAP kinase or NF-κB pathways (Venkataraman et al., 1999; Bone and Williams, 2001; 
Gerondakis et al., 2007). Alternatively, Ikaros may mediate control through 
transcriptional regulation of key transcription factors required to drive differentiation. 
We investigated the latter through gene expression profiling of MZ and FO B cells 
activated and transduced with Ikaros or Ikaros DN expressing vectors. RNA profiling 
confirmed the surface analysis of cells differentiation with the plasma cell markers Cd43 
and Sdc1 showing negative regulation by Ikaros. Protein levels of Ikaros were not 
quantified and as has been seen in Chapter 4.2.3, expression level does not directly relate 
to protein level. However, the surface and mRNA changes demonstrate functional 
activity of transduced Ikaros and Ikaros DN. Analysis of the key plasma cell 
differentiation transcription factors demonstrated only moderate alterations in mRNA 
abundance and did not highlight a critical mediator of these processes. 
The repression of Xbp1 levels in Ikaros transduced cells is intuitive for reduced 
differentiation potential and would explain the reduced Sdc1 levels as its expression is 
directly linked to XBP1 (Reimold et al., 2001). Surprisingly, both plasma cell specific 
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transcription factors Prdm1, Xbp1, Pou2af1 and B cell specific factors Pax5, Ikzf3, Sfpi1, 
showed reduction in levels in Ikaros DN transduced MZ B cells. These modulations 
caused by Ikaros DN could suggest that the surface phenotype of the cell does not reflect 
their true differentiation status. Alternatively, the subtle changes in transcription factor 
levels could suggest that rather than targeting a single or limited pool of factors, Ikaros 
could control differentiation by small modulations of multiple factors to alter the 
pathways activity. A third explanation would be that disruption of Ikaros activity 
reduced the level required for plasma cell factors to induce differentiation. If the levels of 
signals and factors required to stimulate differentiation were reduced, this would result 
in a feed-forward effect resulting in reduced upregulation of all downstream effectors.  
The candidate based approach has obvious limitations in the number of targets genes 
which can be identified. To investigate all the transcriptional networks involved in 
differentiation, we utilised an Ikaros DN transgenic model system which enhances 
plasma cell differentiation of MZ B cells. Surface expression of plasma cell markers were 
detected at 72 and 96 hours activation and these changes reflect alterations to the 
transcriptional program of the cell which are established at earlier time points. We 
therefore used these cells as a model system to study genome wide transcriptional 
changes occurring during early activation steps. We have yet to confirm protein level 
changes of Ikaros at the time points analysed. We found few transcriptional changes at 24 
hours but many more at 48 hours of activation. The transcriptional changes detected 
were not large changes in expression of single transcription factors or key modulators of 
activation, but rather small changes in many enzymes and factors. Of particular note is 
the upregulation of many transcription factors and antigen processing and presentation 
components. This agrees with Ikaros DN cells being more activated than the WT 
counterparts, as LPS has been shown to rapidly upregulate surface MHC class I and II in 
MZ B cells (Oliver et al., 1999) which, in the case of MHC Class II, is caused by both 
increased transcription and translation (Barrachina et al., 1999), suggesting these cells are 
more activated than the wild type counterparts. However, BLIMP1 activity results in 
suppression of CIITA, the coactivator of MHC Class II expression, resulting in extinction 
of MHC Class II expression in plasma cells (Silacci et al., 1994; Piskurich et al., 2000), 
alternatively suggesting that the wild type cells are closer to plasma cells. The kinetics 
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experiments performed (Figure 5.2) would suggest that at 24 and 48 hours, BLIMP1 
activity was not present and as CIITA was not shown to be suppressed on the array, 
antigen processing and presentation could be taken as an indication of cell activation. 
Also upregulated were signalling cascade factors, including members of the MAP kinase 
pathway. This pathway is involved in both BCR and LPS stimulation and thus provides a 
possible target of Ikaros control of differentiation.  Akt/PKB and ERK are key kinases in 
this pathway which both show upregulation. Activity of these protein are regulated by 
phosphorylation so it would be interesting to look at their phosphorylation status in 
Ikaros DN cell to determine if this pathway is hyperactivated (Kohn et al., 1996; Ferrell Jr 
and Bhatt, 1997). Additionally, Cariappa et al., 2001, demonstrated loss of Aiolos causes 
changes in the calcium flux of the cells, with increased background levels and a stronger 
and longer lived response to antigen stimulation. It would be interesting to determine 
whether these changes in calcium flux were also found in the Ikaros DN cells.  
Alternatively, Ikaros could control plasma cell differentiation indirectly by regulating the 
cell cycle behaviour of activated B cells. This would be consistent with data that showed 
commitment to Syndecan1+ plasma cells required 4 to 5 cell divisions after CD40 and IL4 
stimulation, and that subsequent divisions increased the likelihood of commitment 
(Hasbold et al., 2004). Syndecan1+ plasma cells secreted more antibody than Syndecan1- 
counterparts and underwent continued accelerated cell divisions. These findings could 
be explain by an Ikaros control of differentiation, as an Ikaros induced arrest of the cell 
cycle would be expected to prevent differentiation whilst derestricted cell cycle 
progression by disruption/reduction of Ikaros activity would accelerate differentiation 
and thus commitment. It will be important to assess whether Ikaros control of plasma cell 
fate is through such a mechanism. Loading cells with the fluorescent dye 
Carboxyfluorescein succinimidyl ester (CFSE), allows tracking of cell divisions. 
Transduction of CFSE labelled cells and assessment of the ratio of committed to 
uncommitted cells at each division should help determine whether Ikaros alters plasma 
cell commitment though cell division effects. An altered ratio of commitment at each cell 
division would suggest Ikaros control of differentiation beyond cell cycle effects, whereas 
an unaltered ratio would imply the opposite.  
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Chapter 6: General Discussion 
 
The Ikaros family are an enigmatic group of transcription factors which show the ability 
to both positively and negatively regulate gene expression in addition to controlling cell 
cycle progression. The mechanisms underlying the control of these events are still 
unclear. We are beginning to understand some themes of Ikaros activity through the 
analysis of individual target loci. In our previous study, we showed that the Ikaros 
family is involved in regulation of the pre-BCR signalling component Igll1 (Thompson et 
al., 2007). The control here is through competition for binding with the activator EBF, and 
increased expression of Aiolos during development favours repression. We have 
extended these finding here by showing a role for Ikaros in regulation of the Igκ locus 
during early B cell development and while the details of this control are unresolved, it 
seem to function either with or through IRF4. Other groups have shown that loss of 
Ikaros family members results in reduced activation threshold of lymphocyte signalling 
components, and we have extended this by describing a role for Ikaros in regulation of 
plasma cell differentiation of mature B cells. While we show that Ikaros effects at the Igκ 
locus are separate from its influence on cell cycle, further investigation is required to 
determine whether control of plasma cell differentiation is via the cell cycle. The 
suggestion of a bipartite activity of Ikaros at the Igκ locus is supported by the report of a 
similar activity at the Cd4 locus during thymocytes development (Naito et al., 2007). In 
double negative T cells, Ikaros binds the Cd4 silencer within the first intron to repress 
transcription. At the double positive stage, Ikaros complexes with Mi-2β at the locus 
which recruits HATs to antagonise Ikaros activity and promote transcription. Beyond its 
ability to compete for binding sites, Ikaros has been shown to repress transcription 
through modifications of chromatin environment via recruitment of chromatin 
remodelling complexes and perhaps by recruiting target loci to suppressive 
heterochromatic regions. 
The higher order effects of Ikaros remain correlations and we still have no clear 
experimental evidence showing multimerisation and recruitment to heterochromatin to 
be essential for repression. Neither do we have a clear picture of all Ikaros targets during 
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development. The next step in understanding the role of Ikaros will be genome wide 
identification of target sites. We have begun this in our study of differential expression 
when Ikaros activity is impaired by overexpression of Ikaros DN. It will be important to 
complement this with the reciprocal experiment where Ikaros is overexpressed. In 
combination with genome wide Ikaros ChIP experiments, this will allow conformation of 
direct target genes. These experiments could be extended to alternative developmental 
stages and lineages to build a picture of the dynamics of Ikaros activity during 
development. The role of multimerisation and dimerisation in Ikaros control of 
transcriptional activity can be assessed using a similar approach. Overexpression of 
Ikaros mutants where multimerisation or dimerisation is compromised can be analysed 
through expression arrays and genome wide ChIP analysis to determine which genes 
require these aspects of Ikaros activity for regulation. In addition to studying the 
transcriptional activity of Ikaros, a proteomics approach would complement these 
experiments and help identify downstream effects of Ikaros activity. SILAC (Stable 
isotope labelling with amino acids in cell culture) is a proteomics technique which allows 
identification of changes in the protein landscape between two samples (Baek et al., 2008; 
Selbach et al., 2008). Using such a technique in conjunction with gene expression arrays, a 
picture of both the transcriptional events and protein changes resulting from modulation 
of Ikaros activity could be accomplished to help complete our understanding of this 
multifaceted family. 
In addition to the expression and ChIP analysis, a more thorough analysis of Ikaros 
interaction partners is required. Yeast two-hybrid screens and CoIPs have shown Ikaros 
participates in several chromatin remodelling complexes. Immunoprecipitation and mass 
spectrometry could be used to give an unbiased picture of Ikaros interaction partners. 
Such experiments have been performed in VL3 T cell line and multiple interactions were 
observed along with a predominant interactions with the NuRD complex (Sridharan and 
Smale, 2007). Similar experiments in different developmental stages and lineages would 
help build a dynamic picture of how Ikaros activity is controlled during development, so 
that although its expression persists, it can regulate certain loci at particular 
developmental stages. Developmentally regulated control may also be mediated through 
regulated expression of interaction partners or Ikaros family members, as we have 
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previously demonstrated with Ikzf3 expression and downregulation of Igll1 in pre-BII 
cells. Regulation of Ikaros and Ikaros family members also requires further investigation. 
Kaufmann et al., have shown hypersensitive sites and two lineage dependent promoter 
regions in the Ikaros locus, but the regulatory factors which bind these sites await 
identification (Kaufmann et al., 2003). Our own studies and those of the Lu group have 
suggested IRF4 could be involved, if not in Ikaros regulation, then in regulation of Aiolos 
(Thompson et al., 2007; Ma et al., 2008) and future work will need to verify this regulation.  
The development of the Ikaros dominant negative 159A point mutation is extremely 
useful for studying effects of Ikaros activity and provides an alternative to RNAi for 
depleting cells of Ikaros activity. However, simple overexpression of this factor is not 
without drawbacks as the protein heterodimers remain localised to the nucleus where 
unknown interactions could occur, and the dominant negative also blocks the activity of 
Ikaros family members, so that observed effect may not necessarily be specific for Ikaros. 
Thus, while RNAi offers a more precise method for investigating specific Ikaros effects, 
the point mutant allows assessment of the global role of the Ikaros family using well 
established retroviral and transgenic techniques. While the transgenic model system used 
in this study allows study of loss of Ikaros activity, expression is limited to the MZ B cell 
compartment. Development of an inducible Ikaros and Ikaros DN system (along with 
other multimer/dimer mutations) would allow assessment of the role of Ikaros proteins 
at any stage of development. Such a inducible protein could be achieved using the ERt2 
fusion, with expression of the transgene under control of a lymphocyte specific promoter 
such as CD19 for B cell development or Lck for T cell development. An inducible Ikaros 
would also allow a more detailed understanding of the kinetics of gene regulation and 
cell cycle control and will be an essential tool for future studies.  
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Appendix I: Characterisation of pre-B cell cultures 
 
 
 
Figure 7.1 Stage identification of IL7 dependent long term pre-B cell cultures. 
Flow cytometry analysis of d11.5 foetal liver derived kappa-GPF pre-B cultures, adult 
bone marrow derived wild type pre-B cultures and RAG-/- pre-BI and B3 pre-BII cell lines 
for surface expression of CD19 and CD43 and surface and intracellular expression of Igµ. 
The combination of these markers places the Wild type pre-B cell cultures at the pre-BI 
stage and the kappa-GFP+/- cells as a heterogeneous population of pre-BI and pre-BII 
cells. 
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Appendix II: Sequence alignment of Transcript C and D 
with genomic DNA 
 
Features highlighted are: 
RNA adaptor underlined 
Transcriptional start sites (») with underlined bold 
Translational start sites (*) 
Translational stop sites (///) 
GFP coding sequence in italic bold 
A break in the sequence over the 5’κ˚ intron is shown by -/- 
Reverse sequencing primer shown as double underlined in italic bold. 
 
                                  1                                     »5’κ˚     50 
          Genomic Sequence    (1) --------------------------------------GATCCACTTACT 
             Transcript C     (1) CGCGGATCCGAACACTGCGTTTGCTGGCTTTGATGAAG------------ 
             Transcript D     (1) CGCGGATCCGAACACTGCGTTTGCTGGCTTTGATGAAG------------ 
 
                                  51                                             100 
          Genomic Sequence   (13) GTTTTCTCTTTCATGTGAAGTGAAATGGCTGTAGCCTAATGTCCTTCTGA 
             Transcript C    (39) --------TTTCATGTGAAGTGAAATGGCTGTAGCCTAATGCCCTTCTGA 
             Transcript D    (39) -------------------------------------------------- 
 
                                  101                                            150 
          Genomic Sequence   (63) AATCAAGAGACACATCTTCACTTTCCAGACTGGGACCAGACTTTTGTGCC 
             Transcript C    (81) AATCAAGAGATACATCTTCCCTTTCCAGACTGGGACCAGACTTTTGTGCC 
             Transcript D    (39) -------------------------------------------------- 
 
                                  151       ***     ***                          200 
          Genomic Sequence  (113) ACGTTGTGACATGCACACATGCACACACAGGAAAGGACTTGGCTTGTGCC 
             Transcript C   (131) ACGTTGTGACATGCACACATGCACACACAGGAAAGGACTTGGCTTGTGCC 
             Transcript D    (39) -------------------------------------------------- 
 
                                  201                                            250 
          Genomic Sequence  (163) CACATGCCTTTCTTCAGGGACAAGTGGGAATGGACATAAGGAGCGTCTCA 
             Transcript C   (181) CACATGCCTTTCTTCAGGGACAAGTGGGAACGGACATAAGGAGCATCTCA 
             Transcript D    (39) -------------------------------------------------- 
 
                                  251                                          /// 
          Genomic Sequence  (213) TCCTTACGTGGCCTCCTTTGTCTTCCTCCTTCCTGGCCAAGACGGTGATT 
             Transcript C   (231) TCCTTACGTGGCCTCCTTTGTCTTCCTCCTTCCTGGCCAAGACGGTGATT 
             Transcript D    (39) -------------------------------------------------- 
 
                                  301                                            350 
          Genomic Sequence  (263) TACTGCCCAAAGACAAGTCCATCTGAAGCAAGAACTGACTATCGAGGACT 
             Transcript C   (281) TACTGACCAAAGACAAGTCCATCTGAAGCAAGAACTGACTATCGAGGACT 
             Transcript D    (39) -------------------------------------------------- 
 
                                  351       ///                                  400 
          Genomic Sequence  (313) CTGTAGTGACTGATAAACTGGGAAGAGAAAATTGGACCAGAGACTTCAAG 
             Transcript C   (331) CTGTAGTGACTGATAAACTGGGAAGAGAAAATTGGACCAGAAACTTCAAG 
             Transcript D    (39) -------------------------------------------------- 
 
                                  401                                     »3’κ˚  450 
          Genomic Sequence  (363) GCAGCTCTCAGACAAGAATATTCCAGTGCCAGGTAGG-/-CTTCAGTGAG 
             Transcript C   (381) GCAGCTCTCAGACAAGAATATTCCAGTGCCAG------------------ 
             Transcript D    (39) -------------------------------------------------- 
 
                                  451                                            500 
          Genomic Sequence  (413) GAGGGTTTTTGTACAGCCAGACAGTGGAGTACTACCACTGTGGTGGACGT 
             Transcript C   (413) -------------------------------------------------- 
             Transcript D    (39) ----GTTTTTGTACAGCCAGACAGTGGAGTACTACCACTGTGGTGGACGT 
 
                                  501                               ***(GFP)     550 
          Genomic Sequence  (463) TCGGTCGATCGACGCGGCCGCGGGCGCGCAAGAAATGGCTAGCAAAGGAG 
             Transcript C   (413) -------------------------------------------------- 
             Transcript D    (85) TCGGTCGATCGACGCGGCCGCGGGCGCGCAAGAAATGGCTAGCAAAGGAG 
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                                  551                                            600 
          Genomic Sequence  (513) AAGAACTCTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAGATGGTGAT 
             Transcript C   (413) ------------------------------------------ATGGTGAT 
             Transcript D   (135) AAGAACTCTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAGATGGTGAT 
 
                                  601                                            650 
          Genomic Sequence  (563) GTTAACGGCCACAAGTTCTCTGTCAGTGGAGAGGGTGAAGGTGATGCAAC 
             Transcript C   (421) GTTAACGGCCACAAGTTCTCTGTCAGTGGAGAGGGTGAAGGTGATGCAAC 
             Transcript D   (185) GTTAACGGCCACAAGTTCTCTGTCAGTGGAGAGGGTGAAGGTGATGCAAC 
 
                                  651                                            700 
          Genomic Sequence  (613) ATACGGAAAACTTACCCTGAAGTTCATCTGCACTACTGGCAAACTGCCTG 
             Transcript C   (471) ATACGGAAAACTTACCCTGAAGTTCATCTGCACTACTGGCAAACTGCCTG 
             Transcript D   (235) ATACGGAAAACTTACCCTGAAGTTCATCTGCACTACTGGCAAACTGCCTG 
 
                                  701                                     744 
          Genomic Sequence  (663) TTCCATGGCCAACACTAGTCACTACTCTGTGCTATGGTGTTCA 
             Transcript C   (521) TTCCATGGCCAACACTAGTCACTACTCTGTGCTATGGTGTTCA 
             Transcript D   (285) TTCCATGGCCAACACTAGTCACTACTCTGTGCTATGGTGTTCA 
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